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ABSTRACT 
Seth Parker Zimmerman: Motivated by LOV: Design and Application of Optogenetic Tool 
Reveals that Cells Lay Their Own Track During Directed Migration 
(Under the direction of James E. Bear and Brian Kuhlman) 
A cell’s ability to sense a gradient of extracellular cue and move in the direction of the 
gradient is central to many pathological and physiological conditions. For a cell to respond with 
directional migration it must translate the spatial and temporal information from the extracellular 
cue into intracellular signaling and a mechanical output. However, there is a lack of 
methodologies to directly probe these intracellular processes with the spatial and temporal 
precision that is necessary to fully understand how they translate into directed motility. We have 
therefore engineered a light inducible dimer (iLID) that provides spatial and temporal control of 
signaling by modulating protein-protein interactions. iLID was specifically engineered as a 
general use tool to control many aspects of biology. Therefore, we designed and characterized 
multiple variants with a broad range of binding affinities and kinetics. Furthermore, we 
benchmarked our dimer along with other light inducible dimers in the field.  
Rho family GTPases are one of the many downstream intracellular signaling nodes that 
spatially and temporally translate the extracellular cue into cytoskeletal remodeling, producing 
the protrusions and forces necessary for directional motility. Using iLID, we optogenetically 
controlled guanine nucleotide exchange factors (GEFs), specific for Rac or Cdc42. This 
approach allowed us to bypass extracellular signaling events and precisely manipulate localized 
GTPase activity. We first hypothesized and verified that cells expressing either optogenetic 
GEF, plated on fibronectin and exposed to a gradient of light would migrate up the gradient or 
“phototax”. Knowing that signals from integrin based adhesions can also regulate the actin 
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cytoskeleton we were curious if these signals were necessary for phototaxis. We found that 
cells expressing the optogenetic GEF specific for Rac, plated on Poly-L-Lysine (abolishing 
integrin based adhesion) migrate randomly in a gradient of light. We provide evidence that 
integrin based adhesions provide signaling feedback within the optogenetically formed 
protrusions that reinforce the signals necessary for directed migration. Interestingly, we find that 
cells expressing the optogenetic GEF specific for Cdc42 move directionally in a gradient of light 
independent of a fibronectin substrate. Through further optogenetic experiments, we show that 
this is due to a Cdc42 dependent secretion of fibronectin under newly formed protrusions, 
stabilizing the lamellipodia and providing the necessary feedback for directional migration. 
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CHAPTER1: INTRODUCTION 
1.1 Introduction and a brief history of the origin of optogenetics 
With modern genetics, our understanding and ability to probe biological systems has 
greatly expanded. The leaps made in sequencing technology, provided us the blueprints for 
each component of life. Furthermore, current genetic engineering and molecular biology 
approaches allow us to dissect the functions of each component by removing them from the 
system or by slightly altering their blueprint. Optogenetics is a cutting-edge technique that 
empowers the field to go one step further and manipulate individual components within intact 
biological systems, illuminating their spatial and temporal contributions to the system. The 
technique works by targeted expression of genetically encoded light sensitive proteins. With 
laser precision, optogenetics allows researcher to manipulate a protein’s functional state with 
exact spatial and temporal control.  
Optogenetics was initially created and caught traction in the neuroscience field. To 
understand neural computing, the field was challenged to dissect the vast network of neurons 
and link genetically distinct neuron types to specific functions. Before the invention of 
optogenetics, researchers were restricted to electrical stimulation of individual neurons or photo-
uncaging of neurotransmitters. These techniques provided important insights but were limited to 
small numbers and disparate neuron subtypes. With genetically encoded photoreceptors, 
specific neuronal subtypes could be easily targeted. Early attempts to insert light sensitive 
proteins into light insensitive neurons by transgenics proved successful but had limitations that 
prevented broad adoption of the techniques. In 2002 Zemelman et al. successfully reassembled 
the Drosophila eye photosensory proteins in mammalian neurons (1). By expressing Drosophila 
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rhodopsin, β-arrestin 2 and the α subunit of the cognate heterotrimeric G protein in neurons and 
photostimulating, the researchers induced action potentials. Similarly, in 2004 Banghart et. al 
modulated neuronal action potentials with transgenic expression of an engineered K+ channel 
(2). Post-expression, the channel was modified with a chemical gate that could be modulated by 
photo-isomerization. While functional, these methods had drawbacks including the need to 
express multiple components, the addition of an exogenous cofactor, and time scales that were 
too slow to precisely modulate action potentials. These disadvantages inhibited the broad 
application of these techniques. It was not until 2005 when Boyden et. al introduced algal 
channelrhodopsin-2 that the term “optogenetics” was coined (3). Channelrhodopsin-2 consists 
of a light-gated 7-transmembrane channel. Its use requires the expression of a single transgene 
and a cofactor readily available in mammalian cells. Furthermore, the µs kinetics of the protein’s 
state change allowed for the fast activity pulses necessary to regulate action potentials. Due to 
the channel’s optimal excitation wavelength in the blue spectrum, widely available equipment 
used to visualize GFP could be easily adapted for use with the channel. With kinetics that 
matched the needs of neuroscience and their ease of use, channelrhodopsins solidified 
optogenetics as an approach for the field. 
Meanwhile, other fields recognized that optogenetics could be applied to many aspects 
of biological sciences. Like the complex networks of neurons, genetics and cell biology had 
revealed complex networks of intracellular signals and outputs that occurred in all cells and 
regulated every aspect of physiology and homeostasis. The state of the art was to 
pharmacologically inhibit or genetically remove or mutate individual network nodes and measure 
a predetermined output. While these methods provide important insights into signaling networks 
they have significant drawbacks whose effects may confound results. Genetic and 
pharmacological manipulations function on relatively slow time scales (minutes - lifetimes) and 
are difficult or impossible to reverse. The lack of temporal control gives cells an opportunity to 
compensate for the loss or inhibition. The spatial resolution of these techniques is also 
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restricted. Pharmacological inhibition is limited by the distribution of the compound. Genetic 
manipulation can be targeted to specific cell types but cannot be used to manipulate single cell 
or subcellular activity. Furthermore, these techniques mainly work through negative regulation of 
a signaling node. Since optogenetic proteins are genetically encoded and can be manipulated 
with highly focused light sources, the technique provides precise spatial and temporal control at 
the genetic level as well as at the individual and subcellular levels. However, early in the 
development of the technology, optogenetic proteins were restricted to channels. Researchers 
were therefore inspired to return to natural sources to find other light sensitive proteins that 
could be used to manipulate many aspects of biology. 
Throughout the history of life, organisms have evolved many unique methods to sense 
and respond to their environment. From bacteria to animals, each kingdom of life has evolved 
light sensitive proteins to monitor and respond to their surroundings. Many classes of organism 
use light for photosynthesis. To do so efficiently, organisms have evolved light sensitive proteins 
to guide them towards brighter areas; phototaxis in single celled organisms, phototropism in 
plants. While this has been considered a crude form of vision, complex vision in animals often 
relies on multiple proteins, each with a different sensitivity to a particular wavelength of light, 
allowing for colored vision. Furthermore, many organisms evolved light sensitive proteins which 
synchronize their circadian rhythm to the day/night cycle. With such a diversity of functions, 
each protein has a specific structure/function relationship which dictates parameters such as 
cofactor binding, wavelength sensitivity, dynamic range, dynamics, biochemical effect. 
Researchers have begun to exploit the natural variety and even expand upon it through protein 
engineering for optogenetic starting points.  
The study of directional cell motility stands out as a field that could greatly benefit from 
the use of optogenetics. The cells of many organisms, single and multi-cellular, can sense and 
respond to a directional cue. To do so, they must first sense their surroundings with extracellular 
receptors, translate and integrate those senses into an intracellular signal, and finally 
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mechanically respond to move directionally. Each step has a temporal and directional bias to 
move the cell in the intended direction. How and where these signals and outputs are produced, 
integrated and regulated is not well understood, especially in the context of directional migration 
where spatial and temporal patterns are essential. For this reason, the spatial and temporal 
control of optogenetic techniques stands poised for exploitation by the field. Yet, few have 
applied this promising technique to novel questions.  
Below I will review the characteristics of a number of light sensitive proteins and 
domains, their endogenous functions, and how they have been harnessed to manipulate biology 
through optogenetics. In the final portion of this chapter I will review the use of optogenetics to 
study directional cell migration.
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Figure 1.1. Characteristics of photosensitive proteins used for optogenetics
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1.2 Rhodopsins 
Opsin proteins are found in every domain of life. While it is controversial whether 
metazoan and microbial opsins are evolutionarily related, they share structural and functional 
characteristics (4). Both varieties bind a retinal chromophore and depend on its isomerization for 
activity. The chromoproteins are referred to as rhodopsins. Like the microbial rhodopsins used 
in the original optogenetics approaches discussed above, metazoan rhodopsins are formed 
from seven transmembrane helices. However, microbial and metazoan rhodopsins differ in their 
output. While microbial rhodopsins function as light gated ion channels, metazoan rhodopsins 
function as G-protein coupled receptors (GPCR). Both types of rhodopsins depend on an 
isomerization of retinal from 11-cis to all trans upon absorption of a photon for activation. This 
process happens on sub-second timescale with variation between members (3, 5). However, 
microbial rhodopsins have the autonomous ability to reverse isomerization while metazoan 
rhodopsins depend on expulsion of the all trans isoform and binding of a 11-cis cofactor. The 
metazoan reaction also depends on secondary enzymes for reversion of the retinal. The entire 
process is relatively slow so signaling kinetics are also modulated by arrestin protein binding to 
the active rhodopsin (6). In metazoans, rhodopsins are used for diverse physiological roles with 
the most prominent being vision. Other functions include synchronizing the circadian rhythm, 
and coordinating melanin production in the skin (7, 8). To control the diversity of functions, 
evolution has produced a wide variety of rhodopsins that are sensitive to a broad spectrum of 
wavelengths (9). Furthermore, each metazoan rhodopsin interacts with a particular G protein 
family member, allowing for a variety of downstream signaling. Exploiting the diversity of 
rhodopsin family members and downstream targets, researchers have begun to apply these 
proteins outside of their endogenous function and further engineer them to suit their needs.  
In one of the best examples of employing the large diversity of naturally occurring 
rhodopsins to study GPCR signaling, Karunarathne et al. tested several rhodopsins for their 
ability to modulate endogenous G-protein signaling in Hela cells (10). They found that with 
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human blue rhodopsin they could modulate Gi and induce second messenger activation leading 
to PIP3 production. With the other visual rhodopsins they found that each of the wavelengths 
used for microscopic imaging would also activate signaling, making them difficult to control 
experimentally. In parallel they found that human melanopsin can be used to spatially regulate 
Gq signaling and drive localized IP3 production. To target Gs activity, the authors utilized 
jellyfish rhodopsin. However, the authors found that the jellyfish rhodopsin was also activated 
under all imaging conditions. They therefore engineered a chimeric jellyfish/blue rhodopsin 
(CrBlue) to retain Gs signaling while gaining spectral selectivity. This was achieved by 
combining the extracellular and transmembrane portions (retinal binding) of blue rhodopsin with 
the intracellular (G-protein binding) portions of jellyfish rhodopsin. 
Like the jellyfish/blue rhodopsin chimera, Xu et. al soon after engineered a 
rhodopsin/CXCR4 chimera to maintain the Gi signaling that is endogenous to CXCR4 while 
gaining exogenous photoactivation (11). In this study, the authors used their tool to targeted 
directional migration of immune cells. It is known that CXCR4 provides a chemotactic signal to 
T-cells. Therefore, they applied their system to an adoptive transfer technique to direct T-cells to 
the site of a mouse tumor. They found that using this method to increase the overall number of 
T cells in the tumor area improved the adoptive transfer treatment outcome. In this case, the 
spatial and temporal benefit of an optogenetic technique provided the authors with an applied 
targeting scheme that would otherwise be difficult to obtain.  
As discussed in the previous section, microbial rhodopsins have proven extremely useful 
in studying neuroscience. In contrast, metazoan rhodopsins are only beginning to be used in 
other fields to study GPCR signaling. However, this well characterized family of light sensitive 
proteins has many benefits for use in the future and will likely be expanded upon. 
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1.3 Phytochrome 
Phytochromes (Phy) are a class of photoreceptors found in plants and bacteria. In 
concert with other photoreceptors (discussed in later parts of this chapter) Phy is responsible for 
plant morphogenesis. Phy signals are transduced through changes in conformational state. In 
general, the protein consists of two conformers, Pr and Pfr, and are classified based on the 
sensitivity to light (red and far-red respectively). The Pr state is converted to Pfr by red light 
absorption, where Pfr is reverted to Pr by far-red light or time (hours). This conformational 
change is regulated by interactions with a bilin chromophore. Bacteriophytochromes bind 
biliverdin (BV), whereas cyanobacterial and plant Phys bind phycocyanobilin (PCB) and 
phytochromobilin (PφB), respectively (12). In Arabidopsis thaliana, Phys consist of family 
members A through E (13). While there is some redundancy in family member functions, there 
is some variability in absorption spectrum and downstream effectors. The most well studied 
family members, A and B regulate morphogenesis through transcriptional regulation by two 
means; compartmentalization and transcription factor binding. First, the inactive Pr is localized 
to the cytoplasm. Upon light absorption and conformational change it is shuttled to the nucleus 
where it binds to Phy interacting factors (PIF) in a Pfr dependent manner. In the nucleus PIFs 
are constitutively bound to G-box transcriptional promoter elements. Therefore, transcription is 
enhanced by Phy binding. Phys also contain kinase domains and have been verified as active. 
They have been shown to autophosphorylate as well as phosphorylate other ligands such as 
PIF3 (13, 14). However, this kinase activity has yet to be directly linked to any regulatory 
function in plants.  
Due to their ability to form a light dependent heterodimer, Phy and PIFs have been 
modified for use in other organisms. Theoretically, a light induced dimer system could be used 
to manipulate any biochemical event that is regulated by protein-protein interactions. Predating 
much of the work done with channelrhodopsins, Shimizu-Sato et. al used the Phy/PIF 
interaction to regulate transcription in yeast (15). Based on a yeast two-hybrid system, the 
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photosensory domain of PhyB was fused to a GAL4 DNA binding domain and PIF was fused to 
the GAL4 activation domain. In the presence of selective media containing exogenous PCB 
chromophore, the authors found that red light pulses supported growth that could be reversed 
by far-red light. In the first example of using Phy/PIF to modulate mammalian proteins Leung et. 
al dimerized the small rho GTPase, Cdc42, with its effector WASP in a light dependent manner 
(16). They showed that the interaction was sufficient to drive actin polymerization (a known 
effect of WASP activity). Furthermore, they showed that light driven dimerization was sufficient 
to activate WASP even when dimerized with the inactive, GDP bound form of Cdc42. However, 
these experiments were carried out in vitro. One year later the idea was adapted for use in vivo 
by Levskaya et. al (17). The slow kinetics and weak binding of the PhyB/PIF3 demonstrated in 
previous work inspired the authors to optimize the interaction in mammalian cells. By fusing the 
photosensitive domains of PhyA and B to a transmembrane domain as well as a number of PIF 
proteins to fluorescent proteins and expressing them in NIH3T3 cells, the authors were able to 
screen for interactions by assaying for localization of PIF to the membrane upon excitation. For 
these assays to work PCB had to be exogenously supplied. Furthermore, to constrain activity to 
a region within a cell and avoid diffusion of active Pfr, cells had to be completely stimulated by 
far-red light while locally stimulated with red light. The screen identified the PhyB/PIF6 
interaction as having the largest dynamic range, fast kinetics (>10s half-life of activation 
reversion) and reversibility. In a proof-of-principle experiment, the authors used the light 
inducible dimer to localize the active domain of guanidine nucleotide exchange factors (GEFs) 
to the membrane where they activate GTPase signaling. Like what Leung et. al achieved, the 
authors showed that they could modulate actin dynamics but in vivo.  
In 2013 the system was expanded to gain insight into the dynamics of Ras signaling. 
Ras is a small GTPase known to be a central hub of cell signaling. One open question is how a 
single molecule can integrate multiple inputs and translate them into the appropriate output. 
One hypothesis is that the inputs regulate Ras with different kinetics which determine the output 
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pathway. By expanding on the work of Levskaya, Toettcher et. al used Phy/PIF to localize SOS, 
a Ras specific GEF to the membrane and gained control over Ras activity (18). The optogenetic 
approach allowed the authors to test the dynamics hypothesis by stimulating Ras with 
differential spatial and temporal patterns while observing individual cell outputs. They first found 
that Ras acts as a high bandwidth low-pass filter; meaning that any signals with long pulse 
widths (>4 min) stimulated downstream signaling to the same effect while shorter pulse widths 
produced attenuated signals. Second, they found that short signals and long signals activated 
two distinct downstream modules. Lastly, they found that dynamics did not explain the entire 
phenomenon. They hypothesized that under normal signaling conditions, secondary signals 
were integrated with Ras activity to produce differing outputs. Without the optogenetic approach, 
these results would have been difficult to obtain by other methods. 
Beyond the previous study, the Phy/PIF system has not been used to elucidate 
biological phenomenon. This is most likely due to the limitations of the system. The PCB 
cofactor must be supplied during the experiment. Furthermore, while the response to red and 
far-red light can provide precise control, the experimental setup is difficult and requires 
specialized equipment. With that said, the system has been used in biotech for a few 
applications including enhanced viral transduction, and transcription regulation (19, 20). In 
recent years, other light inducible dimers have been engineered that resolve some of the issues 
that restrain Phy/PIF and will be discussed in more detail in the following sections.  
1.4 Cryptochrome 
Cryptopchromes (CRYs) are a blue light photosensitive family of proteins found in a 
diversity of eukaryotic organisms. Due to sequence, structural, and functional similarities, CRY 
is thought to be related to the more ubiquitous photolyase family of proteins. Both protein 
families contain a flavin cofactor as well as a secondary cofactor that varies between members 
(21, 22). Most photolyases contain a nucleotide like secondary cofactor (Flavin Mononucleotide 
(FMN), Flavin Adenine Dinucleotide (FAD), or 8-hydroxydeazaflavin) while cryptochromes 
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contain a 5,10-methenyltetrahydrofolic acid (MTHF). In any case, the secondary cofactor 
dominates the spectral properties of the chromoprotein and is thus designated the antenna 
chromophore. The action of both protein families is enhanced by energy transfer from the 
antenna chromophore to the primary flavin cofactor by fluorescence resonance energy transfer 
and subsequent electron transfer (22). Photolyases and cryptochromes differ in their output 
function. Photolyases use photon energy to repair DNA damage while cryptochromes are 
signaling molecules. Electron transfer through the photolyase primary FAD cofactor directly 
repairs cyclobutane pyrimidine dimer and 6-4 photoproduct DNA damage caused by UV 
irradiation. On the other hand, CRYs signal through light dependent binding interactions. While 
the photocycle for CRY is not fully understood, it is hypothesized that the reduction and 
subsequent protonation of FAD to FADH induces conformational change within the protein and 
transfers its signal through differential binding. This is then quickly reversed by reactive oxygen 
in the environment. Recent work has shown that this conformational change may be aided by 
ATP binding and changing the chemical environment of the FAD (23).  
In animals, cryptochromes synchronize the circadian rhythm. In plants, like 
phytochromes, CRYs regulate many aspects of morphogenesis, as well as circadian rhythm. In 
Arabidopsis thaliana, the two isoforms of CRY (CRY1 and 2) have some overlap in function but 
also regulate distinct pathways. Like phytochrome, CRY’s influence is for the most part 
conveyed through transcriptional regulation (24). Firstly, CRY directly binds to and inhibits the 
E3 ubiquitin ligase complex of COP1/SPA1 in a light dependent manner. Ubiquitination by 
COP1/SPA1 signals for proteasomal degradation. Therefore, its inhibition leads to the 
accumulation of its target, the CO transcription factor. Secondly, CRY2 exhibits light dependent 
binding with E-Box promoter binding proteins called cryptochrome interacting basic-helix-loop-
helix (CIBs). It is unknown how exactly the interaction regulates CIB function, though CIBs have 
been shown to be stabilized under blue light conditions (24).  
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Though little structural information is available about the CRY2/CIB interaction, their light 
dependent dimerization was targeted for use in optogenetics. In 2010, Kennedy et. al used 
Arabidopsis CRY2 and CIB1 to modulate biochemistry in yeast and mammalian cells (25). The 
authors first optimized the system by mapping the necessary parts for light induced 
dimerization. Using a GAL4 based yeast two-hybrid screen like Shimizu-Sato et. al used for 
Phy/PIF, the authors demonstrated differing effects depending on the portions of CRY2 and 
CIB1 that were used. They found that, due to greater expression levels, the Phytochrome 
Homology Region of CRY2 (CRY2PHR) alone produced the largest changes in both the dark 
and light. The authors also found that the CIB N-terminal region (CIBN) was sufficient for CRY 
bunding while the C-terminal basic helix-loop-helix was dispensable for binding activity. 
However, the C-terminal portion of the protein regulates DNA binding and CIB 
heterodimerization and may therefore present advantages in some applications. In a similar 
experimental setup to Levskaya et. al. CRY2/CIB variants were tested in mammalian cells by 
fusing CIBN to a plasma membrane localized tag and expressing a CRY2 fluorescent protein 
fusion in the cytoplasm. Using CIBN, they found that CRY2 and CRY2PHR had similar kinetics 
and dynamic range. They further showed that the popular CRE recombinase genetic tool could 
be manipulated with light through a split CRE system. This work was presented as the first 
optogenetic heterodimer that did not require the cofactor to be supplemented. However, it’s use 
still presented some restrictions. For one, the reversion kinetics were relatively slow ( half-life >5 
min), making it difficult to precisely control subcellular localization as the active dimers could 
diffuse out of the activated region and remain active for some time. Second, CRY2 could only 
have C-terminal protein fusions. And finally, CRY2 was known to homo-oligomerize in a light 
dependent manner. This last restriction may be beneficial in some applications and was in fact 
enhanced and featured in two consecutive publications (26, 27). 
CRY2/CIB1 is the most well used optogenetic dimer to date. This is in part due to its 
robust properties and ease of use. However, in large part, most publications boil down to 
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biotech applications and new pathway manipulations and contain only proof of principal 
experiments. For example, CRY2/CIB1 was used to modulate genome engineering with a split 
Cas9 nuclease (28); optogenetically load exosomes with cargo for protein delivery (29); induce 
apoptosis by recruiting BAX to mitochondria (30); spatially and temporally control actin 
disassembly by recruiting cofilin to actin filaments (31). While these new methodologies may 
prove useful in the future, their creation has yet to provide significant understanding of biological 
phenomenon. 
1.5 Phototropin / LOV domain 
Phototropins are plant blue light photoreceptors found in two isoforms (Phot1 and 
Phot2), each with functional overlap. Originally named for their role in phototropism (growth 
towards light) our understanding of their function has since expanded to include the mediation of 
chloroplast migration, stomatal opening and stem growth (32). The molecular mechanism of 
Phot regulation is not completely understood. However, both isoforms contain two sequential 
light, oxygen voltage (LOV) domains followed by a classic serine/threonine kinase domain. 
Furthermore, studies showed light dependent autophosphorylation of Phot pointing to regulation 
by the LOV domains (32). By expression of individual or tandem LOV domains in E. coli, 
researches also showed stoichiometric binding to a flavin mononucleotide (FMN) chromophore 
(33). Work from Harper et. al and Halavaty et. al provided structural information for both lit and 
dark forms of the Avena sativa (oat) LOV2 domain (34, 35). LOV2 consists of a central Per-
ARNT-Sim (PAS) fold flanked by two helices termed A’α and Jα. In the dark the two helices are 
docked with the PAS fold and bury several hydrophobic residues in the β-sheets of the central 
core. By NMR and X-ray crystallography, both groups found large structural changes upon 
illumination that depended on cysteine 450. They determined that upon illumination C450 forms 
a covalent cysteinyl adduct with the FMN which propagates conformational change through the 
PAS fold and into the A’α and Jα which undergo the largest conformational changes. These 
domain motions expose previously buried residues to solvent. It was proposed that these large 
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changes could be coupled to the kinase domain activity though allosteric interactions or 
autoinhibition. To more fully understand the photocycle of the LOV2 domain, Zayner et. al 
performed mutagenesis studies on the amino acid residues surrounding the chromophore (36). 
The authors found that while certain mutations affected the WT reversion half-life of ~80 s, no 
mutations except the active site cysteine could completely abrogate the photocycle. They 
proposed a model in which return to the ground state was through reduction of the protonated 
FMN by coordinated water molecules. These and other structural and biochemical studies of 
LOV domains have greatly aided their adoption for use in optogenetics. Unlike the other 
domains discussed, which exploit the endogenous functions and interactions of the proteins, the 
structural and biochemical information has allowed scientists to engineer new functions into the 
LOV domain. Three main engineering approaches have been used: direct protein caging, 
functional peptide caging, and engineered light inducible dimerization. Furthermore, its small 
size and ubiquitous cofactor has allowed for broad adoption of the LOV domain’s use. 
Photoactivatable-Rac (PA-Rac) was the first optogenetic use of the LOV domain and a 
major success, paving the way for many future applications (37). Photoactivatible Rac (PA-Rac) 
consists of a constitutively active version of the small GTPase, Rac, with its effector region 
sterically caged by a LOV domain. In tertiary structure, the N-terminus of Rac1 is near the 
effector region of the protein. Therefore, the authors created a variety of LOV-Rac fusions and 
screened them for differences in light and dark activity using an effector of Rac (PAK) to 
pulldown their fusions. After finding a fusion that showed light dependent binding, the authors 
expressed the switch in fibroblasts and found that they could spatially and temporally modulate 
actin dynamics and cell morphology, a known downstream effect of Rac activity. This 
optogenetic switch has since been used to study the role of Rac in physiological circumstances 
such as memory formation and directed migration which will be discussed later (38). 
A second approach to using LOV2 for optogenetics has been its use in caging functional 
peptides. This approach has produced a relatively large number of individual switches. The 
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central idea is to append or chimerize a functional peptide with the Jα so that residues 
necessary for function are buried in the PAS fold and caged in the dark and solvent exposed in 
the light. One of the first examples of this comes from Baarlink et. al (39). The authors caged 
the autoinhibitory peptide of the actin nucleator mDia1 (LOV-DAD). By overexpressing LOV-
DAD in the nucleus they could regulate mDia by competing off the protein’s own autoinhibitory 
domain upon illumination. They showed that mDia nucleated nuclear actin filaments (a 
contentious theory) which regulated serum response factor. Since then other functional peptides 
have been used to modulate processes such as nuclear cytoplasmic compartmentalization (40, 
41), kinase activity (42), and myosin motor activity and cargo loading (43). 
A final approach, which is a central component of this thesis and is discussed in detail in 
later chapters, is engineering the LOV domain to form a light inducible dimer. Like the 
approaches using Phy/PIF and CRY/CIB, a LOV2 based optogenetic dimer can be used as a 
general switch to modulate biochemical pathways regulated by protein-protein interactions. The 
first example of this came in the form of tunable, light-controlled interacting protein tags 
(TULIPs) (44). TULIPs consist of a LOV2 caged PDZ peptide (LOVpep) and a PDZ domain 
binding partner. By applying known mutations to the LOV domain and using an engineered PDZ 
domain with enhanced affinity, the authors tuned the switch’s dynamic range and affinity. Using 
an approach like Levskaya et. al the authors induced subcellular recruitment in mammalian cells 
and controled MAP Kinase activity in yeast. However, even with the modifications, TULIPs are 
restricted by a relatively small dynamic range and affinity. Furthermore, fusions are restricted to 
particular termini. Since its original publication, TULIPs have been used to control molecular 
motor activity (45) and cell motility which will be discussed in the next section.  
The next light inducible dimer, iLID, is discussed in detail in proceeding chapters, as its 
creation and use is the central theme of this thesis. The approach we took is similar to TULIPs 
in that it consists of a LOV2 caged SsrA bacterial peptide and SspB binding partner (46–48). 
However, we have taken great strides to expand the dynamic range of binding and provide a 
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wide range of targeted affinities. We have also carefully compared iLID’s in vitro and in vivo 
properties to that of CRY2/CIB1 and TULIPs (49) 
LOVTRAP, the most recent LOV2 based optogenetic dimer is interesting in that it 
functions in the opposite direction; in the dark the components are dimerized, in the light they 
become monomeric (50). This was achieved by using mRNA display to screen a library of 
domains derived from the Z-domain of protein A that showed enhanced affinity for ground state 
LOV2 over the excited state (Zdk). From the screen, 20 hits were tested by in vivo light 
dependent mitochondrial localization assays. These assays consisted of the LOV domain fused 
to a mitochondrial targeting domain with each Z-domain derivative expressed as a fluorescent 
protein fusion. Cells were then exposed to light while observing Zdk localization. Due to kinetic 
and binding characteristics, three Z-domains were chosen for further application (Zdark; Zdk1, 
2, and 3). These were found to have large dynamic range of binding (26.2 nM in the dark, >4 
µM in the light for Zdk1), fast activation kinetics (seconds) and tunable reversion kinetics using 
known LOV2 mutations. For these reasons this system provides many advantages however it is 
too know if the system will be widely adopted.  
Two central structural themes are pervasive in the engineering of each of these LOV2 
based switches. First of all, in order to obtain a large dynamic range, many switches have 
serendipitously exploited a hydrophobic patch in the PAS fold at the end of the Jα. Switches 
with hydrophobic residues on the Jα or caged protein/peptide that are buried in this region tend 
to have an enhanced dynamic range. It is hypothesized that these interactions stabilize the 
ground state of the LOV domain and enhance caging while maintaining excited state dynamics. 
Second, mutations in the LOV domain that change the kinetics of reversion have been 
applicable to LOV domain based optogenetic switches.  
1.6 Use of optogenetics to study cell motility. 
A cell’s ability to sense a gradient of extracellular cue and move in the direction of the 
gradient is central to many pathological and physiological conditions. For this to occur, cells 
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need to sense the differential cue with receptors, transfer and amplify the signal intracellularly, 
and translate the difference into a biased mechanical output. There are many types of 
directional migration classified by the type of cue the cell is responding too (ex. chemotaxis – 
soluble cue (growth factor), haptotaxis – fixed substrate cue (fibronectin), durotaxis – substrate 
stiffness (bone to flesh transition)). The field is beginning to realize that the biochemical events 
necessary for directional migration to occur are cue dependent, cell type dependent, and often 
redundant. Therefore, to fully grasp the contribution of each biochemical component to 
directional migration, researchers need fine spatial and temporal control of these components to 
probe their local activity. One solution that is gaining popularity is the use of optogenetics. 
Fortunately for cell biologists, many of the tools previously discussed have been adapted to 
manipulate key players in directional migration. 
Two main families of receptors have been implicated in chemotactic sensing; GPCRs 
and receptor tyrosine kinases (RTKs). Many ligands and GPCR pairs, each with its own G 
protein effector and downstream pathway, are used as chemotactic cues in biology. Using the 
approach of Karunarathne et. al researchers can target individual G protein pathways (10). A 
short time after the initial publication. Karunarathne et. al published a follow up paper in which 
they drove localized PIP3 production in immune cells using blue rhodopsin (51). The authors 
found that it was sufficient to induce directed migration. While the involvement of PIP3 in 
immune cell migration had long been realized, they found that their data correlated with a 
switch-like behavior model. In other words, localized PIP3 concentrations had to surpass a 
threshold to initiate migration but once established required significantly less input. Here, 
optogenetics provided a unique ability to spatially and temporally modulate the input to test this 
hypothesis. 
In 2014, Kim et. al capitalized on CRY2’s light dependent oligomerization to cluster the 
receptor tyrosine kinase (RTK), fibroblast growth factor receptor (optoFGFR1) (52). Through 
oligomerization, optoFGFR1 autophosphorylates and signals to downstream pathways such as 
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PI3-Kinase, MAPK and phospholipase C. They found that through biased localized activation 
they could drive cell polarization and directed motility. This expected outcome was studied 
further in a subsequent publication. In 2016, Kim et. al used this same method to study the role 
of Ca+ sparklets in directed migration (53). By spatially modulating RTK signaling while imaging 
calcium transients, they linked RTK effectors to front-back calcium gradients and provided 
evidence for the pathway necessary for strong polarization. In other words, the localized RTK 
signaling induced protrusion in the front and retractions in the back which were mediated by 
Ca+. Furthermore, using PA-Rac the authors demonstrated that inducing Rac activity, a signal 
downstream of RTK was sufficient to drive localized protrusion but did not produce Ca+ 
sparklets or robust rear retraction. This is a strong example of using the available optogenetic 
toolkit to study individual components of a signaling pathway.  
In the previous examples optogenetic approaches were the main technique used in the 
studies. However, as these techniques become more commonplace in laboratories, they are 
beginning to be used to produce supporting data. For example, in a 2016 publication Hayer et. 
al presented non-symmetrical morphological structures (which they termed “cadherin fingers”) in 
a migrating sheet of epithelial cells as a polarity cue (54). To determine if these finger-like 
projections were formed by actin based protrusions or cells contracting the spaces between the 
fingers, they turned to optogenetics. The authors used TULIPs to recruit a Rho GEF (LARG) to 
the membrane to induce myosin contractility downstream of Rho activation. By monitoring local 
morphology of the cell during activation they determined that contractility indeed formed the 
structures.  
We produced a second example of the use of optogetics to support the main data in 
King et. al (55). In this manuscript, we describe the pathway for fibroblast haptotaxis. We 
demonstrate that lamellipodia are necessary for the haptotactic response and that directional 
migration stems from the additive effect of small differences in protrusion up and down a 
gradient of fibronectin. We argue that these small differences are supported by the slight 
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difference in fibronectin density. To support this hypothesis, we turned to the use of iLID to 
activate Rac up and down the gradient by localizing a Rac GEF to two distinct regions of the 
cell. We found that Rac activity produced larger protrusions up the gradient than down the 
gradient, supporting our hypothesis.  
This is just a handful of cases where optogenetics has provided new knowledge about 
the transduction of directional signals during cell migration. However, I believe that we are on 
the brink of an explosion in the use of optogenetics in cell biology, based on the number of new 
techniques being published. Signaling during directed migration has a strong spatial and 
temporal component. Precise control of these components is necessary to properly study the 
phenomenon. Therefore, in the remainder of this thesis I will discuss the creation of the 
improved light inducible dimer (iLID), an expansion of the iLID toolset that allows users to target 
new pathways, an in vitro and in vivo comparison of iLID to other optogenetic dimers, and finally 
the use of iLID to interrogate differences in Rac an Cdc42 signaling during directed cell 
migration.  
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CHAPTER 2: ENGINEERING AN IMPROVED LIGHT-INDUCED DIMER (ILID) FOR 
CONTROLLING THE LOCALIZATION AND ACTIVITY OF SIGNALING PROTEINS1 
2.1 Overview 
The discovery of light inducible protein-protein interactions has allowed for the spatial 
and temporal control of a variety of biological processes. To be effective a photodimerizer 
should have several characteristics: it should show a large change in binding affinity upon light 
stimulation, it should not cross react with other molecules in the cell, and it should be easily 
used in a variety of organisms to recruit proteins of interest to each other. To create a switch 
that meets these criteria we have embedded the bacterial SsrA peptide in the C-terminal helix of 
a naturally occurring photoswitch, the LOV2 domain from Avena sativa. In the dark the SsrA 
peptide is sterically blocked from binding its natural binding partner, SspB. When activated with 
blue light, the C-terminal helix of the LOV2 domain undocks from the protein, allowing the SsrA 
peptide to bind SspB. Without optimization, the switch exhibited a 2-fold change in binding 
affinity for SspB with light stimulation. Here, we describe the use of computational protein 
design, phage display and high throughput binding assays to create an improved light inducible 
dimer (iLID) that changes its affinity for SspB by over 50-fold with light stimulation. A crystal 
structure of iLID shows a critical interaction between the surface of the LOV2 domain and a 
phenylalanine engineered to more tightly pin the SsrA peptide against the LOV2 domain in the 
dark. We demonstrate the functional utility of the switch through light-mediated subcellular 
localization in mammalian cell culture and reversible control of small GTPase signaling. 
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2.2 Introduction 
Inducible protein dimers are complexes that form when a specific stimulus is provided – 
for instance the protein FRB binds to the protein FKBP12 in the presence of rapamycin (1). 
They are powerful research tools because with genetic engineering they can be used to localize 
and activate proteins in living systems (2–5). For example, by fusing one half of an inducible 
dimer to a DNA binding domain and the other half to a transcription activation domain, 
transcription of target genes can be initiated by providing the stimulus that induces dimerization. 
Chemically induced dimers, such as FRB and FKBP12, have been used to control a wide 
variety of biological processes but are limited by irreversibility and lack of spatial control within a 
cell. For this reason, there is strong interest in light-inducible dimers that can be activated in 
specific regions of a cell or an organism using light in a reversible manner. 
Several light-inducible dimers are currently available and have been used to control 
signaling pathways in living cells. In almost all cases, the dimers are derived from naturally 
occurring photoactivable systems. The most widely used pair thus far is cryptochrome 2 (Cry2) 
and CIB1 from Arabidopsis thaliana. The Cry2/CIB1 pair shows blue light induced dimerization 
in both yeast and mammalian cell culture. Association occurs on a sub-second time scale and 
reversion within 10 minutes (4). The mechanism of light-activation is not fully understood and it 
has recently been shown that Cry2 oligomerizes into large clusters under blue light in addition to 
associating with CIB1. This could be a drawback for applications that require precise 
stoichiometry, but the oligomerization itself has been utilized for control of protein activation (6). 
Another dimerization pair is phytochrome B (PhyB) and PIF, also from Arabidopsis thaliana. 
PhyB and PIF interact after irradiation with red light and dissociate with exposure to far-red light 
(3). This system requires a chromophore, phycocyanobilin (PCB), that is not naturally present in 
many organisms, including mammals (7, 8). The tunable light-controlled interacting protein tags 
(TULIPs) make use of the blue light sensing light-oxygen-voltage (LOV) domain and an 
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engineered PDZ domain (9). Sub-cellular localization has been shown with TULIPs in both 
yeast and mammalian cells. However, the presence of a PDZ binding peptide and PDZ domain 
in the system could lead to cross talk with endogenous signaling pathways. The 
FKF1/GIGANTEA (GI) heterodimer pair from Arabidopsis thaliana also relies on a LOV domain 
for light activated binding. This pair dimerizes in response to blue light in mammalian cells, 
associating within a few minutes of activation and dissociating on the order of a few hours (2). 
However, GI is a very large protein and the switching power of the pair is sensitive to expression 
levels.  
An ideal light-inducible dimer would be small and modular, associate quickly in presence 
of signal and quickly dissociate in its absence, and be fully orthogonal to the organisms they are 
to be used in. To fulfill these criteria, we chose to use the LOV2 domain of phototropin 1 from 
Avena sativa as the photoactive element of our light-inducible dimer. In its native setting, the 
AsLOV2 domain senses blue light and activates a C-terminal kinase domain. AsLOV2 can be 
genetically encoded and its chromophore, flavin mononucleotide, is abundant in most 
organisms. It is monomeric in dark state and remains so under activating blue light. The 
structure of AsLOV2 has been determined, making it amenable to structure guided engineering. 
AsLOV2 is made up of a core per-arnt-sim (PAS) fold with flanking α-helicies on the N- and C-
termini (10). Upon blue light irradiation, a conserved cysteine residue in the core of AsLOV2 
becomes covalently bound to the flavin cofactor, structural rearrangement is passed along 
through the PAS fold, and ultimately the flanking helices unfold from the PAS core (11, 12). The 
covalent bond breaks with a half-life of 30-50 seconds, and the helices refold to their dark state 
conformation (13, 14). To reengineer the AsLOV2 domain to be part of a light-inducible 
complex, we incorporated a naturally occurring binding element within the protein; 7 residues of 
the E. coli SsrA peptide that bind SspB, a 13kD adaptor protein also from E. coli.  Both SsrA 
and SspB have been structurally characterized and the SsrA peptide shares sequence identity 
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with the Jα helix of AsLOV2 (15–17). We previously showed that incorporation of SsrA into the 
Jα helix of AsLOV2 led to steric occlusion of SspB binding in the dark and uncaging with blue 
light irradiation, yielding a light-inducible heterodimer pair (18). Our original light inducible dimer 
(oLID), while containing some of the characteristics desirable for a versatile tool, did not show 
large changes in binding affinity with light stimulation. Original fusions of AsLOV2 and SsrA 
yielded a two-fold change in affinity for SspB. This was improved to an eight-fold switch by 
incorporating mutations known to stabilize the Jα helix in the dark as well as including a C-
terminal phenylalanine predicted by molecular modeling to further hold the Jα helix against the 
PAS domain in the dark. However, even in its final form, dimerization in the dark at moderate 
protein concentrations prevented large light induced phenotypic changes in vivo.  
In order to create a generalizable, versatile, and more powerful light-inducible dimer, we 
sought to improve oLID with a novel combination of computational library design and phage 
display screening. Using the Rosetta macromolecular software suite, we ranked point mutations 
within AsLOV2 and created a library of mutations with the goal of improving the dynamic range 
of oLID, specifically reducing dark state binding. We then used phage display and ELISA-based 
binding assays to screen for mutations that both weakened dark state binding and responded to 
light activation.  Here, we describe two improved light-inducible (iLID) pairs that we identified 
with this approach, iLID nano, which switches from 130 nM under blue light to 4.7 µM in the 
dark, and iLID micro, which switches from 800 nM under blue light to 47 µM in the dark. iLID 
nano and iLID micro both co-localize under blue light within seconds, revert to dark state within 
minutes, and can be activated sub-cellularly in mammalian cell culture. To demonstrate 
functional utility in cells, we show light-dependent control of GTPase activity and the 
cytoskeleton through localization of the DH/PH domains of ITSN and Tiam1.  
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2.3 Results 
Computational library screened by phage display and protein ELISA. In our original 
light-inducible dimer (oLID) there was appreciable binding in the dark, ~800 nM. Previous 
studies suggest that a major source of dark state “leakiness” comes from transient undocking 
and unfolding of AsLOV2’s Jα-helix, and mutations that increase the intrinsic stability of the Jα 
helix have proven successful in reducing dark state activity of light-activated AsLOV2 switches (9, 
19). We sought to extend this approach and use molecular modeling combined with high-
throughput screening to find mutations throughout the domain that stabilize the docked state of 
the Jα-helix. The pmut_scan protocol in Rosetta (20) was used to model and score all possible 
point mutations within 6 Å of the Jα helix using the crystal structure of AsLOV2 in its dark state 
(PDB: 2v0u). All mutations that were predicted to be stabilizing or neutral (within 1 kcal / mole of 
the wild type residue) were considered potential mutations that might stabilize the dark state 
and were used as the basis for creating a directed library. The final point mutant library 
consisted of 743 mutations at 49 positions (SI Appendix, Table 2.4), and used the oLID 
sequence as the starting sequence (Fig. 2.1A).  
The oLID library was fused with the phage pIII coat protein and an N-terminal Tat (twin-
arginine translocation) secretion sequence for display on the surface of phage (21). The Tat 
secretion pathway was used because it maintains proteins in the folded state during secretion, 
which allows them to remain bound to cofactors. In this case this was critical, as FMN binding is 
needed for LOV domain activity (Fig. 2.11B, SI Appendix, Fig. 2.14). We screened the library by 
rounds of positive and negative selection; binding under blue light to immobilized MBP-SspB 
and subsequent elution in the dark (Fig. 2.1C). After 4 rounds of lit and dark screening, 
individual sequences were tested by soluble protein ELISA (Fig. 2.1D). We ranked mutations by 
change in dynamic range, defined as ELISA signal under blue light/ELISA signal in darkness. 
Single point mutant LOV variants had minimal improvement to overall switching. The top 
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mutations were pooled and recombined with each other to yield a recombined library. Screening 
of the recombined library was repeated as before (Fig. 2.1E). The top 60 sequences had 
dynamic ranges ranging from 2.4 to 35.4 (SI Appendix, Fig.2.10). Four sequences with the 
highest dynamic ranges were chosen for further characterization (SI Appendix, Fig. 2.7).  
In vitro Characterization. We measured the binding affinity of our four top sequences 
for SspB in the dark and after irradiation with blue light using a competitive fluorescence 
polarization binding assay. All four had improved dynamic ranges compared to the parent clone 
oLID (Fig. 2.2A,B) and switched roughly over the same affinity range, ~100nM to <5μM (SI 
Appendix, Fig. 2.7). Clones D5 and F2 had the highest dynamic range of the clones tested, 43-
fold and 36-fold changes respectively. D5 switched from 77 nM under blue light to 3.4 μM in the 
dark and F2 switched from 132 nM under blue light to 4.7 μM in the dark. As dark state activity 
can be the limiting factor in the usefulness of light-inducible tools, we chose to move forward 
with clone F2, naming it our improved Light Inducible Dimer, iLID (Fig. 2.2C,E)  
The concentration threshold required for activity varies for different signaling proteins 
within a cell. Having tools that switch over different ranges of affinities may allow a wider range 
of targets to be controlled. In order to create an alternate affinity range for iLID as well as retain 
our improved switching, we made a point mutant, R73Q to SspB, reducing the peptide/protein 
affinity to 900 nM (SI Appendix, Fig. 2.8). In the context of SspB R73Q, iLID has an affinity of 
800 nM for SspB R73Q under blue light and a dark state affinity of 47 μM, which is a 58-fold 
change in binding affinity (Fig. 2.2D). Thus, two sets of tools are available for light-inducible 
heterodimerization, iLID nano (makes use of WT SspB) and iLID micro (makes use of SspB 
R73Q). Comparisons of the affinity ranges of these tools to their predecessors can be seen in 
Fig. 2.2F.  
Structural Characterization of iLID. iLID contains 10 mutations when compared to 
oLID. Four of the mutations are clustered in the hinge loop that connects the PAS domain to the 
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Jα helix, four are located in the Jα helix, and two are in the PAS domain. To investigate how 
these mutations are improving the dynamic range of the switch, we solved the crystal structure 
of iLID in its dark state to a resolution of 2.05 Å (Fig. 2.3). In general, there are very few 
structural perturbations when comparing iLID to AsLOV2. Within the core PAS domain (residues 
413-516), the Cα RMSD between iLID and AsLOV2 is 0.42 Å, and the hinge loop showed 
almost no movement in the protein backbone (0.23 Å Cα RMSD)(Fig. 2.3B). Several of the side 
chains in the hinge region are forming interactions that may be important for the stabilizing the 
dark state of the switch. R519 is packed against W491 from the PAS domain. The isoleucine 
replacing valine 520 is buried against sidechains from the Jα helix and the PAS domain and 
packs against a valine at position 493 that is a leucine in AsLOV2. The last residue in the hinge, 
position 522, is an aspartic acid in AsLOV2 and a glycine in iLID. This is the last residue before 
the Jα helix and has a positive phi angle, phi = 49.0°, psi = -126°. Aspartic acids are observed in 
this region of the ramachandran plot, but glycine is by far the most common amino acid in this 
region of the plot. In a set of high-resolution crystal structure, 47% of the residues with phi near 
50° and psi near -130° are glycine, while only 7% are aspartic acids. This suggests that there 
may be some strain that is relieved when the aspartic acid is mutated to a glycine.  
The largest conformational change in the iLID structure was in the N-terminal residues 
and the A'α helix. The first two resolved residues, T406 and T407, point toward the Jα helix 
instead of the Dα helix as in AsLOV2 and the A'α helix is shifted by 3 Å (Fig. 2.3C). A smaller, 
~1 Å movement, is seen in the last 12 residues of the Jα helix toward the A'α helix, allowing for 
tighter packing between the two. The slight unwinding of the A'α helix allows for the terminal 
nitrogen of the helix to be capped by E546 of the SsrA sequence. Additionally, the side chain of 
E409 forms a hydrogen bond with the tyrosine from the SsrA sequence.  
Finally, the structure of iLID revealed the location and conformation of the caged SsrA 
peptide. The designed C-terminal phenylalanine, F549 fits into a hydrophobic pocket on the 
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surface of the PAS domain made up of I417, I428, F429 and Y508 (Fig. 2.3D). SsrA makes 
three hydrogen bonds with the rest of the LOV domain, all within the A'α helix. The carboxyl 
group of D545 interacts with the hydroxyl of T406, the carboxyl group of E546 with the 
backbone amide of L407, and the hydroxyl of Y548 with the carboxyl of E409. In comparison 
with AsLOV2, F549 occupies the same area as the C-terminal L546. Due to extra residues in 
iLID, the last turn of the Jα helix buckles out and wraps back in to make this placement of F549 
possible. iLID atomic coordinates and structure factors have been deposited to the Protein Data 
Bank (PDB ID code 4WF0).   
Reversion and paired down iLID. Based on the structure of iLID, we chose 6 mutations 
to revert to determine their role or necessity in the improved switching of iLID (SI Appendix, Fig. 
2.9, 2.10, Table 2.2). Reversion of R519 and D522, led to a lower dynamic range and weaker 
caging, which is apparent as tighter affinities under blue light and in the dark. Removal of F537 
had a similar effect on dynamic range, but weakened blue-light and dark state affinities for SspB 
to the micromolar range. The remaining three reversions, Y502Q, H521R, and C530M, had little 
effect on the dynamic range. The double reversion mutant Y502Q/H521R, binds about 3 fold 
tighter in both states. In addition to keeping the improved dynamic range, C530M has very little 
effect on the affinity range or reversion kinetics of the switch and can be removed without 
consequence (SI Appendix, Fig. 2.13). 
Subcellular recruitment. As oLID was previously untested in mammalian cell culture, 
we were interested in how well it would function and if the improvements of iLID, measured in 
vitro, would be apparent in cells. To test LID function in cells, we designed constructs by fusing 
the LIDs to the yellow fluorescent protein, Venus, and a well-characterized peptide sequence 
that would anchor the protein to specific subcellular localizations (CAAX = Cell Membrane, Mito 
= Mitochondria). Further, SspB (Nano) and SspB R73Q (Micro) were fused to the red 
fluorescent protein, TagRFP-T (22). IA32 mouse fibroblasts (23) transiently expressing the LID 
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protein pairs were imaged using a confocal microscope and activated with a 488 nm laser. To 
assay whole cell activation, cells expressing TagRFP-T-SspB and the Mito anchored LID pairs 
were imaged during a time course of intermittent whole cell 488 nm light stimulation. Cells 
expressing each pair of switches showed rapid recruitment of TagRFP-T to the mitochondria 
during stimulation followed by dissociation into the cytoplasm with the removal of stimulus (Fig. 
2.4A top row). Recruitment for each pair was quantified and compared between switches by 
measuring the ratio of Mitochondrial/Cytoplasmic TagRFP-T fluorescence intensity throughout 
time (Fig. 2.4B). To prevent bias, mitochondrial and cytoplasmic regions of interest (ROIs) were 
automatically identified for each frame using the Venus channel and the default Threshold 
function in FIJI software. The recruitment phase was fit to a single phase exponential and we 
determined that the iLID/Nano and iLID/Micro pairs showed a 4.4 and 4.3 fold change in 
comparison to a 2.4 fold change seen for oLID/Nano in this assay; each with a half-life < 30 s. 
Further, we hypothesized that the ratio of Mitochondrial/Cytoplasmic TagRFP-T fluorescence in 
the dark state would be representative of the dark state binding affinities observed in vitro. As 
expected, the iLID/Nano dark state ratio is higher than the ratio for iLID/Micro. However, while 
the in vitro evidence would suggest that oLID/Nano would have the tightest binding affinity in the 
dark, their dark state Mitochondrial/Cytoplasmic TagRFP-T fluorescence ratio is the lowest.  
To test if the LID proteins could be used to recruit protein to a subcellular localization 
based on a region of interest (ROI), the CAAX fused LID pairs were expressed and imaged in 
fibroblasts (Fig. 2.4A bottom row). The optical sections obtained using the confocal were thick 
enough to capture light emitted from both apical and basal membrane bound proteins. This 
allowed us to stimulate a region of interest on these membranes and image the re-localization of 
TagRFP-T to these regions of the cell. Again, we imaged cells with intermittent stimulation at a 
ROI. During stimulation the TagRFP-T signal increased within the ROI while diminished outside 
the ROI. From this assay it is difficult to determine differences in dark state binding as we do not 
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know what portion of TagRFP-T-SspB is membrane bound versus cytoplasmic. However, by 
quantifying the TagRFP-T fluorescence intensity in a relatively small ROI (260 um2) the 
cytoplasmic concentration of TagRFP-T-SspB should remain constant before and after 488 nm 
light stimulation. Therefore by calculating pre:post stimulation ratio of TagRFP-T fluorescence 
intensity within the ROI we determined the relative fold change of binding in the light and dark. 
These values correlate with in vitro measured dynamic ranges (SI Appendix, Fig. S7). These 
experiments led us to realize that by anchoring the switching half of the dimer pair we obtained 
a relatively tight spatial resolution of activation. Combined with the minute time scales of 
association and dissociation we were able to exemplify these attributes of the switch by 
sequentially writing the letters i,L,I, and D on the membrane of a cell (Fig. 2.4C). 
Light induced GTPase signaling through GEF localization. One area of interest for 
the use of light-inducible dimers is to control and study cell signaling. The Rho family of small 
GTPases (consisting of RhoA, Rac1, and Cdc42) are signaling proteins involved in many 
aspects of cell physiology including actin cytoskeleton remodeling. In general GTPase signaling 
is considered active when the GTPase is bound to GTP and inactive after the GTPase 
hydrolyzes GTP to GDP. Canonically, active Rac1 leads to branched actin formation and 
lamellipodial morphology; active Cdc42 leads to bundled actin and filopodial morphology; and 
active RhoA leads to bundled actin and actin stress fiber formation. Other groups have found 
that small GTPases can be controlled through the localization of guanine nucleotide exchange 
factor (GEF) Dbl homology (DH) / pleckstrin-homology(PH) domains to the membrane (3, 24). 
At the membrane the DH/PH domains are colocalized with GTPases where they can aid in 
exchange of GDP for GTP, activating the GTPases. We hypothesized that the LID switches 
could be used to locally activate GTPase signaling, leading to a change in actin dynamics and a 
visible change in cell morphology (SI Appendix, Fig. 2.12A). Therefore we fused the DH/PH 
domains of Intersectin (ITSN, Cdc42 GEF) and Tiam1 (Rac GEF) to the N-terminus of the 
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TagRFP-T-SspB constructs (SI Appendix, Fig. S8B). Fibroblasts were transiently transfected 
with each construct in combination with Venus-iLID-CAAX using a 1:1 ratio of DNA.  As each 
construct is under the control of a CMV promoter we expect that on average each construct is 
expressed at equal levels. Two days later the cells were imaged and stimulated in a similar 
manner to the spot stimulation previously described. Here, stimulated areas were at the edge of 
the cell. As expected, the cells expressing the Tiam1 fusions, within minutes of stimulation, 
began to ruffle and formed a lamellipodia at the site of recruitment (Fig. 2.5A). Surprisingly, the 
cells expressing the ITSN fusions displayed a similar phenotype in the area of stimulation (Fig. 
2.5B). While we would expect a filopodial morphology to form, our results may be explained in 
two ways; crosstalk between GTPase pathways that leads to an increase in Rac GTPase 
signaling or a direct catalytic effect on a Rac GTPase such as RhoG from the ITSN DH/PH (25, 
26). In addition to forming lamellipodia, most cells displayed increased appearance of vesicles 
in the stimulated area consistent with the role of Cdc42 in endocytosis (Fig. 2.5B arrowheads).  
 
2.4 Discussion 
A novel aspect of our study was the use of high throughput screening and selection to 
improve the dynamic range of a photoactivatable protein switch. A specific challenge of 
engineering a switch is that the selection protocol should be sensitive to protein activity in both 
the on and off state. In our case, it was critical that the LOV domain be presented on the surface 
of the phage in a functional form. In phage display it is common to use signal sequences that 
direct a protein to the Sec-mediated translocation pathway, which transports proteins through 
membranes in an unfolded state. This was not appropriate for our application because we 
needed the LOV domain to remain folded during translocation so that it would remain bound to 
the flavin cofactor. Therefore, we made use of the Tat- secretion pathway that maintains 
proteins in a folded and cofactor-bound state during secretion. Once the LOV domain was on 
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the surface of phage, we were able to find functional switches by selecting for binding under 
blue light, and then collecting phage that unbound when the light was turned off. The phage 
protocol was useful as a first filter in the search for better switches, but explicit screening in the 
light and dark with the ELISA-based binding assay allowed us to identify the top performing 
variants. The ELISA assay was particularly informative because the binding properties of single 
variants could be characterized side-by-side in the light and dark. This allowed us to detect 
small improvements in switching, which allowed us to select variants to include in the 
recombination library.  
In creating the directed library we used molecular modeling to find mutations predicted to 
be compatible with the dark state of the switch. We used this approach because we were 
interested in stabilizing the closed state of the switch. Ideally modeling would be used to find 
mutations that are compatible with the dark and lit state. This was not possible because there is 
not detailed structural information about what happens to the PAS domain when it is 
photoactivated. It is informative to see where the final mutations were located in iLID. The 
cluster of mutations in the hinge loop indicates that it has an important role in the docking and 
undocking of the Jα helix. In a multiple sequence alignment of the LOV domain, there is 
variability in the hinge loop suggesting that LOV-domain homologs may have different switching 
properties. 
Previous studies have highlighted the role of the A'α helix in stabilizing the docked state 
of the Jα helix in the dark and releasing it in the light (12).  In the iLID structure the A'α helix 
rearranges to form several contacts with the Jα helix and the embedded SsrA sequence. 
Interestingly, the alternate conformation of the A'α helix is almost identical to that of the A'α helix 
of PA-Rac1, another photoactivatable switch based on the AsLOV2 domain (Fig. 3C).  A shared 
feature of the iLID and PA-Rac1 structures is the capping of the A'α helix. In the AsLOV2 
structure, the A'α helix is capped by a water molecule, however in iLID, the carboxyl group of 
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E546 in SsrA caps the helix and in PA-Rac1 it is capped by the carbonyl group of N595 in Rac1. 
These capping interactions in Pa-Rac1 and iLID may enhance cooperativity between folding of 
the A'α helix and caging, and therefore lead to effective switching.  
Our goal in creating iLIDs was to create a genetic tool for studying biochemical and 
cellular processes. We showed that both iLID pairs can be used in mammalian cell culture to 
form dimers and recruit fusion proteins to sub-cellular structures. Furthermore, the differing 
affinity ranges of iLID nano and iLID micro measured in vitro, translate to different in cell 
characteristics, and can be used accordingly. We postulate that this inherent tuneability of the 
switch will lead to use in a broader spectrum of applications. Here, we were able to control local 
GTPase activity by driving GEF DH/PH domains to a localized spot on the membrane and we 
expect that the small, modular nature of iLID nano/micro will open up control of a much wider 
variety of cellular targets.   
 
2.5 Materials and Methods 
Design and Construction of Computationally Directed Library. Rosetta’s pmut_scan 
protocol was used to predict stability of all possible AsLOV2 point mutations. Stabilizing and 
mildly destabilizing mutations were filtered for proximity to the Jα helix and a library of single 
point mutations was generated using a comprehensive mutagenesis protocol (27).  The 
recombined point mutant library was generated using a gene assembly protocol with 
oligonucleotides encoding for the top mutations suggested by ELISA ranking. See SI Methods 
for details. 
Phage Display Selection and Ranking by Soluble Protein ELISA. The AsLOV2 
library was cloned as a fusion with phage pIII coat protein and the Tat secretion sequence. 
Phage expressing the library was added to plates coated with MBP-SspB and placed under blue 
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light, left for 1 hour, washed, and moved to the dark. After 10 minutes in the dark, the eluted 
phage was collected, propagated, and quantified (28). Four rounds of positive and negative 
selection were performed before cloning into a modified pET-21b vector with an N-terminal 
FLAG tag. Overnight cultures were lysed and added to plates with immobilized MBP-SspB 
under blue light and in the dark. ELISA signal to anti-FLAG antibody was detected via ECL 
reagent. See SI Methods for details. 
Growth and Purification of Recombinant Proteins. Purified proteins were prepared 
as previously published (18). See SI Methods for details. 
Fluorescence Polarization Binding Assays. Binding assays were performed as 
previously described (18). See SI Methods for details. All measured affinities can be found in SI 
Appendix, Table 2.1-3. 
Crystallization and Structural Determination of iLID. Initial crystals of iLID were 
grown using hanging drop vapor diffusion with 800 mM lithium chloride, 100 mM TRIS:HCl pH 
8.5, 32% PEG 4000. Crystals were optimized with microseeding and grew to full size within 3 
days. X-ray diffraction data was collected at Southeast Regional Collaborative Access Team 
(SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. The 
structure was determined using molecular replacement with PDB ID 2v0u. See SI Methods for 
details.  
Mammalian Cell Culture and Transfection. IA32 mouse fibroblast cells were cultured 
at 37° C and 5% CO2 in DMEM supplemented with 10% FBS (HyClone), 100U/ml penicillin, 100 
μg/ml streptomycin and 292 μg/ml L-glutamine. Cells were transiently transfected using 
NanoJuice (EMD Millipore) as recommended by manufacturer. 
Mammalian Cell Localization/GEF Microscopy and Image Analysis. Fibroblasts 
were transfected with two vectors containing each component of the switch in equal amounts.  
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Two days later, cells were imaged and photo-activated with an Olympus FluoView FV1000 
scanning confocal inverted microscope equipped with a 1.30 N.A. 40 x oil immersion objective. 
Images were analyzed using FIJI software (29). See SI Methods for details. 
Cloning and Vector Information.  See SI Methods for details and SI Appendix, Table 
2.6. for a list of constructs and corresponding Add Gene numbers. 
Design and Construction of Computationally Directed Library.  The pmut_scan 
protocol in the Rosetta molecular modeling suite was used to evaluate all possible point 
mutations in AsLOV2 (PDB: 2v0u). The set of all possible point mutations was filtered to include 
only mutations that decreased the Rosetta score or increased it by less than 1 REU (Rosetta 
Energy Unit). For a few positions on the PAS β sheet mutations with ΔΔG’s of +2 REU’s were 
allowed.  The list was then filtered to only include mutations that were within 6Å of the Jα helix. 
The resulting library contained 743 mutations at 49 positions (additional mutations were allowed 
due to degenerate primer design).  The Rosetta-biased point-mutant library was constructed 
using a comprehensive mutagenesis protocol (1).  Mutagenic oligos with degenerate codons 
flanked by 15-18 bases were pooled. 200 picomoles of the oligo pool were incubated with 20 
units of T4 Polynucleotide kinase (NEB) for 1 hour at 37°C in the presence of 1x T4 PNK buffer.  
The enzyme was heat-inactivated at 65°C for 20 minutes.  Single-stranded template uracil-DNA 
encoding TorA-LovSsrA-pIII_C-terminal domain was amplified and purified as described (2). 
One microgram of template DNA (0.75 picomoles) were combined with 2-fold excess 5’-
phosphorylated oligo pool.  Template-oligo annealing followed by polymerase extension and 
ligation of the mutagenic strand was performed as described (1).  Template DNA was degraded 
with 5 units of Uracil DNA Glycosylase (NEB) and 2 units of Exonuclease III (NEB) before 
desalting and electroporation into SS320 cells.  The experimental library size was 5 x 107, which 
most likely samples all possible point-mutants and a large fraction of double-mutants. 
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Construction of the shuffled library. Mutagenic oligos encoding substitutions 
suggested by the primary ELISA screens of the point-mutant library were pooled and assembled 
using a gene-assembly protocol.  Gene-SOE PCR was performed with Q5 DNA Polymerase 
(NEB), 1 μM total oligo (31 total oligos) and the following cycling conditions: 20 cycles of (98°C 
10s, 52°C 30s, 72°C 10s) in 50 μL.  One μL of the assembled product was PCR-amplified using 
outside primers for restriction cloning. Two μg’s of linearized and gel purified pFNOM6-tat-pIII 
plasmid was ligated to 1 μg of shuffled-lovssrA library insert (4:1 insert:vector ratio).  Ligated 
DNA was ethanol precipitated and electroporated into SS320 cells.  The number of total 
transformants was 2 x 108, which partially covers the designed sequence space (1.2 x 108). 
Phage Display Selection Against SspB.  The LOV library was expressed as an N-
terminal fusion of the phage pIII coat protein using the tat secretion pathway as export via the 
DsbA signal peptide pathway was not possible (Fig. S10). All libraries were subjected to four 
rounds of panning prior to ELISA screening.  Maxisorp 96-well plates were coated overnight at 
4°C with 100 μg/mL of 5 micrograms/mL His-MBP-SspB fusion in the presence of 50 mM 
sodium bicarbonate pH 9.6 buffer.  Coated wells were washed with PBS-0.1% (v/v) Tween 
(PBST) and blocked at room temperature for 2 hours with 200 μL of PBST-BSA (5 mg/mL).  
Blocked wells are washed with PBST and incubated with 1011 – 1012 library phages for 1 hour 
under a collimated blue LED array (1.2 mW*cm-2  at 450nm).  Wells were washed 10-times with 
PBST while keeping the plate under blue light.  Plates were moved into dark and incubated in 
the dark for 10 minutes.  Dissociating phages were collected with PBST buffer.  Early log SS320 
cells (OD600: 0.2-0.5) were infected with eluted phage and infected cells were grown in 25 mL 
2xTY media supplemented with 100 μg/mL of ampicillin.  When cells reach early log phase, 
M13KO7 helper phage was added with 20:1 multiplicity of infection.  Following a 20-minute 
incubation at 37°C without shaking, 0.1 mM IPTG and 5 μM flavin mononucleotide (FMN) were 
added and the culture was moved to a 30°C shaker covered with foil to ensure dark conditions.  
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After 1.5 hour, kanamycin was added to 25 μg/mL and the culture was grown overnight.  The 
following day, the phage was PEG-precipitated and quantified using A268 values (2). Gene pool 
post-Round-4 selection was PCR amplified and cloned into a previously modified pET21b vector 
that introduces an N-terminal FLAG epitope.  The ligation reaction was directly transformed into 
BL21(DE3)pLysS cells for protein expression and ELISA screening.  
Fasta of Tat-oLID-p3 
>MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAGSGEFLATTLERIEKNFVITDPRL
PDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQ 
LINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVRDAAEREAVMLIKKTAEEI 
DEAANDENYFSGLESRGPFSGDFDYEKMANANKGAMTENADENALQSDAKGKLDSVATDYG
AAIDGFIGDVSGLANGNGATGDFAGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPFV
FSAGKPYEFSIDCDKINLFRGVFAFLLYVATFMYVFSTFANILRNKES 
Fasta of DsbA-oLID-p3 
>MKKIWLALAGLVLAFSASAAELAAAGSGEFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTE
YSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQK
GDVQYFIGVQLDGTEHVRDAAEREAVMLIKKTAEEIDEAANDENYFLESRGPFEGKPIPNPLLG
LDSTRPFVCEYQGQSSDLPQPPVNAGGGSGGGSGGGSEGGGSEGGGSEGGGSEGGGSGG
GSGSGDFDYEKMANANKGAMTENADENALQSDAKGKLDSVATDYGAAIDGFIGDVSGLANGN
GATGDFAGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPFVFSAGKPYEFSIDCDKIN
LFRGVFAFLLYVATFMYVFSTFANILRNKES 
Photoswitch Evaluation by Soluble Protein ELISA.  BL21(DE3)pLysS cells carrying 
pET21b_FLAG_LovssrA clones were plated on LB/Amp plates.  Next day, 96-well growth blocks 
containing 500 μL LB medium supplemented with 25 μg/mL chloramphenicol, 100 μg/mL 
41 
 
ampicillin, and 0.6 mM IPTG were inoculated with individual colonies and grown overnight in the 
dark at 30°C.  One well per plate was reserved for the parent for comparison.  200 μl of cells 
were lysed in the dark with 10 μl Popculture reagent and 1 unit of Benzonase nuclease for 15 
minutes.  Lysates were centrifuged and supernatant diluted 5-10 fold in PBST with 1mM DTT 
was used for the assays.  Duplicate Maxisorp plates (96-well or 384-well) were coated with His-
MBP-SspB as described above.  Plates were blocked with PBS-3% (m/v) BSA and incubated 
with the lysate supernatant for 1 hour in the dark and under blue-light (1.2 mW*cm-2  at 450nm, 
collimated blue LED array).  Plates were washed 5 times with PBST and incubated for 30 
minutes with 1:20,000 diluted anti-FLAG antibody HRP conjugate (Sigma A8592). Plates were 
washed 3 times with PBST and twice with PBS.  100 μl TMB was added and color was 
developed for 15 minutes.  The reaction was quenched with 100 μl 0.5 M sulfuric acid before 
measuring A450.  LovssrA variants for the positive clones were PCR amplified using 4 μl cells as 
template and sequenced. 
Growth and Purification of Recombinant Proteins.  All expressed and purified 
proteins were cloned into the pQE-80L protein expression vector.  All LOV clones contained an 
N-terminal 6x(His) tag and SspB clones contained an N-terminal 6x(His)-MBP-TEV site tag.  
Sequence-verified clones were transformed into BL21(DE3)pLysS E.Coli cells.  Cultures were 
grown to an OD of 0.6 at 37°C, then induced with 333 mM IPTG and moved to 18°C for 16 
hours.  Cell pellets were resuspended in loading buffer (50 mM sodium phosphate pH 7.5, 500 
mM NaCl, 20 mM Imidazole, 100 μM PMSF).  Resuspended cells were sonicated and lysate 
spun down for 30 minutes at 20,000 rpm.  Proteins of interest were isolated via Ni2+ affinity 
chromatography using HisTrap HP columns (GE), and eluted with elution buffer (50mM 
phosphate pH 7.5, 500 mM NaCl, and 500 mM imidazole).  Proteins expressed as MBP fusions 
were then cut with TEV, dialyzed overnight into loading buffer, and re-run over the HisTrap HP 
column, collecting the tag-less protein.  Finally, size exclusion chromatography with a Superdex 
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75 column (GE) was used for a final cleanup step and buffer exchange to final binding buffer, 
PBS (10 mM dibasic sodium phosphate, 1.8 mM monobasic potassium phosphate, 137 mM 
NaCl, 2.7 mM KCl).  Protein concentration was determined via BCA protein assay (Pierce).  
Expression (E.coli & mammalian) constructs of iLID and SspB variants used can be found in 
Table 2.6 and will be available on Addgene. 
Fluorescence Polarization Binding Assays.  Fluorescence polarization experiments 
were conducted with a Jobin Yvon Horiba FluoroMax3 spectrofluorometer in a 1 cm quartz 
cuvette.  Polarization of the TAMARA-SsrA peptide was measured through excitation at 555 nm 
and emission at 584 nm.  For direct binding experiments between SspB and TAMARA-SsrA, 
starting peptide concentration was 25 nM in PBS.  For competitive binding assays, 25 nM 
TAMARA-SsrA and 40 nM SspB (in PBS) were incubated prior to titrating LOV fusions.  At each 
titration, the sample was irradiated with 6.0 mW*cm-2 blue light for 1 minute, turned off and a lit 
state polarization was measured.  After 5 minutes in the dark, a second measurement was 
taken, representing the dark state population.   
Thermal Reversion Assay.  Purified iLID protein was dialyzed against 4L of PBS buffer 
twice before measuring reversion kinetics.  Protein samples were prepared at 10μM and 
allowed to equilibrate to room temperature in a 1cm quartz cuvette.  Samples were then 
irradiated with blue light (6.0 mW*cm-2  at 450nm, collimated blue LED array) for 30 seconds.  
Recovery of absorbance at 450nm was then measured every 0.1 seconds for 5 minutes.   
Crystallization and Structural Determination of iLid.  Initial crystals of iLid were 
grown using hanging drop vapor diffusion.  Drops consisted of 2 μL well solution (800 mM 
lithium chloride, 100 mM TRIS:HCl pH 8.5, 32% (m/v) PEG 4000) and 1 μL iLid protein (10 
mg/mL in 100mM ammonium acetate).  Initial conditions were optimized by microseeding.  Final 
crystal drops were 2 μL well solution, 1 μL iLid (10 mg/mL), 0.5 μL microseed solution.  Crystals 
grew to maximum size in 3 days.  X-ray diffraction data was collected at Southeast Regional 
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Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, 
Argonne National Laboratory.  Data was indexed with XDS and scaled with Scala (3–5).  The 
structure of iLid was determined using PAS fold residues N414-D515 of PDB id 2v0u as a 
molecular replacement model in Phaser (6).  Phenix and Coot were used to iteratively refine the 
final structure (7, 8).  
Mammalian Cell Localization/GEF Microscopy and Image Analysis.  IA32 mouse 
fibroblasts were transfected in 6 well tissue culture plates with equal amounts of 2 vectors, each 
containing a component of the switch (ex. 0.5 μg pll7.0 Venus-iLID-CAAX : 0.5 μg  pll7.0 tgRFPt 
–Nano; See Table 2.6 for vector information). 24 hr after transfection and 24 hr before image 
aquisition, cells were plated on No. 0 glass bottomed dishes (MatTek) coated with a 10 μg/ml 
solution of Fibronectin. Image acquisition was performed using a FluoView FV1000 scanning 
confocal inverted microscope equipped with a 1.30 N.A. 40 x oil immersion objective, a 
Hamamatsu PMT, environmental chamber (Precision Plastics) and controlled by Fluoview 
software (Olympus, Version 3.1b).  A 25 mW argon laser provided the 488 nm and 515 nm laser 
lines while a 15 mW diode laser provided the 559 nm laser line.  The environmental chamber 
was used to continue culture at 37° C and 5 (v/v) CO2 throughout image acquisition.  The 
software Time Controller was used to set a timeline of image acquisition and LOV domain 
excitation within a predefined region of interest.  During periods of excitation, the ROIs were 
continuously scanned with 488 nm light except during the time it took to aquire an image (< 3 
sec).  1% power of the 488 nm laser was used for all LOV domain excitation.  During all 
experiments, images were acquired every 10 sec before and after excitation while image 
acquisition times varied during each type of excitation, due to the difference in excitation area.  
For spot activation and whole cell activation LOV excitation and image acquisition required 7.6 
sec 14.7 sec respectively.  
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All images were analyzed using FIJI software (9). For spot activation, the average tgRFPt 
fluorescence intensity within the activated ROI was measured for each frame and the 
background subtracted.  The values for each image set were normalized to the average of the 
first three frames before excitation.  For half-cell activation, ROIs of similar tgRFPt fluorescence 
were manually chosen within the activated area and outside the activated area. Mean values 
were acquired for each frame and background subtracted.  The reported values are a ratio of 
the fluorescence inside to outside the activated area.  For whole cell activation, analysis was 
automated.  For each frame, ROIs were produced by applying the default Auto Threshold 
function to the Venus channel(Mito ROI).  To produce a Cyto ROI the Mito ROI was expanded 
by 10 pixels and then removed from the new ROI. The average tgRFPt intensity was then 
measured for each ROI and frame. The ratio of mitochondrial to cytoplasmic signal was then 
calculated for each frame like so: (Mito – Cyto)/Cyto.  The cytoplasmic signal was first 
subtracted from the mitochondrial signal to remove any signal that was contributed to the 
mitochondrial ROI from the cytoplasm above and below the mitochondria.  
Cloning and Vector Information. All mammalian constructs were cloned into pLL 7.0 
lentiviral vectors. Therefore, a CMV promoter drives expression. Mammalian constructs were 
assembled through PCR amplification and subsequent restriction enzyme digestion and ligation. 
The constructs were verified by sequencing. See Table 2.6 for more information and Addgene 
numbers 
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2.7 Figures 
 
Figure 2.1. Schematic overview of selection and screening protocol for improved 
LOV variants. (A) Using Rosetta’s pmut_scan, we generated a library of point mutations at 49 
positions within the AsLOV2 domain (blue residues). (B) Phage display construct illustration. (C) 
The phage library was added to plates coated with MBP-SspB (Grey-blue) in the presence of 
blue light and washed. Plates were moved to the dark and eluted phages were collected. (D) 
Top single mutation sequences were re-cloned as flag tag fusions and individually expressed. 
Binding of soluble protein to MBP-SspB coated plates was measured after exposure to blue 
light and sequestration in the dark by ELISA. (E) Mutations with the highest dynamic range were 
recombined to generate a new library of LOV variants, which was screened using the procedure 
shown in C & D.  
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Figure 2.2. Characterization of iLID nano and iLID micro. Competitive fluorescence 
polarization binding assays measure affinities of heterodimerization under blue light (open 
circles) and in the dark (closed circles). (A) Incorporation of SsrA into final turn of the AsLOV2 
Jα helix (B) Addition of helix-strengthening mutations (G528A, N538E) and C-terminal 
phenylalanine. (C) Top sequence from phage display and screening, iLID, has a 36 fold change 
in affinity for SspB due to light. (D) A mutation to SspB (R73Q) yields a heterodimer pair that 
switches over the micromolar range of affinities with a 59 fold change in affinity. (E) Sequence 
alignment of starting, original (oLID) and improved (iLID) light-inducible dimers. Black-
unmutated, grey-similar amino acid mutation. Grey dots indicate iLID mutations that converged 
in all top four sequences. (F) Comparison of lit (open circle) and dark (closed circle) affinities 
between the original heterodimer pairs and our two new pairs, iLID nano and iLID micro. 
  
50 
 
 
Figure 2.3. Structure of iLID yields insight to role of mutated residues. (A) Overall topology 
iLID (green) remains unchanged from AsLOV2. Boxes surround three areas of interest to be 
shown in B,C,D. (B) Alignment with AsLOV2 (PDB:2v0u, purple) reveals no major backbone 
rearrangement of the hinge region due to mutations. (C) Close up view of A'α helix from iLID 
(green), AsLOV2 (purple) and PA-Rac1 (PDB:2wkp, dark green), show different orientation in 
caged LOV variants from uncaged. (D) SsrA epitope (blue) contains an extra helical turn before 
wrapping back and interacting with the PAS fold. Designed C-terminal phenylalanine (green) 
packs nicely into a hydrophobic pocket of the LOV domain. 
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Figure 2.4. iLID provides improved local recruitment in cell culture. (A) IA32 fibroblasts 
expressing membrane (CAAX) and mitochondrial anchored Venus-iLID and cytoplasmic 
TagRFP-T-Nano. Localized activation (denoted by blue markings) caused relocalization of 
TagRFP-T-Nano. Bar = 50 um (B) A ratio of mitochondrial to cytoplasmic TagRFP-T signal 
intensity during a time course of whole cell activation as shown in Row 1 of A for each pair of 
mitochondria anchored switches. (C) Patterned activation of Venus-iLID-CAAX shows tight 
spatial and temporal control of TagRFP-T-Nano localization within a cell. 
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Figure 2.5. Spatial control of GEF DH/PH domains by iLID produces localized control of 
Rac and Cdc42 activity. IA32 cells expressing Venus-iLID-CAAX and (A) Tiam DH/PH-
TagRFP-T-Nano or (B) ITSN DH/PH-TagRFP-T-Nano. iLID was activated in the regions 
highlighted in blue. White arrowheads mark vesicles. Images are representative (n>5). Bar = 50 
μm 
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Figure 2.6. ELISA recombined point mutant ratios.  Lit/Dark signal ratios for top sequences 
out of recombined library.  C11, D5, H10, and F2 were selected to characterize (red columns). 
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Figure2.7. In vitro binding data for top four sequences. Florescence polarization competition 
binding assays for the top four sequences (shown in Fig. S2).  All four have a greater fold 
change in affinity than their parent oLID (Fig. 2B).  Binding affinities can be found in Table 2.3 
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Figure 2.8.  Binding of SspB R73Q to ssrA peptide. Fluorescence polarization binding of 
ssrA labeled peptide to SspB R73Q (Micro).  Affinity was measured to be 900 nM ± 200 nM. 
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Figure 2.9. In Vitro Binding of Reverted iLID Mutants. Florescence polarization competition 
binding assays for point mutation reversions show that only C530 can be removed without 
substantially affecting dynamic range or affinity range.  Binding affinities can be found in Table 
2.2. 
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Figure 2.10. Affinities of Reverted iLID Mutations. Reversion of iLID mutations elucidate role 
each plays in switch improvement. Left: structure of iLID with six mutations shown (boxes, dark 
blue). Right: Blue light and dark binding affinities due to the reversion of each of the mutations 
shown on left. C530 appears to have little to no effect on overall switching or range of affinity. 
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Figure 2.11. The maximum recruitment of sspB to activated LIDs in cells. Measurements 
were made from a time course of localized activation as shown in Fig. 4A, Row 2. The 
maximum tgRFPt signal intensity in an activated region of a cell, normalized to the intensity 
before activation was measured. 
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Figure 2.12. Activating GTPase pathways through GEF recruitment. (A) A schematic, 
demonstrating that in the absence of blue light, Micro fused to a DH/PH domain remains 
cytoplasmic and inactive. In the presence of blue light, Micro fused to the DH/PH domain binds 
to iLID, localizing the DH/PH to the membrane, where it increases the rate of GTPase 
nucleotide exchange to induce signaling. (B) Schematic of constructs made and tested. 
  
60 
 
 
Figure 2.13. Thermal Reversion of iLID and iLID C530M. Reversion of iLID C530M (right) 
yields similar reversion kinetics as iLID (left).  Experiments were performed at room 
temperature. 
  
t 1/2 =  15 ±  1 s t 1/2 =  13 ±  2 s
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Figure2.14. Binding of LIDs expressed via Tat and SRP pathways to SspB.  Secretion of 
LID constructs via the TAT pathway yields functional protein that binds immobilized SspB in a 
light-dependent fashion.  Using the DsbA signal sequence, the secreted protein does not bind 
SspB tighter under blue light than in darkness. 
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2.8 Supporting Information 
Table 2.1. Beginning and Improved iLID affinities 
Construct Blue Light Affinity Dark Affinity 
Starting LOV-SsrA 0.031 ± 0.006 μM* 0.057 ± 0.005 μM* 
LOV-SsrAC 0.120 ± 0.01 μM* 0.9 ± 0.07 μM* 
iLID nano 0.132 ± 0.005 μM 4.7 ± 0.7 μM 
iLID micro 0.8 ± 0.1 μM 47 ± 13 μM 
SspB R73Q - 0.9 ± 0.2 μM 
*Previously published values 
 
 
Table 2.2. Reversion Mutation Affinities 
Construct Blue Light 
Affinity 
Dark Affinity Fold Change 
iLID nano 0.132 ± 0.005 μM 4.7 ± 0.7 μM 36 
502/521 0.043 ± 0.005 μM 1.60 ± 0.05 μM 37 
519 0.024 ± 0.004 μM 0.49 ± 0.05 μM 20 
522 0.032 ± 0.01 μM 0.88 ± 0.04 μM 28 
530 0.113 ± 0.004 μM 4.6 ± 0.6 μM 41 
537 1.4 ± 0.1 μM 37.3 ± 0.7 μM 27 
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Table 2.3. Top ELISA Sequence Affinities 
Construct Blue Light Affinity Dark Affinity 
D5 77 ± 0.001 μM* 3.4 ± 0.02 μM* 
C11 97 ± 0.001 μM* 1.7 ± 0.03μM* 
H10 123 ± 0.001 μM* 2.0 ± 0.02 μM* 
F2 (iLID nano) 0.132 ± 0.005 μM 4.7 ± 0.7 μM 
*Error shown is standard error to binding curve fit 
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Table 2.4. Rosetta predicted point mutations included in library 
Residue # Mutations WT AA Rosetta Predicted Library 
404 13 L ACDEGKMNQRSTY 
406 1 T S 
407 17 T ACDEFGIKLMNPQRSVY 
408 3 L MTV 
411 5 I KLQRV 
413 11 K ACDEHMNQRSW 
414 3 N AHS 
415 1 F H 
417 4 I VTLA 
428 14 I ACEGHKLMNQRSTV 
429 4 F HKRY 
431 1 S A 
475 9 E ACKMQRSTV 
477 3 T CAV 
479 2 Q EI 
493 13 L ACDEGHIMNQSTV 
497 6 Q AEHKMR 
499 14 M ACDEFHKNQRSTWY 
500 9 R ACEIKMQTV 
502 15 Q ACDEGHIKLMNRSTV 
508 7 Y ACFHKMR 
510 4 I VTLC 
65 
 
512 1 V T 
514 3 L MQY 
519 16 H ACDEFIKMNPQRSVWY 
520 13 V ACDFHKLMNRSTY 
521 13 R ACEGHKMNQSTVY 
522 15 D ACEFGHKLMNQRSWY 
523 15 A CDEGIKLMNQRSTVY 
524 11 A CDEGKLMNQRS 
525 10 E AFHKLMQRWY 
526 17 R ACDEFGIKLMNQSTVWY 
527 16 E ACDGIKLMNQRSTVWY 
529 15 V ACDEFHIKMNQRTWY 
530 18 M ACDEFGHIKLNQRSTVWY 
531 18 L ACDEFGHIKMNQRSTVWY 
532 5 I AMSTV 
533 10 K AEHLMQRTVY 
534 17 K ACDEFGILMNQRSTVWY 
535 18 T ACDEFGHIKLMNQRSVWY 
537 12 E ACDIKLMNQRTV 
539 3 I LTV 
540 16 D ACEFGHKLMNQRSTWY 
541 14 E ACDIKLMNQRSTVY 
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Table 2.5. Data collection and refinement statistics 
 
Wavelength (Å)  1.0 
Resolution range (Å)  31.08  - 1.95 (2.02  - 1.95) 
Space group  P 21 21 21 
Unit cell  62.156  70.339  80.378  90  90  90 
Total reflections  158984 
Unique reflections  26276 (2574) 
Multiplicity 6.0 
Completeness (%)  99.8 (100.00) 
Mean I/sigma(I)  9.63 (2.41) 
Wilson B-factor  25.4 
R-merge  0.088 
R-meas  0.038 
R-work  0.231 (0.356) 
R-free 0.244 (0.398) 
Number of non-hydrogen atoms  2711 
Macromolecules 2392 
Ligands  63 
Water                256 
Protein residues  288 
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RMS(bonds)  0.013 
RMS(angles)  1.26 
Ramachandran favored (%) 99 
Ramachandran outliers (%) 0 
Clashscore  6.36 
Average B-factor  29.5 
Macromolecules  28.4 
Ligands 30.6 
Solvent  39.8 
Statistics for the highest-resolution shell are shown in parentheses. 
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Table 2.6. Construct Information 
Construct Description Addgene ID 
E. coli Expression 
iLID pQE-80L: iLID (C530M) 60408 
SspB Nano pQE-80L: MBP-SspB WT 60409 
SspB Micro pQE-80L: MBP-SspB R73Q 60410 
Mammalian Cell 
Venus-iLID-CAAX pLL7.0: Venus-iLID-CAAX (from KRas4B) 60411 
Venus-oLID-CAAX pLL7.0: Venus-oLID-CAAX (from KRas4B) 60412 
Venus-iLID-Mito pLL7.0: Venus-iLID-Mito (From ActA) 60413 
Venus-oLID-Mito pLL7.0: Venus-iLID-Mito (From ActA) 60414 
tgRFPt-Nano pLL7.0: tgRFPt-SSPB WT 60415 
tgRFPt-Micro pLL7.0: tgRFPt-SSPB R73Q 60416 
Tiam DH/PH-tgRFPt-Nano pLL7.0: mTiam1(64-437)-tgRFPt-SSPB WT 60417 
Tiam DH/PH-tgRFPt-Micro pLL7.0: mTiam1(64-437)-tgRFPt-SSPB R73Q 60418 
ITSN DH/PH-tgRFPt-Nano pLL7.0: hITSN1(1159-1509)-tgRFPt-SSPB WT 60419 
ITSN DH/PH-tgRFPt-Micro pLL7.0: hITSN1(1159-1509)-tgRFPt-SSPB 
R73Q 
60420 
 
1This work originally appeared in Biochemistry. The original citation is as follows: Zimmerman 
SP, et al. (2016) Tuning the Binding Affinities and Reversion Kinetics of a Light Inducible Dimer 
Allows Control of Transmembrane Protein Localization. Biochemistry 55(37):5264–71. 
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CHAPTER 3: TUNING THE BINDING AFFINITIES AND REVERSION KINETICS OF A LIGHT 
INDUCIBLE DIMER ALLOWS CONTROL OF TRANSMEMBRANE PROTEIN 
LOCALIZATION1 
3.1 Overview 
Inducible dimers are powerful tools for controlling biological processes through co-
localizing signaling molecules. To be effective, an inducible system should have a dissociation 
constant in the “off” state that is greater (i.e. weaker affinity) than the concentrations of the 
molecules that are being controlled, and in the “on” state a dissociation constant that is less (i.e. 
stronger affinity) than the relevant protein concentrations. Here, we reengineer the interaction 
between the light inducible dimer, iLID, and its binding partner SspB, to better control proteins 
present at high effective concentrations (5-100 µM).  iLID contains a light-oxygen-voltage (LOV) 
domain that undergoes a conformational change upon activation with blue light and exposes a 
peptide motif, ssrA, that binds to SspB. The new variant of the dimer system, contains a single 
SspB point mutation (A58V), and displays a 42-fold change in binding affinity when activated 
with blue light (from 3 ± 2 µM to 125 ± 40 µM), and allows for light activated co-localization of 
transmembrane proteins in neurons, where a higher affinity switch (0.8 M to 47 M) was less 
effective because more co-localization was seen in the dark. Additionally, with a point mutation 
in the LOV domain (N414L), we lengthened the reversion half-life of iLID. This expanded suite 
of light induced dimers increases the variety of cellular pathways that can be targeted with light. 
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3.2 Introduction 
Optogenetics provides temporal and subcellular spatial control over biochemical 
pathways in living systems. In particular, genetically encoded light inducible dimers have 
emerged as a tool for controlling signaling. In the most common approach, one component of 
the dimer is fused to a protein that directs localization and the other component to a protein of 
interest, imparting control of localization and activity of the target protein with light. This strategy 
has been used to control transcription, GTPase protein signaling, epigenetic modifications, and 
nuclear localization (1–6). One example, the improved Light Inducible Dimer (iLID) system 
(developed by our laboratory), is derived from the LOV2 domain of Avena sativa Phototropin 
(AsLOV2) and consists of iLID (the light reactive component) and SspB (the binding partner). 
We previously produced two versions of SspB, SspB_nano and SspB_micro, that have different 
lit and dark state affinities for iLID. We compared iLID with some other light inducible systems in 
a set of biophysical and activity assays and we found that the iLID switches have several useful 
features including a large dynamic range of binding, tunable affinities, strictly monomeric 
components, easy to use in many organisms, and have no restrictions on fusion location(7). 
Here we aim to further expand the iLID system’s capabilities by focusing on two aspects: (1) 
utility when effective proteins concentrations are on the order of 100 micromolar and (2) less 
frequent requirement of light stimulation. 
Ideally, inducible dimers would have no binding affinity in the dark, and very strong 
binding affinity in the light. However, light inducible dimers typically do not behave in such a 
binary fashion, and therefore the concentrations of the proteins and their dissociation constants 
in the light and dark are critical for determining whether there will be a change in the 
monomer/dimer equilibrium when the system is activated with light. For instance, iLID in 
combination with SspB_nano (iLID / SspB_nano) has a dissociation constant for dimerization of 
132 nM in the light and 4700 nM in the dark. This indicates that this switch will be most effective 
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when the component proteins are present at high nanomolar concentrations. However, proteins 
present at mid-micromolar or low nanomolar concentrations are less compatible with this switch.  
At high concentrations it will dimerize in the absence of light and at low concentrations it will 
remain monomeric, even when activated.  In many cases, protein concentrations in a cell or 
organism are not known, highlighting the need for a suite of light inducible tools that function in 
different affinity regimes. In the case of proteins found in constrained locales, like the plasma or 
mitochondrial membranes, avidity effects and high effective concentrations require low affinity 
switches to properly modulate dimerization. To address these issues, we have engineered a 
panel of light-inducible protein pairs that function over a range of affinities that can be 
empirically tested in localization experiments. Here, we expand the panel by creating a new 
variant of SspB, SspB_milli, that has a weaker affinity for iLID and functions at higher protein 
concentrations, and demonstrate that this re-engineered system is more effective at regulating 
the localization of trans-membrane proteins in neuronal cells. 
When excited with blue light, the flavin mononucleotide (FMN) cofactor in iLID forms a 
metastable covalent bond with Cys450, leading to a conformational change exposing a peptide 
sequence (ssrA) that binds to the bacterial SspB protein(8, 9). The rate at which AsLOV2, and 
hence iLID, reverts to its dark state following photoactivation is relatively fast (T½ = ~20 s) which 
means light must be applied frequently in order to sustain the induced interaction. It has been 
shown that excess light can have undesired experimental effects on the cell or animal being 
studied(10). Slowing the reversion rate will allow iLID to be kept in the lit state longer, reducing 
necessary light, and improving experimental conditions. To this effect we have applied a mutation 
to iLID (N414L) that has been shown to extend the reversion half-life of AsLOV2 and show that it 
has a similar effect on iLID. 
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3.3 Results and Discussion 
To engineer a light inducible dimer that would be effective at higher protein 
concentration, we introduced the mutation A58V into SspB_micro.  Alanine 58 is located in the 
ssrA binding site of SspB, and mutating this residue to a larger valine is predicted to create a 
steric clash and weaken the affinity of SspB for ssrA, and hence weaken the affinity of SspB for 
iLID.  We refer to the A58V variant of SspB_micro as SspB_milli. Using a competitive 
fluorescence polarization assay, the dissociation constant for lit state binding between iLID and 
SspB_milli was measured to be 56 ± 6 µM, indeed weaker than the interaction between iLID 
and SspB_mico which has an affinity of 800 nM in the light. In the dark, non-specific interactions 
interfered with our measurements when concentrations were raised above 1 mM, but we were 
able to estimate that dark state affinities were at least 25 fold weaker than lit state affinities 
(Figure 3.1A, C).  
To generate a slower reversion time variant of iLID (sLID (slow Light Inducible Dimer)), 
we added a single mutation to iLID, N414L, known to increase the half-life of the metastable 
bond formed between Cys450 and the FMN cofactor (11). N414 is a second shell residue in the 
FMN binding pocket, solvent exposed, and not highly conserved in the LOV domain family(12). 
The N414L mutation is hypothesized to prevent water from entering the chromophore binding 
pocket and therefore prevents proton transfer and degradation of the metastable bond(11). To 
determine the kinetics of sLID, we monitored recovery of FMN absorbance at 450 nm after blue 
light photoactivation and measured the lit state half-life of sLID to be 214 ± 4 s, 12-fold slower 
than the dark-state recovery time for iLID (Figure 3.1B).  
To determine if SspB affinity for sLID is altered due to the N414L mutation, we measured 
the affinity of sLID for SspB_nano, SspB_micro, and SspB_milli. We found that in all cases the 
mutation increased binding affinity in both the light and the dark; SspB_nano lit: 7 ± 2 nM, dark: 
310 ±90 nM, SspB_micro lit: 110 ± 10 nM, dark: 2.5 ± 0.4 µM and SspB_milli lit: 3 ± 2 µM, dark 
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125 ± 40 µM (Figure 3.1A and C, Figure 3.5). Strikingly, the 7 nM affinity for SspB_nano with 
sLID in the lit state is tighter than the affinity between the free ssrA peptide and SspB_nano, 
suggesting that N414L may result in additional favorable interactions between the LOV2 domain 
and SspB. This result was unanticipated, but potentially useful, as it expands the range of 
affinities over which the iLID variants function. While it is likely that he N414L mutation will have 
a similar effect on the photocycle of other AsLOV2 based switches, we do not know if the 
change in affinity is generalizable to other binding partners. 
Next, we tested the performance of sLID and SspB_milli in protein localization assays in 
mouse fibroblasts. By expressing SspB_milli fused to tagRFPt (tRFPt-SspB_milli) and a Venus 
labeled iLID fused to either a plasma membrane or a mitochondrial targeting sequence (Venus-
iLID-CAAX, Venus-iLID-Mito) we controlled and monitored the localization of SspB_milli before 
and after irradiation with blue light. Understanding that in this assay the effective cellular 
concentration of both components is important to our results, but extremely difficult to measure 
on a single cell basis, we aimed for a nominal range of protein expression levels. We controlled 
expression levels by transfecting cells with a 1:1 ratio of each component DNA at the same 
concentration for each sample. Furthermore, the microscope settings were held constant and 
only cells expressing at concentrations that fell within the dynamic range of the PMT at these 
settings were imaged. This means that the concentrations of each component are not optimized 
to produce the largest change in localization for each pair of dimers but rather allows 
comparison between samples at similar concentration. The membrane and mitochondrial 
localization assays provide different information while reinforcing our results. The membrane 
localization allows us to test subcellular recruitment by stimulating a specific region of interest. 
However, in this assay we cannot determine the portion of tRFPt signal at the membrane versus 
the cytoplasm in the dark state, preventing us from calculating the dark state localization. 
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However, the mitochondrial localization assay allows us to determine localization of tRFPt signal 
in both the lit and dark states but is a whole cell assay.  
 With the Venus-iLID-CAAX localization, we activated a specific region of interest (ROI) 
and over time compared the average tRFPt fluorescence intensity in that ROI to similar ROI 
elsewhere in the cell. When using iLID / SspB_milli, we observed weaker recruitment of tRFPt-
SspB_milli to the activated ROI when compared to SspB_nano or SspB_micro (SspB_nano 
~6.4x, SspB_micro ~4.9x, SspB_milli ~1.5x) (Figure 3.2A and B). This result suggests the lit 
state dissociation constant between SspB_milli and iLID (56 µM) is greater than the effective 
concentration of the molecules. However, when using SspB_milli with sLID we observed 
effective recruitment, consistent with the stronger affinity between sLID and SspB_milli in the lit 
state (3 µM). Interestingly, sLID combined with SspB_micro produces only ~1.8x change in 
localization (Figure 3.2A and B). In this case, dynamic range was limited because much of the 
protein was co-localized in the dark, consistent with the relatively high affinity between sLID and 
SspB_micro in the dark (2.5 µM).  
In the mitochondrial localization assays, the entire field of view was irradiated with blue 
light and the average mitochondrial tRFPt fluorescence intensity was compared to the average 
cytoplasmic fluorescence intensity. As with the membrane localization assay we found that iLID 
/ SspB_milli showed a smaller dynamic range (~1.9x) than SspB_nano (5.4x) and SspB_micro 
(5.2x), as only a small amount of the protein was recruited to the mitochondria (Figure 3.3A and 
B). Similar to the membrane localization experiments, the largest dynamic range observed for 
sLID was with SspB_milli (2.2x).  sLID / SspB_micro experiments showed that high dark state 
affinity localized SspB_micro to the mitochondria pre-activation (Figure 3A and B).  
In the mitochondrial and plasma membrane localization experiments we also measured 
the kinetics of reversion to equilibrium after the light was turned off. As expected, dark state 
recovery times (t1/2 ) were slower with sLID than with iLID in both experiments; plasma 
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membrane experiments were  ~60 and ~100 s respectively for iLID and sLID (Figure 3.2C), and 
mitochondrial experiments were ~30 and ~430 s (Figure 3.3B; Table 3.1). Since the in vitro and 
in vivo reversion half-lives of sLID were longer than iLID we hypothesized that sLID would 
maintain maximum recruitment of SspB_milli to the membrane with less frequent light 
stimulation. To test this, we compared Venus-iLID-CAAX / tRFPt-SspB_micro with Venus-sLID-
CAAX / tRFPt-SspB_milli as these two combinations showed large dynamic ranges simplifying 
our ability to observe a change due to activation frequency. For each pair, we repeated the spot 
localization experiment while lengthening the times (15, 30, and 60 s intervals) between 
activations. We found that for iLID / SspB_micro the 30 and 60 s intervals recruited ~60% and 
~15% of the SspB_micro that was observed for the 15 second interval (Figure 3.2D and F). 
However, with sLID / SspB_milli, the amount of SspB_milli recruitment for the 30 s interval was 
indistinguishable from the 15 s and the 60 s interval recruited ~30% of the SspB_milli that was 
observed with the 15 s interval (Figure 3.2E and F).  This suggests that sLID requires less 
frequent light stimulation to maintain maximum activation. 
Next, we were curious if there are scenarios in which it would be advantageous to use 
SspB_milli instead of the tighter binding SspB variants. In particular, we hypothesized that 
weaker binding affinities may be needed to conditionally control interactions between two 
membrane-associated proteins, (i.e. their effective concentrations are increased by being 
restricted to the membrane). To test this hypothesis, we examined the ability of sLID and SspB 
variants to conditionally recruit neurotransmitter receptor proteins to the postsynaptic density 
(PSD) of neuronal excitatory synapses. The PSD is a protein dense region associated with the 
plasma membrane of dendritic spines, the major sites of excitatory synaptic contact in the 
central nervous system. The PSD anchors neurotransmitter receptors and signaling proteins 
apposed to presynaptic terminals. sLID was fused to YFP and the PSD scaffold Homer1c (h1c), 
which strongly localizes to the PSD(13). This construct was co-expressed with fusion proteins 
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containing the trans-membrane AMPA receptor subunit GluA1, mCherry, and variants of SspB. 
AMPA receptors are ionotropic glutamate receptors that mediate most fast neurotransmission in 
the central nervous system and their dynamic regulation at the PSD is critical for synaptic 
function and plasticity(14).  As expected, h1c-YFP-sLID was primarily localized to the PSD in 
neurons. Before activation, GluA1-mCh-SspB_nano was almost exclusively co-localized with 
the YFP signal and no appreciable difference in localization upon light stimulation (Figure 3.4A). 
The majority of GluA1-mCh-SspB_micro was also localized to the PSD in the dark. However, 
upon activation, there was a 1.2x increase in maximal signal (Figure 3.4A and C). In contrast, 
GluA1-mCh-SspB_milli was evenly distributed throughout the dendrite before activation, 
signifying less dark state binding between SspB_milli and sLID. With light activation, a 1.4x 
increase in signal at the PSD was measured. To further quantitate dark and lit state binding, we 
measured the GluA1-mCh-SspB intensity along the spine (which houses the PSD), and 
dendritic shaft in lit and dark conditions. Lower dark-state binding and maximal dynamic range 
of sLID / SspB_milli is exemplified by the increase in the spine/shaft ratio of GluA1-mCh-SspB 
fluorescence, which increased from 1.5 ± 0.09 in the dark to 2.4 ± 0.18 in the light compared to 
sLID / SspB_micro (1.5 ± 0.05, dark vs 1.8 ± 0.06 light) and sLID/ SspB_nano (2.8 ± 0.20, dark 
vs 2.9 ± 0.19, light) (Figure 3.4B and D). In addition, the kinetics of localization and reversion for 
both SspB_micro and SspB_milli with sLID were slowed in comparison to what we measured in 
fibroblasts (Activation ~3 min; Reversion ~6.5 min). The discrepancy between 
accumulation/dissociation rates using PSD localized sLID compared to our fibroblast 
experiments likely reflects slower diffusion of GluA1 within the plasma membrane and geometric 
constraints on diffusion imposed by dendritic spines.  
In summary, the iLID suite of optogenetic dimers has been expanded to include 
SspB_milli and sLID. SspB_milli has been developed to shift the dynamic range of binding to 
higher protein concentrations with minor effects on the breadth of the dynamic range. sLID 
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lengthened the half-life of reversion, allowing for a reduction in the frequency of light exposure 
while maintaining the same activity. In vitro measurements of affinity and kinetics correlated with 
the in vivo localization experiments, and can be used as a guide when designing future 
experiments with the switches. In a case study, we showed that when applying these switches 
to proteins with high effective concentrations, such as GluA1 concentrated in the plasma 
membrane, the weaker affinity SspB_milli reduced unwanted dark state binding. In addition, 
sLID allowed for less frequent light exposures, potentially maintaining the structural integrity of 
the postsynaptic density. Because of these advantages this expanded tool set should permit the 
use of iLID and its variants in a wider set of applications.  
3.4 Materials and Methods 
Molecular cloning - pQE80L-sLID, pLL7.0-Venus-sLID-CAAX, and pLL7.0-Venus-sLID-
Mito were generated by quick change site directed mutagenesis of the corresponding iLID 
constructs using the following primers: 
CTGGAACGGATCGAGAAACTGTTCGTGATTACTGATCCG; 
CGGATCAGTAATCACGAACAGTTTCTCGATCCGTTCCAG. pQE80L-SspB_milli and pLL7.0-
tgRFPt-SspB_milli were generated by quick change site directed mutagenesis of the 
corresponding SspB_micro constructs using the following primers: 
CTGTCTGCAAGTGTGACCGGCAACCT; CAGGTTGCCGGTCACACTTGCAGACAG. These 
constructs can be found on Addgene.  GluA1-mCh-SspBnano, GluA1-mCh-SspBmicro, and 
GluA1-mCh-SspBmilli were generated by PCR amplifying SspB_nano (addgene #60415), 
SspB_micro (addgene #60416), and SspB_milli, respectively, and cloning into a custom GluA1-
mCh mammalian expression vector with using the chick beta-actin promoter to drive expression. 
Homer1c-YFP-iLID and Homer1c-YFP-sLID were generated by PCR amplifying iLID and sLID, 
respectively, and cloning into Homer1c-YFP. The cDNA for Homer1c-YFP was a gift from 
Shigeo Okabe (University of Tokyo). GluA1 cDNA was a gift from Michael Ehlers (Pfizer, Inc). 
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Constructs were generated using standard cloning techniques in either a custom chick beta-
actin promoter (pCAG; for GluA1-mCh-SspB constructs) or cytomegalovirus promoter (pCMV; 
for iLID constructs). 
Protein expression and purification - Proteins were expressed as described in Hallett 
et. al. (2015). Briefly, BL21(DE3) cells were transformed by heat shock with each expression 
vector and used to inoculate 1.5 L of LB media. Cells were grown at 37°C to OD 0.6 and 
induced with 333mM IPTG at which point proteins were expressed for 16 hours at 18°C. Cells 
were then lysed and pelleted and the proteins of interest were purified from the supernatant by 
sequential HisTrap affinity purification and size exclusion chromatography on a Superdex 75 
column (GE). All proteins were stored, quantified, and characterized in PBS buffer (10 mM 
dibasic sodium phosphate, 1.8 mM monobasic potassium phosphate, 137 mM NaCl, 2.7 mM 
KCl) + 5mM BME. 
Fluorescent polarization Binding Assay - Fluorescent polarization binding assays 
were performed as described in Hallett et. al. (2015). Briefly, Fluorescence polarization 
measurements were recorded using a Jobin Yvon Horiba FluoroMax3 fluorescence 
spectrometer. All binding assays were performed in PBS buffer in either a 1 cm or 3 mm quartz 
cuvette at 25 °C. Polarization of a TAMRA labeled peptide was measured with an excitation of 
555 nm and 584 nm emission. Initial affinities of the labelled peptides were measured through 
direct binding titrations to each SspB. For the competition assay, at each titration point, the 
sample chamber was illuminated with 6.0 mW cm-2 blue light using a collimated blue LED 
(ThorLabs).  A lit state time point was taken immediately after removal of the blue light. For iLID 
a dark state measurement was made 5 min later while for sLID a dark state measurement was 
made 15 min later.  Starting peptide concentrations were 25 nM. 
Absorption Recovery after Activation - Absorption recovery after activation was 
performed as in Hallett et. al. (2015) Briefly, excited state recovery times were measured using 
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a Cary 50 UV-Visible Spectrophotometer. Using a blue light collimated LED (ThorLabs), 
samples were irradiated (6.0 mW cm-2) for 30 seconds and absorbance at 450 nm was recorded 
until recovery. 
Mammalian Cell Culture and Transfection - Mouse IA32 fibroblasts were cultured in 
DMEM supplemented with 10% (vol/vol) FBS (HyClone), 100 U/ml penicillin, 100 µg/mL 
streptomycin, and 292 µg/mL L-glutamine. Cells were cultured at a constant 37 °C and 5% 
(vol/vol) CO2. Transfections were performed in 6 well or 35 mm cell culture dishes using 1 µg 
total DNA at 1:1 ratio. NanoJuice (EMD Millipore) transfection reagent was used as 
recommended by the manufacturer. 
Mammalian cell localization microscopy - Experiments were performed according to 
the methods found in Guntas et al. Briefly, cells were co-transfected with vectors encoding the 
sequence of each switch piece at a 1:1 stoichiometry. 24 hr later tranfected cells were 
trypsonized and transferred to 10 ug/ml fibronectin coated 3.5 cm MatTek glass bottom dishes. 
24 – 48 hr later cells were imaged and photo-activated with an Olympus FV1000 confocal 
microscope equipped with a 1.30 N.A. 40x oil immersion objective. Experiments were performed 
at 37° C, and 5% CO2.The Fluoview software Time Controller was used to produce a timeline of 
image acquisition and photo-activation using the same standard parameters found in Guntas et 
al.  Standard settings were maintained for each image to ensure similar protein expression 
levels which fell within the dynamic range of the instrument under these settings.  Activation 
parameters were also kept constant between samples. In short laser power was set at 1% for 
the 488nm line. For whole cell activation the entire field of view was activated in a 512x512 pixel 
grid with a 2us/pixel dwell time and repeated 5x. before the next image was acquired. For ROI 
activation a 60x60 pixel grid was activated with a 8us/pixel dwell time and repeated 10x before 
the next image was taken.  
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Image analysis and quantification - All images were analyzed using FIJI software. 
Spot localization was quantified according to Guntas et al. Briefly the tgRFPt fluorescence 
intensity was measured within the activated ROI and an initial intensity and size matched area 
outside the activated ROI. A ratio of fluorescence intensity inside : outside the ROI  was 
analyzed throughout time. The values that correspond to the period of activation were fit to the 
equation Y= 1 + Ymax*(1-exp(-K*X)). The values that correspond to the period of reversion 
were normalized to the maximum values and fit to the equation Y=(Y0 - Plateau)*exp(-K*X) + 
Plateau. Whole cell activation was quantified according to Hallett et. al. (2015) In short, 
computationally defined mitochondrial and cytoplasmic ROIs were determined based on the 
images captured. The ROIs were used to measure the tRFPt fluorescence intensity in each 
area over time. The ration of mitochondrial to cytoplasmic intensity was plotted though time and 
curves were fit to the values during the activation and reversion periods using the equations 
Y=S+Ymax*(1-exp(-K*X)) & Y=(Y0 - Plateau)*exp(-K*X) + Plateau respectively. The fold change 
was determined by (S+Ymax)/S. All curve fittings were performed using Prism (GraphPad) 
software. 
Cultured Neuron Preparation and Transfection - Primary hippocampal neurons were 
prepared from neonatal Sprague Dawley rats. Hippocampi were dissected from the brains of 
postnatal day 0–2 rats and dissociated by papain digestion. Neurons were plated at 100,000 
cells/ml in MEM, 10% FBS (Hyclone) containing penicillin/streptomycin on 18 mm poly-D lysine 
coated glass coverslips. After 1 d the media was replaced with Neurobasal-A supplemented 
with B27 (Invitrogen). The neurons were then fed with Neurobasal-A, B27, and mitotic inhibitors 
(uridine + fluorodeoxyuridine [Ur+FUdR]) by replacing half the media on day 4 or 5 and then 
twice weekly. Neurons were transfected between 16 and 18 days in vitro (DIV) with 1.0 μg of 
plasmid/1.5 μl of Lipofectamine according to the manufacturer’s protocol and imaged on DIV 
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18–21. All animal procedures were performed in accordance with the University of Colorado 
School of Medicine guidelines. 
Neuronal live-cell Imaging - Live cell imaging of dissociated hippocampal neurons was 
carried out at 32˚C on an Olympus IX71 equipped with a spinning disc scan head (Yokogawa) 
with a 60x NA1.4 objective. Excitation illumination was delivered from an AOTF controlled laser 
launch (Andor) and images were collected on a 1024x1024 pixel Andor iXon EM-CCD camera. 
Data acquisition and analysis were performed with Metamorph (Molecular Devices) and ImageJ 
(National Institutes of Health). Some images were smoothed (averaging over 3 × 3 pixels) using 
ImageJ for display, but never before quantification. We simultaneously activated iLID and 
imaged GFP with a fiber coupled 488 nm laser through the microscope objective (typical 
photoexcitation conditions were 25% laser power from a 50 mW 488 nm laser, 25-50 ms 
exposure time). 
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3.6 Figures 
Figure 3.1. In vitro characterization of iLID SspB_milli and sLID. A) Left panel: Binding of 
iLID to SspB SspB_milli under blue light (blue) and in dark (black) measured by fluorescence 
polarization. Right panel: Binding of sLID to SspB_nano (circles) or SspB_milli (squares) under 
blue light (blue) and in dark (black). B) Reversion of FMN-LOV2 covalent adduct is measured by 
recovery of absorbance at 450nm after 30 sec of blue light activation for WT iLID (blue) and 
sLID (green). C) Schematic displaying dynamic range of each characterized photoswitch. Blue 
circles denote the lit state affinity, dark circles mark the dark state affinity, and the connecting 
line represents change due to blue light. Data shown are representative experiments, affinities 
reported incorporate standard deviation over replicate experiments. 
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Figure 3.2. Membrane localization A) Representative images of membrane recruitment and 
reversion analyzed in B and C. Cells transfected with each membrane bound switch pair were 
imaged and activated by confocal microscopy. Blue square marks the ROI activated with blue 
light. B) Ratio of RFP fluorescence intensity inside the activated ROI to outside the ROI during 
activation. C) Ratio of RFP fluorescence intensity inside the activated ROI to outside the ROI 
after activation. D and E) Venus-iLID-CAAX / RFP-SspB_micro or Venus-sLID-CAAX / 
SspB_milli were activated with 15, 30, or 60 s between activations. Plots represent the 
normalized ratio of RFP fluorescence intensity inside the activated ROI to outside the ROI 
during activation. F) The maximum normalized fluorescence intensity ratio from D and E 
determined by fitting the curves. (Data for Nano and Micro has been previously published (7).) 
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Figure 3.3. Mitochondrial localization A) Representative images of mitochondrial recruitment 
and reversion analyzed in B. Cells transfected with each mitochondrial bound switch pair were 
imaged and activated by confocal microscopy. B) Ratio of mitochondrial to cytoplasmic RFP 
fluorescence intensity for each switch pair. Fold change in localization is represented by the 
bars to the right. (Data for Nano and Micro has been previously published (7).) 
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Figure 3.4. Induced localization of membrane protein, GluA1, is enhanced by use of sLID 
/ SspB_milli. A) Representative images of GluA1-mCh-SspB localization using SspB nano 
(bottom), micro (middle) and milli (top) as analyzed in B, C and D. Arrowheads mark PSD. B) 
Representative change in GluA1-mCh-SspB fluorescence intensity over the spine and shaft 
before and after activation for SspB nano (bottom), micro (middle) and milli (top). Linescan 
profiles were generated using the grey dotted lines in A. C) PSD-localized mCherry 
fluorescence intensity is plotted over time normalized to the initial intensity for GluA1-mCh fused 
to SspB nano (n=89 spines from 5 neurons), micro (n=50 spines from 5 neurons) and milli 
(n=53 spines from 7 neurons). D) Ratio of spine to shaft mCherry fluorescence intensity before 
and after activation for GluA1-mCh fused to SspB nano (n=30 spines from 3 neurons), micro 
(n=30 spines from 2 neurons) and milli (n=30 spines from 5 neurons). ***p<0.001, paired 
student’s t-test. Scale Bar = 2 µm 
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Figure 3.5. Binding of sLID to SspB micro measured by fluorescence polarization. 
Samples were measured after illumination with blue light (blue circles) and in their dark state 
(dark circles). 
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3.7 Supporting Information 
Table 3.1. In vitro and In vivo characteristics 
 
 
Switch Binder Lit Affinity (μM) Dark Affinity (μM) Reversion Halflife (s) N Max In/Out Activation Halflife (s) Reversion Halflife (s) N Starting Value Max Value Fold Change Activation Halflife (s) Reversion Halflife (s)
iLID Nano 0.132 ± 0.005 4.7 ± 0.7 18 7 6.36 100 58 5 1.72 9.22 5.4 21 33
iLID Micro 0.8 ± 0.1 47 ± 13 18 7 4.88 65 50 5 1.58 7.52 5.9 28 23
iLID Milli 56 ± 6 ND 18 3 1.49 23 82 3 0.88 1.65 1.9 15 22
sLID Nano 0.0072 ± 0.002 0.310 ± 0.09 214 NA NA NA NA NA NA NA NA NA NA
sLID Micro 0.110 ± 0.01 2.5± 0.4 214 5 1.97 29 100 3 7.15 8.05 1.1 67 NA
sLID Milli 3 ± 2 125 ± 40 214 4 5.317 69 100 3 4 8.94 2.2 79 340
Membrane Localization Mitochondrial LocalizationIn Vitro Measurements
1This work originally appeared in ACS Synthetic Biology. The original citation is as follows: 
Hallett RA, Zimmerman SP, Yumerefendi H, Bear JE, Kuhlman B (2016) Correlating in Vitro and 
in Vivo Activities of Light-Inducible Dimers: A Cellular Optogenetics Guide. ACS Synth Biol 
5(1):53–64. 
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CHAPTER 4: CORRELATING IN VITRO AND IN VIVO ACTIVITIES OF LIGHT INDUCIBLE 
DIMERS: A CELLULAR OPTOGENETICS GUIDE1 
4.1 Overview 
Light inducible dimers are powerful tools for cellular optogenetics as they can be used to 
control the localization and activity of proteins with high spatial and temporal resolution.  Despite 
the generality of the approach, application of light inducible dimers is not always straightforward 
as it is frequently necessary to test alternative dimer systems and fusion strategies before the 
desired biological activity is achieved. This process is further hindered by an incomplete 
understanding of the biophysical/biochemical mechanisms by which available dimers behave 
and how this correlates to in vivo function.  To better inform the engineering process we 
examined the biophysical and biochemical properties of three blue-light inducible dimer variants 
(Cryptochrome2 (CRY2)/CIB1, iLID/SspB, and LOVpep/ePDZ) and correlated these 
characteristics to in vivo co-localization and functional assays.  We find that the switches vary 
dramatically in their dark-state and lit-state binding affinities, and that these affinities correlate 
with activity changes in a variety of in vivo assays including transcription control, intra-cellular 
localization studies and control of GTPase signaling.  Additionally, for CRY2 we observe that 
light induced changes in homo-oligomerization can have large effects on activity that are 
sensitive to alternative fusion strategies. 
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4.2 Introduction 
Optogenetics originally described the use of the light sensitive cation channel, 
Channelrhodopsin-2, to manipulate the action potential of neurons (1, 2).  More recently, 
optogenetics has extended into the realm of cell biology with the development of cellular 
optogenetic tools.  These tools are not limited to the manipulation of action potentials, but 
encompass any genetically encoded and light dependent system that can be used to 
manipulate cellular processes.  Particularly successful has been the use of light induced 
dimerization to control a variety of processes such as gene transcription, GTPase signaling, 
protein degradation, and organelle transport (3–10).  For example, by fusing one half of an 
inducible dimer to a protein anchored in the plasma membrane and the other half to a guanine 
nucleotide exchange factor (GEF) it is possible to localize the GEF to the membrane with light 
and activate GTPase signaling.   
While light inducible dimerization has proven to be a general approach for regulating 
biological processes, it is frequently necessary to test alternative dimer systems and fusion 
strategies to determine which approach will be most robust and appropriate for a given 
application (11).  Part of the challenge is that there are a variety of light inducible dimers that 
have been described in the literature, but few studies have compared switches side-by-side or 
characterized their intrinsic biophysical properties.  Here, we establish correlations between the 
in vitro and in vivo activities of three blue-light inducible dimers: Cryptochrome2 (CRY2)/CIB1, 
iLID/SspB, and LOVpep/ePDZb (12–14) (Fig.1A).  These results provide valuable input for 
future efforts to control biological pathways with light inducible dimerization.  
As a family, blue light inducible dimers provide a powerful experimental platform.  Their 
photosensitive cofactor is abundant in nature making them broadly applicable to many 
organisms, and the single wavelength of light necessary to manipulate their dimerization makes 
for a simple experimental setup.  CRY2/CIB1 is a naturally occurring light-dependent 
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heterodimer from Arabidopsis thaliana.  Additionally, it has been shown that CRY2 forms 
homooligomers when activated with light (15). Both CRY2/CIB1 dimerization and CRY2 
homooligomerization have been used to control a variety of cellular processes (11, 16–20).  
However, neither the dark state nor lit state binding affinities between CRY2 and CIB1 have 
been measured, and the stoichiometry of oligomerization has also not been determined.   
The TULIP (LOVpep/ePDZb) (13) and iLID (iLID/SspB) (14) systems are engineered 
heterodimer pairs built upon the light-induced conformational change of the Avena sativa (As) 
phototropin LOV2 domain (21). In the TULIP system a PDZ binding motif was encoded in the Jα 
helix of AsLOV2, sterically caged from binding an engineered PDZ (ePDZ) domain in the dark 
(13). Blue light induces a conformational change within AsLOV2, relieving this occlusion and 
increasing affinity to ePDZ. The iLID system works in a similar fashion, caging the E. coli ssrA 
peptide from its binding partner, SspB (14, 22). Despite the mechanistic similarities between 
TULIPs and iLID, the lack of molecular characterization prevents direct comparison and 
empirical switch selection when developing a new application.  
Recently, the Tucker group began the process of benchmarking light inducible dimers by 
comparing CRY2/CIB1, TULIPs, and Phy/Pif in a set of standardized yeast functional assays 
(23).  The Phy/Pif pair is a light induced dimer that rapidly forms under red light and rapidly 
dissociates when illuminated with far red light.  The Phy/Pif system requires a cofactor, 
phycocyanobilin (PCB), which is not readily available in some organisms.  These studies 
demonstrated a wide range of activities when using the switches to co-localize DNA binding and 
activation domains for control of reporter gene transcription in yeast.  To better understand 
these variations and extend the results to mammalian systems, we continue the benchmarking 
process by measuring binding constants for the dimers in the lit and dark states, and performing 
a variety of activity assays including: co-localization experiments in mammalian cell culture, 
transcription-control assays in yeast, and the activation of small GTPases via the sub-cellular 
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recruitment of guanine nucleotide exchange factors.  In general, we find that the measurements 
made in vitro correspond to what we observe in cells.  The switches with the largest changes in 
in vitro binding affinities upon light stimulation make the most effective switches for the in-cell 
benchmarks. 
4.3 Results and Discussion 
Biochemical Comparison of the Switches: 
Dark and Lit-state Binding Affinities - We used fluorescence polarization binding assays 
to measure the lit and dark state binding affinities of each pair. For the TULIPs and iLID this was 
performed using a competitive binding experiment. The photoactivatable domains were used to 
compete off fluorescently labeled peptides from the binding partners. The interaction between 
AtCRY2 and CIB1N (the N-Terminus of CIB1 necessary for dimerization) was not amenable to 
this experimental format, so CIB1N was covalently labeled with a fluorescent dye and direct 
binding was measured.  As we previously reported, the iLID binding partner SspB comes in two 
variations, Nano and Micro; each with a different affinity range. The iLID Nano system has an 
affinity of 0.13 μM under blue light and 4.7 μM in the dark. The iLID Micro pair has an affinity of 
0.8 μM under blue light and 47 μM in the dark (Fig.4.1B) (14).  The TULIP switches we 
examined function over a weaker range of affinities.  The LOVpep construct binds to ePDZb 
with an affinity of 12 μM under blue light and 72 μM in the dark, for a 6-fold change. The 
presence of additional “caging” mutations, T406-7A, I532A (LOVpep+), weaken the lit state 
affinity to 18 μM and the dark state affinity to 150 μM, for an 8 fold change (Fig.4.1B). The 
different affinity ranges sampled by the TULIP and iLID switches reflects the affinities of the 
peptides that are being caged in each case. The SsrA peptide used to create iLID binds to its 
partner, SspB (Nano), with an affinity of 35 nM (22). The PDZ binding peptide used in TULIP 
binds to ePDZb with an affinity of 14 μM.  
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To biophysically characterize the binding properties of CRY2 we purified full-length 
protein from insect cells.  We were not able to observe a light-dependent change in binding 
affinity between CRY2 and CIB1N. In our direct binding assay, we observed low micromolar 
binding (~4μM) with and without blue-light stimulation (Fig.4.1B). This result is consistent with 
the previous observation that CRY2 purified from insect cells did not show differential affinity for 
CIB1 in pull-down assays performed in the light and the dark (24).  It has been hypothesized 
that insect cell purified CRY2 is missing an important chromophore, 5,10-
methylenetetrahydrofolate (MTHF) (24). However, even in the presence of saturating MTHF 
concentrations, we did not observe a significant change in binding affinity due to light (Fig.4.8). 
We ran an electrophoretic mobility shift assay with CRY2 and CIB1N and found the same result. 
CRY2 binds CIB1N similarly under blue light as in the dark, both in the low micromolar range 
(Fig.4.9). We were unable to express and purify a shorter variant of CRY2, CRY2PHR, that has 
also been shown to exhibit light-dependent binding to CIB1 in cells. 
Light-dependent CRY2 Homo-oligomerization - Although purified CRY2 did not show 
light-dependent changes in CIB1N binding, we did observe robust homo-oligomerization of 
CRY2 with light stimulation as probed by multi-angle light scattering (SEC-MALS).  A single 
symmetric peak was observed both in the light and the dark, with the retention time being 
delayed in the dark (Fig.4.2A). The light scattering indicated a species with a molecular weight 
of 75 kD in the dark and 301 kD in the light.  The expected molecular weight of monomeric 
CRY2 is 71 kD, so these results are consistent with the formation of a monomer in the dark and 
a tetramer in the light.  Saturating amounts of MTHF did not change the elution times or 
molecular weight fits (Fig.4.10).  Using dynamic light scattering (DLS), we were able to measure 
the kinetics of the lit state oligomer to dark state monomer transition. In this assay, there is a 60 
second delay between removal of blue light and the first DLS reading, as shown in grey 
(Fig.4.2B). Factoring in this dead time, the reversion to dark state has a half-life of 90 ± 20 
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seconds. We also ran co-elution experiments of CRY2 and CIB1N in gel filtration experiments 
(Fig.4.11).  Samples of CRY2 and CIB1N (2:1 molar ratio) were run in the light and dark, 
however in both states CIB1N did not co-elute with CRY2.  This is consistent with the 
micromolar binding affinities that we observed in the fluorescence experiments.  
Reversion Kinetics - We used our purified protein samples to also measure the reversion 
kinetics of the photoactivated states. Using an absorbance recovery after photoactivation assay, 
we determined the lit state half-life for each of our photosensitive domains. In order of fastest to 
slowest, the half-lives were measured to be 18 ± 2 s for iLID, 23 ± 1 s for LOVpep, 51 ± 2 s for 
LOVpep+, and 92 ± 10 s for CRY2 (Fig.4.3).   
Comparison of Switch Behavior in the Cytoplasm of Live Cells 
Controlling Sub-cellular Localization - Next, we examined how effective the 
photoswitches were at recruiting proteins to a specified region of the cell.  In particular, we were 
curious if the in vitro binding properties of the dimers would correlate with in-cell behavior.  Each 
half of the switches were fused to a fluorescent protein (Venus or tgRFPt) with spectral 
properties distinct from the excitation wavelength of the photoactive domain. The Venus labeled 
half of the switch was also fused to a membrane-anchoring domain (N-Myristoylation (Myr) or C-
Farnesylation (CAAX)). The two proteins were then co-expressed in mouse fibroblasts and 
continuously imaged with a confocal laser-scanning microscope. During imaging a region of 
interest (ROI) was activated with a 488 nm laser, and changes in protein localization were 
quantified as a function of time by measuring the ratio of tgRFPt fluorescence intensity inside 
the activated ROI to the intensity in a ROI of the same size outside the area of activation. The 
analysis produces a maximum intensity ratio as well as the half-life of activation and reversion 
(Table 4.1).  
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For each of these assays the iLID half of the switch was anchored to the membrane with 
a CAAX motif while Nano and Micro were diffuse in the cytoplasm. Upon activation the tgRFPt-
Nano and micro fluorescence intensity increased to produce an average maximum ratio value of 
6.36 and 4.88 respectively (Fig. 4.4A, B). As these constructs have been previously tested (14), 
we have reanalyzed all data using a standardized quantification strategy to allow comparison 
between switches.  To establish a baseline for our recruitment assay cells were also transfected 
with the mismatched pair, Venus-iLID CAAX and tgRFPt-ePDZ. No localization was observed in 
this control experiment (Fig. 4.4A, B).  
Our first experiments with the TULIP system used a similar approach, LOVpep+ was 
fused to Venus and a CAAX motif while ePDZb was fused to tgRFPt. However, with LOVpep+ 
fused to a CAAX motif the C-terminal PDZ binding motif was prevented from binding to ePDZb 
and no change in fluorescence intensity at the activated ROI was observed (Fig. 4.12A). 
Therefore, we fused the LOVpep+ to an N-Terminal myristoylation sequence, freeing the PDZ 
binding motif. Upon expression, we found that the myristoylated sequence localized to the 
plasma membrane but also localized to other membrane bound organelles. This lead to two 
issues; while the overall expression levels were similar to iLID a large portion of the protein was 
not localized to the membrane, and the portion of the protein that was in the ER could lead to 
background signal. To circumvent the second issue we chose ROIs that predominantly 
consisted of only plasma membrane bound LOVpep+ for activation and analysis. Upon light 
stimulation, we observed a small increase in protein localization (average maximum ratio value 
= 1.34) (Fig. 4.4A, B). 
The initial CRY2 publication was unable to show functionality with CRY2 bound to the 
plasma membrane (12).  However, Pathak et. al. recently maintained functionality in yeast by 
fusing CRY2PHR to the C-terminus of Mid2, a membrane anchored protein (23). We therefore 
tested 3 experimental approaches varying the switch positions as follows: Venus-CRY2PHR-
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CAAX, tgRFPt-CIB1N; Myr-Venus-CRY2PHR, tgRFPt-CIB1N; and Venus-CIB1N-CAAX, 
tgRFPt-CRY2PHR. While the CAAX fused CRY2PHR localized to the plasma membrane, the 
tgRFPt fluorescence intensity did not increase upon activation within the ROI (Fig. S5A).  Myr-
Venus-CRY2PHR had a similar localization pattern as Myr-Venus-LOVpep+ so we again 
carefully chose ROIs outside of the ER. Upon activation we observed an increase in tgRFPt 
intensity within the ROI and measured the average maximum ratio value to be 1.52 (Fig. 4.4A, 
B). Additionally, upon activation Myr-Venus-CRY2 formed large clusters at the membrane (Fig. 
4.4A inset). To better understand CRY2 cluster formation and dissociation we performed the 
same ROI analysis on the Venus channel. During activation, we observed an increase in Venus 
fluorescence intensity within the ROI, which represents cluster formation. Interestingly, we 
observed a persistent increase in intensity for ~1 min after the light was turned off, suggesting 
that the clusters continue to form after the blue light is turned off (Fig. 4.13B).  
In the experiments with Venus-CIB1N-CAAX anchored to the membrane, tgRFPt-
CRY2PHR is diffuse throughout the cytoplasm before activation. Upon activation with blue light 
the tgRFPt intensity increases within the ROI and in some cases small tgRFPt-CRY2PHR 
clusters begin to form (Fig. 4.4A inset). Surprisingly, we measured the average maximum ratio 
value to be 4.98; significantly higher than when CRY2PHR is anchored to the membrane.  
However, we hypothesized that CRY2PHR oligomerization alone may be responsible for a 
portion of the increase in fluorescence measured at the ROI. The idea being that once 
oligomerized, diffusion of tgRFPt-CRY2PHR would slow while recruiting more monomers, 
increasing the signal. We tested this hypothesis by expressing and activating tgRFPt-CRY2PHR 
alone in cells and found that this was indeed the case. CRY2PHR alone had a maximum ratio 
value of 2.67 (Fig. 4.13C and D). We also hypothesized that expressing the photoactive half of 
the switch in the cytoplasm would provide less spatial control as compared to membrane 
anchored. Our reasoning was that once activated the CRY2PHR could more easily diffuse 
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through the cytoplasm and bind to CIB1N outside of the ROI. Interestingly, the gradient of 
tgRFPt intensity peripheral to the activated ROI was similar to what we measured for the iLID 
switches where the photoactive domain was anchored to the membrane (Fig. 4.13A).  
For all of the dimers, the dissociation rate constants in cells when the light is turned off 
were longer than the in vitro measured half-lives for the photoswitches.   This may reflect that 
the in vitro experiments measured only the photocycle kinetics while in cells our measurement 
depends on photocycle kinetics as well as dissociation and diffusion. However, the 
measurements parallel the in vitro patterns and what has been previously observed. The LOV2-
based switches are all similar at about 60 sec while the CRY2PHR/CIB1N switches are slower. 
Interestingly the CRY2PHR/CIB1N reversion half-lives are dependent on the orientation of the 
switch. The Myr-Venus-CRY2 has a faster half-life at 132 s while the tgRFPt-CIB1N-CAAX is 
significantly slower with a half-life of 242 s (Fig. 4.4C).  
Except in the case of Venus-CIB1N-CAAX with tgRFPt-CRY2PHR the activation half-life 
seems to correlate with the dynamic range of the switch (larger dynamic range takes longer to 
reach equilibrium after activation) and not on the kinetics of the protein conformational change 
(Fig. 4B). This suggests that the rate-limiting step is diffusion. While we are unsure what causes 
the slower rate of Venus-CIB1N-CAAX with tgRFPt-CRY2PHR, we hypothesize that it is due to 
CRY2PHR oligomerization and is discussed further below.  
Mitochondrial re-localization assay - A limitation of the membrane localization assay is 
that it is difficult to accurately determine the portion of tgRFPt labeled protein that is at the 
plasma membrane prior to activation due to the axial spatial resolution of the microscope 
(~600nm). In the relatively flat cultured fibroblasts we used for these experiments, the apical 
and basal membrane fluorescence values are captured but cannot be distinguished from the 
cytoplasmic fluorescence. By anchoring the Venus labeled half of the switch to the 
mitochondrial membrane we were able to more accurately determine the initial amount of 
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tgRFPt labeled protein at the mitochondria relative to the cytoplasm and monitor its change 
during and after activation. Proteins were anchored to the mitochondrial membrane by fusion to 
TOM20 at the N-terminus or Mito anchor sequence from Listeria monocytogenes ActA protein 
(25) at the C-terminus. After co-expression of each half of the switch, whole cells were activated 
with 488 nm light and imaged. Using an automated ImageJ macro, we measured the ratio of 
mitochondrial to cytoplasmic fluorescence intensity throughout activation and reversion. For 
each switch this assay produces parameters describing the half-life of activation and reversion, 
a starting mito/cyto intensity (representative of dark state binding), a maximal mito/cyto intensity 
and the fold change in intensity (Table 1.). To establish a baseline for the recruitment assay 
cells were transfected with the mismatched pair, Venus-iLID Mito and tgRFPt-ePDZ. The cells 
were activated, and the data was analyzed as described above (Fig. 4.5A, B).  
Again, the data for the iLID switch has been previously reported. However, the data was 
reanalyzed using an improved ImageJ macro, which was able to better differentiate the 
cytoplasm from background. In this assay iLID was fused to the Mito anchoring domain of ActA 
while Micro and Nano were cytoplasmic. We measured the average fold change for iLID-Nano 
and Micro to be 5.4 and 5.2 respectively (Fig. 4.5A, B). As expected, the initial relative 
mitochondrial fluorescence intensity for iLID-nano is higher than iLID-micro, paralleling the in 
vitro measured dark state affinity being tighter (Fig. 4.5B). 
To test the TULIP switch we fused Venus labeled LOVpep+ to TOM20 at the N-terminus 
to preserve an accessible C-Terminal PDZ binding motif. Upon co-expression with tgRFPt-
ePDZb and activation, the switch produces an average 2.4 fold change in relative mitochondrial 
tgRFPt fluorescence intensity (Fig.4.5A, B). This fold change parallels the smaller in vitro 
measured dynamic range of binding in comparison to the iLID switches. TULIP also showed a 
lower starting mitochondrial tgRFPt intensity (0.59); again paralleling TULIP’s lower in vitro dark 
state affinity (Fig. 4.5B). 
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We tested the CRY2PHR/CIB1N switch in both orientations. We first tested TOM20-
Venus-CRY2PHR with tgRFPt-CIB1N. Unfortunately, TOM20-Venus-CRY2PHR appeared to be 
toxic to the cells and therefore expression levels in the surviving cells were significantly lower 
than all other constructs to the extent that the laser power of the microscope had to be 
substantially increased to obtain a clear image. Additionally, the distribution of mitochondria 
within the surviving cells was abnormal. Upon activation the cells did not produce a 
measureable increase in mitochondrial tgRFPt intensity (Fig. 4.12B). We therefore reversed the 
orientation of the switch. By co-expressing and activating Venus-CIB1N-Mito and tgRFPt-
CRY2PHR we measured an average 3.1 fold change in relative mitochondrial tgRFPt 
fluorescence intensity (Fig. 4.5A, B). The average initial value of mito/cyto tgRFPt was also high 
(2.88) compared to the other switches (Fig. 4.5B). This suggests a relatively tight dark state 
binding affinity. 
Functional Comparison of the Switches  
Light Controlled Transcription in Yeast - To examine if our findings from the in vitro 
binding assays and the localization studies correlate with outcomes in a functional assay, we 
used the light dimerization pairs to control transcription in yeast.  The yeast two-hybrid approach 
has previously been used to demonstrate light dependent transcription for CRY2PHR with 
CIB1N as well as ePDZb and LOVpep. We used diploids generated from mating Y187 and 
Y2HGold strains to test for the activation of the lacZ, his3 and ade2 reporter genes (Fig. 4.6A) 
transformed with the split Gal4 transcription factor constructs (Fig. 4.6B). We observe an 
assortment of induced transcription levels dependent on the protein pair used and the reporter 
gene observed. We identified strong light dependent transcription using β-galactose expression 
as readout for iLID with Nano (19.5 fold) and iLID with Micro (9.4 fold) (Fig. 4.6C and D). We 
previously showed that iLID had an improved dynamic range when compared to its parental 
construct, oLID, by a multitude of measurements. However, we were curious how the two 
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switches compared in their ability to control yeast transcription. As expected light dependent 
transcription was not detected for the oLID paired with either Nano or Micro (Fig. 4.14). In our 
hands, there was also no detectable β-galactose expression for ePDZb paired with LOVpep or 
LOVpep+. 
In addition to monitoring β-galactose expression, we also tested for light-dependent 
survival on histidine and histidine/adenine dropout plates. Interestingly, iLID when paired with 
Nano or Micro conveyed growth in the light and dark for single and double dropout plates.  In 
contrast, yeast expressing the LOVpep did not survive in the dark, but there was growth on 
histidine dropout plates in the light. On the other hand, ePDZb paired with LOVpep+ exhibited 
no detectable transcription for any reporter, which is consistent with the weaker affinities 
observed for this pair (Fig. 4.15). These results are consistent with the survival assays being 
more sensitive to low levels of expression. iLID Nano and Micro have stronger binding affinities 
in the dark than LOVpep and LOVpep+ to ePDZb, and in this context this “leakiness” is 
sufficient to allow growth even when the switch is in the inactive/dark state.   
In previous studies CRY2-DBD paired with CIB1 or CIB1N has been shown to activate 
transcription in yeast (12, 23), although the overall levels of transcription with these constructs 
were lower when compared to results with full-length CRY2.  To date the inversed orientation 
has not been reported to our knowledge. When we paired CIB1N-DBD with CRY2PHR-AD we 
observed strong light dependent expression of lacZ achieving about 9 fold difference, similar to 
when combining Micro with iLID, but overall lower levels for both light and dark levels. In 
contrast, when testing CRY2PHR-DBD with CIB1N-AD we saw no significant transcriptional 
activation of lacZ but only of his3 reporter genes, which as expected was in a light-dependent 
manner.  
Manipulation of lamellipodial protrusion - To test each pair’s ability to functionally 
manipulate a mammalian cell we targeted the Rho GTPase family. The Rho family of small 
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GTPases is known to regulate the dynamics of the actin cytoskeleton and therefore the cells 
shape. Canonically, activation of the membrane bound Rac family member produces highly 
branched actin, leading to dynamic lamellipodial protrusions (26). The inactive/active state of 
GTPases is determined by the state of the bound nucleotide (GDP/GTP respectively). Guanine 
nucleotide exchange factors (GEFs) activate GTPase by aiding in the exchange of GDP for 
GTP (27, 28). Using iLID we have previously shown that by localizing the catalytic DH/PH 
domain of a Rac GEF (Tiam) to a portion of the plasma membrane we can induce lamellipodial 
protrusions in that region (14). We therefore used this approach as a functional test of the 
CRY2PHR/CIB1N or TULIP switches. To this end, we fused the Tiam DH/PH domain to each of 
the tgRFPt labeled halves of the switch. The Tiam constructs were then co-expressed with the 
appropriate membrane bound switch half. Cells were imaged and activated in a similar manner 
to the previous membrane localization experiments, though here the activation ROIs were 
located at the edge of the cell. For each cell, the maximal protrusion distance at the ROI was 
then quantified by kymography (25). In order to,control for the background flux of a cell 
membrane under light stimulation, tgRFPt-Nano without the DH/PH domain was recruited to the 
edge of the cell. In the time frame of activation, minor changes in membrane position were 
measured by kymography and the average displacement was negligible (Fig. 4.7A, B). iLID-
Nano and Micro produced on average a maximal protrusion distance of 12.0 and 14.5 µm 
respectively (Fig. 4.7A, B). The TULIP switch caused an average protrusion distance of 1.5 µm, 
significantly less than the iLID switches (Fig. 4.7A, B). The CRY2PHR/CIB1N switches were 
again tested in both orientations (CRY2PHR or CIB1N anchored at the membrane) and 
produced an average protrusion distance of 4.2 and 2.2 µm respectively (Fig. 4.7A, B).  It is 
interesting that the scenario with CIB1N anchored in the membrane produces such a small 
effect in this assay as this configuration showed more robust co-localization of CRY2PHR and 
CIB1N with light-activation. It may be that homo-oligomerized TIAM DH/PH-CRY2PHR has 
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reduced activity. In fact, CRY2 oligomerization has previously been used to inhibt GEFs and 
GTPase activity (29). 
Correlating in vitro binding measurements with in vivo activities - The protein switches 
tested here cover a wide range of dark and lit state affinities; each with different dynamic 
ranges. For the LOV2 based switches, we found a correlation between in vitro affinities and 
behavior in living cells.  The iLID switches had the largest fold-change in binding affinity upon 
light stimulation and were the most effective at localizing protein to the plasma membrane, 
inducing cellular protrusions via localization of Tiam DH/PH, and controlling -galactose 
expression in yeast.  However, the iLID switches also had higher dark state affinities than the 
TULIP switch, which was evident in the mitochondrial localization assay where more dark-state 
localization was observed for both iLID pairs than for the TULIP switch.  Also, the iLID pairs 
exhibited more dark-state activity in the yeast two-hybrid survival assays.  
The results for CRY2 and CIB1 present a more complicated story.  First, we did not 
observe a light dependent change in CIB1N binding with full-length CRY2 purified from insect 
cells.  This may be due to an unrecognized issue with the purification of CRY2, such as a 
missing cofactor or post-translational modification.  However, the CRY2/CIB1 results also 
provide evidence for another hypothesis; which is that changes in the oligomerization state of 
CRY2 are what lead to co-localization with CIB1 in cells, rather than an intrinsic change in 
affinity for CIB1.  Evidence for this hypothesis comes from the sensitivity of the CRY2/CIB1 
system to different fusion strategies.  In cases where CRY2 homo-oligomerization could lead to 
multivalent interactions with CIB1, we observed more robust light-dependent changes.  In 
contrast, when multivalent interactions were not created, only small changes were observed 
with light stimulation.  For example, when CIB1N is fused to the plasma membrane, there is 
stronger recruitment of CRY2PHR to the membrane with light stimulation.  In this scenario, 
multivalent interactions are possible between light-induced CRY2PHR oligomers and CIB1N, 
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which is already co-localized via membrane anchoring (Fig. 4.16A).  In the reverse scenario 
where CRY2 is localized to the membrane, cytoplasmic CIB1N is monomeric and there is no 
way to generate a multivalent interaction with CRY2PHR oligomers.  With this setup, we only 
observed weak recruitment of CIB1N to CRY2PHR (Fig. 4.16B).  An alternative explanation for 
the observed behavior is that the large clusters that form when membrane anchored CRY2PHR 
is light-activated may preclude robust CIB1N binding.   
Changes in valency that accompany CRY2 oligomerization may also help explain the 
yeast two-hybrid results with CRY2/CIB1.  We observed more robust light-dependent changes 
in transcription when CIB1N was fused to the DNA binding domain.  The Gal4 DNA binding 
domain forms a dimer when bound to DNA, and therefore CIB1N–DBD is presented as a dimer 
to CRY2PHR-AD.  This may allow for a multivalent interaction when CRY2PHR oligomerizes 
and therefore enhance the affinity between CRY2PHR-AD and CIB1N-DBD.  The same 
multivalent interaction would not be created with the CRY2PHR-DBD/CIB1N-AD pair.  When 
taken together, our results and results from previous studies (19, 20, 29) indicate that CRY2 
homo-oligomerization is likely to play a significant role in the activity of the switch, and this can 
be used to enhance light-dependent signaling if multivalent interactions can be created. 
Correlating in vitro and in vivo kinetics of activation and reversion - The activation and 
reversion kinetics of the switches become important when planning experiments as they 
determine how often you must expose the proteins to blue light in order to maintain 
dimerization.  In the context of a cell this may be important in avoiding phototoxicity or regulating 
fast signaling processes. In turn, this needs to be balanced with the rate at which the switch 
needs to be fully off in the context of the experiment. The CRY2 switch reverted to dark state 
with the slowest kinetics of all switches tested. The quicker kinetics of iLID and the LOVpep 
switches give more precise temporal resolution, allowing for less lag time between light removal 
and dissociation.  One important point to note is the photocycle of AsLOV2 switches can be 
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tuned with some previously discovered mutations (30, 31), so these switches can be altered to 
fit a variety of contexts.  These mutations haven’t been tested in the heterodimerization context, 
but they may have little impact on dynamic range as they don’t directly interact with the Jα helix.  
The in cell rate of binding, except in one CRY2PHR/CIB1N orientation, seems to be limited by 
diffusion. The Venus-CIB1N-CAAX / tgRFPt-CRY2PHR produced a maximal plasma membrane 
recruitment level similar to the iLID switches. However, the rate of activation was significantly 
slower. This is surprising, as the other switches recruitment half-life were proportional to their 
dynamic range. This suggests that in addition to CRY2PHR – CIB1N binding, an additional 
process is driving the increase in tgRFPt fluorescence intensity, such as CRY2 oligomerization.  
The rates of dissociation maintain the same rank order as the in vitro measurements but are 
longer in cells. This is most likely due to rates of diffusion out of the measured ROIs. 
Interestingly, in the membrane localization assay, the CRY2PHR/CIB1N reversion rates are 
orientation dependent and may also be explained by CRY2PHR oligomerization. 
Practical considerations - Each switch contains other characteristics that we found to 
influence experimental design. While both components of iLID can be tagged on either the N- or 
C-terminus, we have found that both CRY2 and LOVpep C-terminal fusions inhibit binding to 
their partners. These stipulations have hindered particular applications in the past (10).  When 
using the CRY2/CIB1 pair, orientation specific effects must be considered.  Fusions of CRY2 
with a protein of interest can have activating or inhibiting effects, which can be used 
advantageously if designed to do so.  The time scale of experiment and physical light activation 
should also play a role in switch selection.   We noticed that for multi-day experiments, weak 
dark state affinity was crucial as even ~50 μM binding was enough to elicit activation in the 
yeast growth assays (3 days).  However, for shorter timescale responses like GTPase activation 
or transcription, tighter affinity pairs created a quicker functional output.  On these shorter 
timescales, dark state activity had less of an effect.    
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While blue light induced dimers provide a powerful set of tools for use in cellular 
optogenetics there are some technical challenges that are worth considering. In our hands, high 
intensity blue light is cytotoxic.  For this reason, it is imperative to optimize the light conditions 
used for your experiment.  We have found that for confocal microscopy, that exposure to 1% of 
our 25mW Argon laser every 10s is enough to fully activate each of the switches tested without 
causing cytotoxic effects within the time periods presented here.  Furthermore, imaging multiple 
fluorescent proteins without spectral overlap with the photoactive domain proved challenging. 
Here we have imaged Venus and tgRFPt but have relied upon a suboptimal GFP filter set for 
imaging of Venus which leads to a high signal to noise ratio for that channel as we are not 
collecting the entirety of light emitted from the fluorophore.  While this setup works, we 
recommend labeling your protein or signal of interest with tgRFPt.  Alternatively, filter sets 
compatible with photoactivation and desired fluorophores can be custom ordered.  
In conclusion, through rigorous benchmarking we have determined in vitro, in vivo and 
functional characteristics of three sets of blue light inducible dimers. This information can be 
used to guide future efforts aimed at cellular optogenetics. 
4.4 Materials and Methods 
Cloning - All clones are available via Addgene. iLID, LOVpep, and WT AsLOV2 were all 
cloned into pQE-80L BamHI and HindIII sites for E. coli expression with an N-terminal 6x His 
tag.  The respective binding partners, SspB Nano & Micro, and ePDZb were cloned into a 
modified pQE-80L vector (BamH1/HindIII sites) with an N-terminal 6xHis-MBP-TEV tag.  Both 
full length AtCRY2 as well as the PHR domain alone was cloned into the SalI site of the 
pFastBac HT A vector for insect cell expression.  Recombinant bacmid DNA was made in 
DH10Bac E. coli cells and virus amplified in Sf9 insect cells. CIB1N was cloned into the BamH1 
and HindIII sites of pQE-80L for expression in E. coli with a 6xHis-tag. All mammalian constructs 
were cloned into the pLL7.0 lentiviral vectors. Expression is therefore driven by a CMV 
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promoter. The constructs were assembled by PCR based overlap extension, enzyme restriction, 
and ligation or through Gibson assembly. 
Expression and Purification - Bacterial expression was performed as follows: BL21(DE3) 
cells were transformed through heat shock with each of the expression vectors.  For each 
construct, 1.5L of LB media was inoculated and grown at 37°C to OD 0.6 and induced with 
333mM IPTG.  iLID, LOVpep, AsLOV2, SspB nano & micro, and ePDZb were expressed at 
18°C for 16 hours.  CIB1N was expressed at 25°C for 6 hours.  After expression, cells were 
spun down at 3500 rpm for 10 minutes and pellets were frozen until purification.  Insect cell 
expression was performed as follows: SF9 cells were inoculated with baculovirus at an MOI of 
10 and expressed at 27°C for 48 hours according to (32).  After 48 hours, cells were spun down 
at 2000 rpm, washed with cold PBS buffer and frozen at -80°C until purification.  Bacterial cell 
pellets of LOV based switches and their binding partners were resuspended in phosphate lysis 
buffer (50 mM sodium phosphate pH 7.5, 500 mM NaCl, 20 mM Imidazole, 100 μM PMSF) and 
sonicated.  Cell lysates were spun down for 30 minutes at 20,000 rpm.  Cell supernatants were 
filtered with a 5 μm filter, run over HisTrap HP columns (GE) and eluted with elution buffer (50 
mM sodium phosphate pH 7.5, 500 mM NaCl, 500 mM Imidazole, 100 μM PMSF).  Proteins 
expressed as 6xHis-MBP fusions were dialyzed overnight in PBS with TEV protease and re-run 
over HisTrap columns to separate the protein of interest from His-MBP.  Finally, all proteins 
were passed over at Superdex 75 column (GE) as a final clean up and buffer exchange to PBS 
(10 mM dibasic sodium phosphate, 1.8 mM monobasic potassium phosphate, 137 mM NaCl, 
2.7 mM KCl, pH 7.4) for characterization.  AtCRY2 and CIB1N purification was similar to the 
above protocol except Tris buffers were used instead of phosphates buffers as previously 
published (32).  Insect cells were lysed by sonication without detergents to prevent 
contamination.  The final size exclusion buffer for both AtCRY2 and CIB1N was 50 mM Tris-HCl 
pH 7.4, 250 nM NaCl, 5 mM BME.  We also expressed AtCRY2PHR domain (domain necessary 
107 
 
for dimerization) of AtCRY2 alone, but poor yields precluded in vitro experiments with this 
variant.  Most of the dimer systems expressed highly and we had little handling or solubility 
issues with them.  The notable exception was AtCRY2, which precipitated at concentrations 
above 20 μM. 
Fluorescent Probe Generation - To measure direct binding between AtCRY2-CIB1N, 
CIB1N was labeled with 5(6)-TAMRA (Anaspec) at a single cysteine residue; position 103.  
Purified proteins were buffer exchanged on PD-10 desalting columns (GE) into 20mM Tris-HCl 
pH 7.5, 150mM NaCl, 1mM TCEP.  Ten-fold excess dye was added to the prep and was left on 
a rotator at 4°C overnight.  Labeled proteins were then passed through another PD-10 column 
to remove free dye.  Absorbance at 555 nm (ε=65,000 M-1 cm-1) was used to quantify dye 
concentration and BCA assay (Thermo Scientific) was used to quantify protein concentration.  
Competitive binding assays were used to measure binding for the iLID and LOVpep systems.  
The sequence for the LOVpep competitor peptide was 5(6)TAMRA-EEIDKAVDTWV and the 
sequence for the iLID competitor peptide was 5(6)TAMRA-QIEEAANDENY. 
Fluorescent Polarization Binding Assay - Fluorescence polarization measurements were 
recorded using a Jobin Yvon Horiba FluoroMax3 fluorescence spectrometer.  All binding assays 
except CRY2/CIB1N were performed in PBS buffer in either a 1 cm or 1 mm quartz cuvette at 
25 °C.  CRY2/CIB1N binding was performed in a Tris (20mM Tris-HCl, pH 7.4, 200 mM NaCl, 5 
mM BME) buffer due to solubility issues.  Polarization of TAMRA was measured with excitation 
at 555 nm and emission at 584 nm. For AtCRY2-CIB1N binding, the concentration of TAMRA-
CIB1N started at 200 nM and AtCRY2 was titrated in. At each titration point, the sample 
chamber was illuminated with 6.0 mW cm-2 blue light using a collimated blue led array.  A lit 
state time point was taken immediately after removal of the blue light and another 5 minutes 
later for AsLOV2 binding and 10 minutes later for AtCRY2 binding.  Initial affinities of the iLID 
and LOVpep competitor peptides were measured through direct binding titrations.  Starting 
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peptide concentrations were 25 nM for the iLID peptide and 250 nM for the LOVpep peptide.  
For iLID nano competitive binding assays, 25 nM peptide and 40 nM SspB nano were incubated 
with enough competitor to bind approximately 60% of peptide prior to titration.  Competitive 
binding titrations were illuminated with blue light as in the direct binding assays and dark state 
measurements were taken after 5 minutes of darkness. 
Multi-Angle Light Scattering - SEC-MALS experiments were performed on a Wyatt 
DAWN HELEOS II light scattering instrument interfaced to an Agilent FPLC System with a 
Superdex S200 column, Wyatt T-rEX refractometer and Wyatt dynamic light scattering module.  
CRY2 samples were prepared at 15 μM (in 50 mM Tris-HCl pH 7.4, 250 nM NaCl, 5 mM BME) 
and run through the S200 either in the presence of blue light (2 mW cm-2, blue led array) or in 
darkness. 
Dynamic Light Scattering - CRY2 oligomerization was measured in a DynaPro Dynamic 
Light Scattering Plate Reader at room temperature.  CRY2 at 15 μM was illuminated with blue 
light (6.0 mW cm-2 blue light, collimated blue led array) for 1 minute and placed in the 
instrument.  Measurements were taken every 5 seconds for 20 minutes. 
Absorption Recovery after Activation - Excited state recovery times were measured 
using a Cary 50 UV-Visible Spectrophotometer.  Samples were irradiated with blue light (6.0 
mW cm-2 blue light, collimated blue led array) and absorbance at 450 nm was recorded until 
recovery. 
Yeast Plasmids Generation - Clontech pGBKT7 vector was modified to substitute the 2µ 
origin with CEN4 origin of replication by restriction digest with SacI and XmaI introduced from 
primers of a vector PCR and CEN4 from pNIA-CEN-MBP (33) yielding pGBKT7-CEN. 
CRY2PHR (1-498) was cloned with NdeI and NotI, ePDZb with NdeI and BamHI and finally, 
SspB Nano and Micro were cloned with EcoRI and BamHI into the newly generated pGBKT7-
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CEN plasmid. Additionally, CIB1N (1-170) was cloned in the original pGBKT7 vector using NdeI 
and BamHI. CIB1N was cloned in pGADT7 with NdeI and BamHI, LOV-pep and variant were 
cloned as well as oLID and iLID were cloned with EcoRI and BamHI. Finally, CRY2PHR was 
cloned in pGADT7 via NdeI and NotI restriction digest as well.  All plasmids were sequence 
verified using Eurofins DNA sequencing service. 
Yeast Transformation and Mating - The resultant plasmids were transformed via high 
efficiency lithium acetate transformation (34) in Y187 for pGADT7-derived plasmids and 
Y2HGold for pGBKT7-derived plasmids. After about 72 hours, single colonies for each were 
isolated and inoculate 0.5 mL YPD culture overnight in order to mate them and generate the 
respective diploids. The next day, the mated yeast were pelleted at 3000 rpm for 5 minutes and 
plated on douple dropout plates (SC-Leucine/-Tryptophane). 
β-Galactose Assay - β-Galactose assay were performed as follows: Freshly mated yeast 
colonies were grown for about 36h at 30°C in 5 ml SC-Leu/-Trp. Cell density was measured at 
OD600 and 2.5 mL cultures were diluted to OD600 = 0.2 in duplicates – one for a light and 
another for a dark condition (falcon tubes were wrapped in aluminium foil). Cultures were grown 
at 30°C in a shaking incubator (250 rpm) for 3 hours in the dark and then for another 4 hours 
under blue light (465 nm) at 500 µW/cm2 via LED strip light wrapped around the tube rack. The 
resulting cultures were pelleted in triplicates and β-Galactose assay using CPRG for a substrate 
was performed according Clontech yeast handling protocols. 
Yeast Growth Assays - Survival assays were performed as follows: Fresh colonies were 
grown for about 36 h at 30°C in 5 ml SC-Leu/-Trp. Cell density was measured at OD600 and 
cultures diluted in 200 µl of OD600 = 1, followed by eight 5-fold serial dilutions. Then, 2 µl of 
each of the dilutions were pipetted and spotted using a multichannel pipette (Gilson) onto 
respective dropout plates. The dark condition plates were wrapped in aluminum foil and placed 
in the same incubator as the lit condition at 30°C. Continuous blue light (465 nm) at 500 
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µW/cm2 was provided with LED strip lights attached at the incubator. Yeast plates were imaged 
after 70 hours incubation, the resulting images were cropped and arranged using Adobe 
Photoshop. 
Mammalian Cell Culture and Transfection - Mouse IA32 fibroblasts were cultured in 
DMEM supplemented with 10% (vol/vol) FBS (HyClone), 100 U/ml penicillin, 100 µg/mL 
streptomycin, and 292 µg/mL L-glutamine. Cells were cultured at a constant 37 °C and 5% 
(vol/vol) CO2. Cells were transiently transfected in 6 well cell culture dishes using 1 µg total 
DNA at 1:1 ratio and NanoJuice (EMD Millipore) transfection reagent as recommended by 
manufacturer. 
Mammalian Cell localization/GEF Microscopy - Experiments were performed according 
to the methods found in Guntas et al. Briefly, cells were co-transfected with two vectors 
containing the sequences encoding each component of the switch in equal parts. 24 hr later 
tranfected cells were trypsonized and transferred to 3.5 cm MatTek glass bottom dishes coated 
with a 10 ug/ml solution of fibronectin. 24 – 48 hr later cells were imaged and photo-activated 
with an Olympus FV1000 confocal microscope equipped with a 1.30 N.A. 40x oil immersion 
objective. The Fluoview software Time Controller was used to produce a timeline of image 
acquisition and photo-activation using the same standard parameters found in Guntas et al.  
These standard settings were meant to keep protein expressions levels similar between the 
switches as only cells whose fluorescence fell within the dynamic range that these settings 
could capture were imaged.  Activation parameters were also kept constant between samples. 
In short laser power was set at 1% for the 488nm line. For whole cell activation the entire field of 
view was activated in a 512x512 pixel grid with a 2us/pixel dwell time and repeated 5x. before 
the next image was acquired. For ROI activation a 60x60 pixel grid was activated with a 
8us/pixel dwell time and repeated 10x before the next image was taken.  
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Image analysis and quantification - All images were analyzed using FIJI software. Spot 
localization was quantified according to Guntas et al. Briefly the tgRFPt fluorescence intensity 
was measured within the activated ROI and an initial intensity and size matched area outside 
the activated ROI. A ratio of fluorescence intensity inside : outside the ROI  was analyzed 
throughout time. The values that correspond to the period of activation were fit to the equation 
Y= 1 + Ymax*(1-exp(-K*X)). The values that correspond to the period of reversion were 
normalized to the maximum values and fit to the equation Y=(Y0 - Plateau)*exp(-K*X) + 
Plateau. Whole cell activation was quantified with an improved version of the method described 
in Guntas et al. Mitochondrial ROIs (Mito) are determined by automated thresholding of the 
tgRFPt channel. Cytoplasmic ROIs (Cyto) were determined by first creating a 5 pixel buffer 
outside of the Mito and selecting a ROI 10 pixels outside of that. The cytoplasmic ROIs were 
further refined by removing a small subset of pixels that are representative of the background. 
The values described in the paper are the average tgRFPt fluorescence intensities from the 
algorithmically determined ROIs expressed as (Mito-Cyto)/Cyto. Cytoplasmic values were first 
subtracted from mitochondrial values to remove any fluosecence signal contributed by the 
cytoplasm above and below the mitochondria. Curves were fit to the values during the activation 
and reversion periods using the equations Y=S+Ymax*(1-exp(-K*X)) & Y=(Y0 - Plateau)*exp(-
K*X) + Plateau respectively. The fold change was determined by (S+Ymax)/S. All curve fittings 
were performed using Prism (GraphPad) software. The protrusion distance reported in the Tiam 
DH/PH localization experiments was measured by kymography. A line one pixel thick was 
drawn through each of the activated ROIs. The image values through time along that line were 
concatenated to form a new image. This image was then used to determine the initial and 
maximal position of the membrane within the time of activation to determine the maximum 
protrusion distance. 
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4.6 Figures 
 
Figure 4.1: Binding affinities of lit and dark states highlight difference in photoswitch 
dynamic range. Fluorescence polarization binding plots for A) LOVpep constructs and ePDZb 
(left) iLID nano and micro (middle) and CRY2 and CIB1N (right).  B) Fluorescence polarization 
of each complex was measured under blue light (blue) or darkness (black) to determine binding 
affinity. C) Affinity values from binding data plotted on a Dynagram highlight the dynamic range 
of each tool.  
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Figure 4.2: Light induces CRY2 oligomerization. A) Size exclusion chromatography multi-
angle light scattering traces for full length CRY2 run under blue light (blue line) or darkness 
(black line).  Fit molecular weight from MALS data for each peak is shown for lit (blue dots) and 
dark (black dots) peaks. B) Reversion of light induced oligomer to monomer by dynamic light 
scattering.  Blue bar represents blue light irradiation of sample; grey bar represents instrument 
dead time before initial measurement  
117 
 
 
Figure 4.3: Photoreceptor reversion kinetics. Thermal reversion kinetics of the excited state 
for each photoreceptor show differences in timescale of deactivation.  Reversions were 
measured at room temperature in Tris-HCl buffer.  
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Figure 4.4:  Targeted localization to the plasma membrane shows differences in switch 
dynamic range and kinetics. A) Representative images of the data analyzed in B and C. Cells 
transfected with each membrane bound switch pair were visualized and activated by confocal 
microscopy. Venus labeled constructs are bound to the plasma membrane while tgRFPt labeled 
constructs are cytoplasmic.  The activated ROI is identified by the blue arrow. The activation and 
post activation images represent the final image of the specified time frame. (Bar = 50 μm) B) A 
ratio of tgRFPt fluorescence intensity inside the activated ROI to outside the activated ROI during 
the period of activation as shown in A. C) A normalized ratio of tgRFPt fluorescence intensity 
inside the activated ROI to outside the activated ROI during the period of activation as shown in 
A. 
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Figure 4.5: Targeted mitochondrial localization identifies differences in dark state binding 
dynamic range and kinetics. A) Representative images of the data analyzed in B. Cells 
transfected with each mitochondrial bound switch pair were visualized and activated by confocal 
microscopy. Venus labeled constructs are bound to the plasma membrane while tgRFPt labeled 
constructs are cytoplasmic. The entire field of view is activated. The activation and post activation 
images represent the final image of the specified time frame. (Bar = 50 μm) B) A ratio of 
mitochondrial to cytoplasmic RFP fluorescence intensity throughout the experiments shown in A.  
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Figure 4.6: Yeast two hybrid transcription comparison A) A schematic of the genome 
reporters. B) A schematic of the constructs tested. C) ß-galactose transcription induced with the 
iLID paired with Nano or the Micro (n = 9 each, mean reported ± SEM and statistical significance 
is calculated with unpaired two-tailed t-student’s test (p<0.0001)) and D) CIB1N with CRY2PHR 
(n = 3 each, mean reported ± SEM and statistical significance is calculated with unpaired two-
tailed t-student’s test (p<0.0001)) (Blue Bars – growth under continuous blue light at 465nm, Black  
Bars – growth in the dark). 
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Figure 4.7: Targeting Tiam DH/PH domains to the plasma membrane with each switch 
causes varying degrees of protrusion.  A) Representative images of the data analyzed in B. 
Cells transfected with each membrane bound Tiam DH/PH switch pair were visualized and 
activated by confocal microscopy. Venus labeled constructs are bound to the plasma membrane 
while tgRFPt labeled constructs are cytoplasmic.  The activated ROI is is represented by the blue 
square. (Bar = 50 μm) B) Protrusion distances for each cell were measured by kymography. 
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Figure 4.8 Addition of MTHF does not significantly change CRY2-CIB1N binding. Direct 
fluorescence polarization binding experiment of CRY2 to CIB1N with the addition of MTHF, a 
possible CRY2 cofactor. 
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Figure 4.9 Binding measured by native gel shift indicates weak binding. Titration of TAMRA 
labeled CIB1N with CRY2 at indicated concentration.  Samples were prepared identically and run 
on two native-PAGE gels, one in the presence of blue light and one in darkness.  Binding is 
indicated by shift of TAMRA-CIB1N to higher molecular weight species.  Binding affinity does not 
appear to change drastically with addition of blue light. 
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Figure 4.10 Addition of MTHF does not change CRY2 oligomerization. Size exclusion 
chromatography multi-angle light scattering traces for full length CRY2 with saturating MTHF 
cofactor added run under blue light (blue line) or darkness (black line). Fit molecular weight from 
MALS data for each peak is shown for lit (blue dots) and dark (black dots) peaks.  Elution traces 
from Figure 3 are shown in grey dashed lines for comparison. 
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Figure 4.11 CRY2 and CIB1N do not fully co-elute in size exclusion chromatography.  
Analytical size exclusion chromatography traces of CRY2 alone (dashed line), CRY2+CIB1N 
(solid line), and CIB1N alone (grey line) while A) under blue light and B) in darkness.  Vertical 
dashed lines indicate void volume and peaks of Lit or Dark CRY2 for comparison to CRY2+CIB1N 
traces.   
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Figure 4.12 For CRY2PHR/CIB1N and TULIPs, orientation matters for function. a) CRY2 and 
TULIP switches do not function in particular orientations in respect to the plasma membrane 
localization. b) CRY2PHR anchored to the mitochondria is toxic to cells and does not function in 
binding CIB1N upon activation. (Bar = 50 μm) 
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Figure 4.13 CRY2PHR oligomerization affects observed binding in cells. A) CRY2PHR in the 
cytoplasm has similar spatial resolution of activation to the iLID switches anchored to the 
membrane. B) Myr-Venus-CRY2PHR clusters form slower than CIB1N binding occurs and 
continues to form after stimulation. C) Representative images of tgRFPt-CRY2PHR alone signal 
increase upon activation. (Bar = 50 μm)  D) Quantification of tgRFPt-CRY2PHR alone signal 
increase upon activation as compared to CRY2PHR in combination with CIB1N.  
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Figure 4.14 oLID does not allow light dependent transcription in yeast ß-galactose 
expression under blue light or dark for oLID paired with Nano or Micro (n = 9 each, mean reported 
± SEM and statistical significance is calculated with unpaired two-tailed t-student’s test). NS – not 
significant. 
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Figure 4.15: Light dependent growth on dropout plates demonstrates that low-level 
transcription is achieved for ePDZb-LOVpep and CRY2PHR-CIB1N A) Y2H positive control 
p53-DBD paired with Large T-antigen-AD, B) Y2H negative control empty pGBKT7 and pGADT7 
vectors, C) CRY2PHR-DBD paired with CIB1N-AD, D) CIB1N-DBD paired with CRY2PHR-AD, 
E) ePDZb-DBD paired with LOVpep, F) ePDZb-DBD paired with LOVpep+, G) Nano-DBD paired 
with iLID-AD, H) Micro-DBD paired with iLID-AD. 
132 
 
  
 
Figure 4.16 Model of how CRY2PHR oligomerization enhances CIB1N binding in an 
orientation dependent manner. A) CIB1N-CAAX gains multivalency through localization at the 
membrane. Upon light stimulation CRY2PHR oligomerizes, enhancing affinity for CIB1N through avidity. 
B) CRY2PHR-CAAX forms oligomers at the membrane upon light stimulation. However, monomeric CIB1N 
binds without the avidity affect modeled in A. 
 
 
CIB1N-CAAX CRY2PHRA
B Myr-CRY2PHR CIB1N
133 
 
4.7 Supporting Information 
Table 4.1 Characteristic Optogenetic Switch Values 
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CHAPTER 5: CELLS LAY THEIR OWN TRACKS: OPTOGENETIC ACTIVATION OF CDC42 
STIMULATES LOCALIZED FIBRONECTIN DEPOSITION IMPORTANT FOR DIRECTED 
MIGRATION 
5.1 Overview 
Rho GTPase family members are known regulators of directed migration and therefore 
play key roles in processes including development, immune response and cancer metastasis. 
However, their individual contributions to these processes are complex.  Here, we directly target 
the activity of two family members, Rac and Cdc42, by optogenetically recruiting specific GEF 
DH/PH domains to defined regions on the cell membrane. We find that the localized activation 
of both GTPases produce lamellipodia in cells plated on a fibronectin substrate. Using a novel 
phototaxis assay, we show that biased activation can drive directional migration. Interestingly, in 
the absence of exogenous fibronectin, Rac activation is insufficient to produce stable 
lamellipodia or directional migration while Cdc42 activation is sufficient. We find that a 
remarkably small number of fibronectin molecules (<10) are necessary to support stable 
GTPase-driven lamellipodia. Cdc42 bypasses the need for exogenous fibronectin by stimulating 
cellular fibronectin deposition through N-WASP activation under the newly formed lamellipodia. 
5.2 Introduction 
A cell’s ability to sense extracellular cues and respond with directed migration is central 
to many pathological and physiological conditions such as development, wound healing, 
immune response and cancer metastasis (1). For directional migration to occur a differential cue 
is first sensed through transmembrane receptors, transduced and amplified into a differential 
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intracellular signal and eventually manifested into a physical force aligned with the extracellular 
gradient through cytoskeletal reorganization. One form of directional migration that has received 
recent attention is haptotaxis where the cell is responding to substrate cues such as differential 
ECM concentrations. The basic module of ECM sensing consists of transmembrane receptors, 
mainly integrins, and the multimeric protein complexes that assemble at the cytoplasmic side 
where integrins cluster (2, 3). We recently found that fibroblast haptotaxis requires biased 
lamellipodial dynamics using protrusions formed by Arp2/3-branched actin (4). Furthermore, we 
linked the graded ECM sensing module to the cytoskeletal dynamics and directed migration 
through a pathway including the known adhesion signal transducer and Rac-specific GEF, 
Tiam, and activation of the Rac GTPase. 
Rho-family GTPases are one of several downstream intracellular signaling nodes that 
spatially and temporally transduce extracellular cues into cytoskeletal remodeling (5). Two 
critical members of the family are Rac and Cdc42. While we showed that Rac is essential for 
haptotaxis in fibroblasts, others studies have shown that localized activity of Cdc42 is critical 
during directed migration (6). Rac and Cdc42 activities are highest at the front where they 
regulate actin polymerization to drive the plasma membrane in the direction of the cue (1, 6, 7). 
Rac activity produces branched actin and lamellipodia while Cdc42 produces bundled filaments 
and filopodia (5). While this simplified view of the Rho family provides an easy-to-grasp model of 
their role in polarization and directed migration, they are also involved in other motility relevant 
processes such as endocytosis, exocytosis, ECM remodeling and microtubule dynamics (8–11). 
Further complicating the matter, many GTPases cross-regulate other GTPases (12, 13). For 
example, early work from Alan Hall’s group showed that Cdc42 activity produced lamellipodia. 
Only upon inhibition of Rac did Cdc42 produce filopodia, pointing to a close interplay of the two 
proteins (14). The multi-faceted functions of Rho family activity as well as their interconnected 
signaling makes it difficult to study the cause and effect relationships of their individual roles in 
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directed migration. Normally, directed migration is studied by supplying cells with a graded 
extracellular cue while genetically and/or pharmacologically manipulating intracellular 
components on a whole-cell basis. While these methods have produced informative results, 
much is left to be learned by directly manipulating the spatial and temporal activity of individual 
components within cells.  
Cellular optogenetics provides the means to do just that. Optogenetics takes advantage 
of engineered light sensitive proteins to manipulate the localization and/or activation state of a 
protein of interest. Guanine nucleotide exchange factors (GEFs) activate GTPases by aiding in 
the exchange of GDP for GTP (15). Each GEF has a functional domain (DH/PH) with a specific 
affinity for one or more GTPase. For example, several studies have shown that the DH/PH 
domains of Tiam1 and Intersectin1 (ITSN) are highly specific for Rac and Cdc42, respectively 
(16–19). Here, we employ the improved light inducible dimer (iLID) system to drive the DH/PH 
domains of Tiam and ITSN to the cell membrane to specifically activate Rac or Cdc42 in the 
presence of light to study protrusion and directional migration (20).  
 
5.3 Results 
Optogenetically-biased GTPase activity is sufficient to spatially regulate lamellipodia 
protrusion and directed migration.Previous work has shown that spatial and temporal Rho family 
GTPase activity functions to regulate cytoskeletal remodeling during cell polarization by 
producing lamellipodial protrusions in the front. Here we use a light inducible dimer system 
(iLID) to separately localize two GEF DH/PH domains to the plasma membrane where they 
function to activate specific Rho GTPases (Fig. 5.1A). iLID was fused with a yellow fluorescent 
protein (Venus) and a CAAX motif which localizes the protein to the plasma membrane. The 
iLID binding partner, SspB_Micro (referred to here as Micro), was genetically fused with 
tagRFPt (RFP) and the DH/PH domain of either Tiam or Intersectin (ITSN) to target Rac and 
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Cdc42 GTPases respectively. We used a laser scanning confocal microscope to stimulate a 
small region of interest (ROI) at the cells edge. Upon illumination with 488 nm light, the DH/PH 
domains were localized from the cytoplasm to the cell membrane within the ROI. In the cells 
expressing the Tiam DH/PH construct (abbreviated Tiam-Micro throughout), a lamellipodial 
protrusion formed locally with respect to the ROI as we expected for Rac activation (Fig. 5.1B). 
However, stimulation of cells expressing the ITSN DH/PH construct (abbreviated ITSN-Micro 
throughout), also formed lamellipodial protrusions within the stimulated ROI. This was an 
unexpected result since canonically Cdc42 activity is thought to induce filopodia. Importantly, 
localization of control RFP-Micro (without any DH/PH component) left the cell’s morphology 
unchanged (Fig. 5.1B).  
O’Neil et. al directly tested the ability of the Tiam and ITSN-Micro switches to activate 
Rac and Cdc42 by imaging translocation-based biosensors while activating iLID (21). Here, by a 
similar means, we test the specificity of each DH/PH domain. We used GTPase binding 
domains (GBD, pGBD binds active Rac, rGBD binds active Cdc42) fused to a yellow fluorescent 
protein (Venus or YPet) to image GTPase activity upon localization of each DH/PH. We found a 
corresponding local increase in pGBD but not rGBD signal upon Tiam localization (Fig. 5.8A 
and B). Upon ITSN localization both pGBD and rGBD signals increased, most likely due to 
crosstalk between Cdc42 and Rac (Fig. 5.8 C and D). To ensure that the biosensor signal 
increases that we observed was not due to an increase in volume in the activated area, we also 
imaged soluble Venus upon stimulation and found no corresponding increases in signal. (Fig. 
5.8A-E) 
Based on these findings we hypothesized that a biased localization of DH/PH domain 
would functionally bias cell migration towards high light intensities. To test this, we designed a 
device to create a stable blue light gradient. The device consists of a 467 nm LED light source 
projecting through a 3D-printed housing containing a graded neutral density filter; producing a 
139 
 
graded light intensity. The housing is placed on top of a 35 mm glass bottom dish, mounted on a 
microscope and imaged over 12-20 hours (Fig. 5.1C and D, Fig. 5.9A and C). The collected 
bright field image produced by the light gradient was sufficient for whole cell tracking purposes 
(Fig. 5.9C). We measured the gradient of light by analyzing line scans parallel to the direction of 
the gradient and found that, on average, the device produced a 2% gradient over 100 µm (Fig. 
5.9B). In pilot experiments, using Tiam-Micro/iLID-CAAX expressing cells plated on fibronectin 
(FN)-coated glass, we found that cells expressing each protein at high levels would flatten out in 
all directions and become largely immobile. Based on this, we sorted a stable population of low 
expressing cells using fluorescence activated cell sorting. To measure directional motility, we 
manually tracked all cells and calculated the forward migration index (FMI, net distance in 
relation to the gradient divided by the total path length, Fig. 5.9D) for each cell. For the purpose 
of this study, we considered a postitive FMI with 95% confidence intervals not encompassing 0 
as directional migration. Consistent with our visual impression, we found that cells expressing 
high levels of the optogenetic components did not migrate while low expressing cells did (Fig. 
5.9E). Although not directly tested, we assumed that the signaling produced by the switch in 
high expressing cells was saturated across the entire cell independent of the light intensity. 
Using the low expressing population, we found that the direction of cell migration was biased 
toward the higher intensity of light as measured by forward migration index (FMI). However, the 
bias was small. To find the optimal light intensity along the gradient, we imaged 5 equally 
spaced sections along 1 cm of the gradient, tracked cells in each, and found a biphasic 
response in FMI values (Fig. 5.1D and E). The area producing the optimal FMI was used in all 
subsequent experiments. Cells expressing either Tiam- or ITSN-Micro/iLid-CAAX plated on FN 
coated glass migrated directionally toward the higher intensity light while the cells expressing 
the RFP-Micro control migrated randomly (Fig. 5.1F). Interestingly, cell velocities varied 
depending on the DH/PH. These data show that spatially biased GTPase activity is sufficient to 
induce directional cell migration. We named this phenomenon “phototaxis”. 
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Arp2/3 is necessary for optogenetically induced lamellipodia and phototaxis. Previous 
work from our group and others have shown that fibroblasts require the Arp2/3 complex for 
lamellipodia formation (22, 23). Since localization of both DH/PH domains formed lamellipodia 
and biased directional migration, we hypothesized that perturbing Arp2/3 activity would inhibit 
the optogenetic induction of lamellipodia and phototactic fidelity. Using fibroblasts harboring a 
conditional allele of the Arpc2 gene, we produced cells genetically null for the p34 subunit 
(encoded by the Arpc2 gene) of the Arp2/3 complex. We illuminated small regions of interest in 
the parental (Arpc2+) and null cells expressing iLID-CAAX with either Tiam or ITSN-Micro. As 
expected, Tiam localized to the membrane within the ROI and produced a lamellipodium in the 
parental line, but this treatment did not produce detectable morphological changes in the null 
cells (Fig. 5.2A). However, while ITSN localization produced lamellipodia formation in the 
parental line, we observed that local filopodia formation occurred in the p34 null cells with 
exposure to light (Fig. 5.2D). This is consistent with ITSN localization to the membrane inducing 
filopodia formation through Cdc42 activity. This further suggests that ITSN may induce 
lamellipodia formation in the parental cells through GTPase crosstalk, with Arp2/3-containing 
lamellipodia overwhelming the smaller filopodial structures. 
We next tested the necessity of Arp2/3 in Tiam and ITSN-based phototaxis by treating 
fibroblasts with CK666 (Arp2/3 inhibitor) while performing the previously described phototaxis 
assay. We found that cells inhibited by CK666 migrated randomly in both cases while control 
DMSO treated cells migrated in the direction of the more intense light (Fig. 5.2B and E). To 
ensure the efficacy of CK666, each dish was fixed, permeabilized, and stained for the p34 
subunit of Arp2/3 and phalloidin. Cells treated with CK666 almost entirely lacked p34-positive 
lamellipodial structures (Fig. 5.2C and F). These data suggest that Arp2/3 activity is necessary 
for differentially localized Rac or Cdc42 activity to bias migration direction. In the case of ITSN 
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localization, it also implies that biased filopodia are not sufficient to bias directionality of whole 
cell migration. 
Exogenous FN is necessary for Tiam but not ITSN induced phototaxis. We previously 
found that Arp2/3 and lamellipodia were necessary for haptotaxis and that a haptotactic gradient 
of FN reinforced Tiam-induced lamellipodial protrusions in the direction of higher FN 
concentrations (4). We were therefore interested in whether a FN substrate was necessary for 
Tiam and ITSN induced phototaxis. To test this, we coated glass bottomed dishes with either 10 
µg/mL FN back-filled with 0.01% poly-L-lysine (poly-LL) or 0.01% poly-LL alone and performed 
phototaxis assays for both Tiam and ITSN-Micro / iLID-CAAX expressing cells. Poly-LL allows 
cells to adhere to the glass substrate through electrostatic interactions with cell glycocalyx but 
without specific receptor-ECM interactions. In the case of Tiam-induced phototaxis, cells on FN 
migrated directionally towards the higher intensity light, while cells on poly-LL migrated 
randomly (Fig. 5.3A). Interestingly, ITSN expressing cells moved directionally independent of 
the substrate on which they were plated (Fig. 5.3B). Interestingly, in both cases cells on poly-LL 
migrated slightly faster (Fig. 5.3A and B). These results raised two connected yet separate 
questions: 1. Why is differential Tiam localization (Rac activity) insufficient to directionally bias 
migration in the absence of a FN substrate? 2. Why is differential ITSN localization (Cdc42 
activity) sufficient to directionally bias cell migration independent of an ECM substrate?  
A small number of FN molecules is sufficient to reinforce Tiam induced protrusions. To 
address our first question, we used Tiam-Micro/iLID-CAAX expressing fibroblasts to perform 
single cell activation assays on FN or poly-LL coated dishes. We first ensured that poly-LL pre-
coating blocked surface adsorption of FN from the serum component of our media (10% fetal 
bovine serum). (Fig. 5.10A). Using these conditions, we found that cells plated on 10 µg/mL FN 
formed stable protrusions upon light activation within the ROI (Fig. 5.4A). Using kymography, 
we found that, on average, the induced protrusions extended about 12 µm during the period of 
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activation (Fig. 5.4A and B). However, cells activated on poly-LL-coated substrates formed a 
series of ruffle-like lamellipodial protrusions that were quickly retracted and the overall distance 
protruded during activation was negligible (less than 5 µm; Fig. 5.4A and B). To determine how 
much FN was required to support stable protrusions, we coated with 10-fold dilutions of FN back 
filled with poly-LL and performed the same assay. We hypothesized a linear relationship 
between coating concentration and protrusion distance. However, we found that on any coating 
concentration greater than or equal to 10-3 µg/mL FN cells protruded to a similar average 
distance as cells on 10 µg/mL FN. At any concentration less than 10-3 µg/mL , cells ruffled (Fig. 
5.4B). Importantly, extracellular staining of FN on cells plated on poly-LL revealed that cells 
produced and secreted their own FN, but it was not found in regions beyond the cell perimeter. 
(Fig. 5.10C) This suggests that de novo protrusions produced via the optogenetic switches are 
dependent on exogenously supplied FN present under the area of the new protrusion. 
The surprising ability of a cell to form robust protrusions at such low coating 
concentrations of FN prompted us to test the relationship between FN coating concentration and 
the concentration of FN adhered to the glass. We imaged the FN coating at different 
concentrations using Cy-5-labeled FN. At higher concentrations, the Cy-5 FN signal was evenly 
distributed across the glass. However, at lower concentrations, labeled FN puncta were 
distributed far enough apart to accurately count them (Fig. 5.10B). Therefore, by imaging glass 
coated with 10-fold dilutions of unlabeled FN supplemented with 10-4 µg/mL Cy-5 FN, we were 
able to count individual FN puncta on the glass across a range of coating concentrations. 
Importantly, we found that in the range of concentrations tested, the concentration of bound FN 
on the glass scaled linearly with the solution concentration used for coating. Furthermore, we 
determined that at a 10-3 µg/mL FN coating concentration (the lowest concentration at which a 
cell will form a stable Tiam-induced protrusion) an induced protrusion will encounter less than 
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10 FN puncta on average (Fig.5.4C and Fig. 5.10B). At 10-4 µg/mL (the first concentration at 
which ruffles form) induced protrusions will encounter less than 1 FN puncta. 
Integrin binding and myosin contractility are necessary for stable Tiam induced 
protrusions and directed migration. Integrins are the primary FN receptors on cells; specifically, 
β1, β3, and β5 containing integrins. To ensure that the Tiam induced protrusion stability, 
provided by FN, was due to interactions with integrins, we took advantage of the integrin 
inhibitor, cilengitide (an inhibitor specific for αvβ3, αvβ5 and α5β1 integrins). In contrast to 
untreated cells, Tiam-Micro/iLID-CAAX expressing fibroblasts plated on 10-3 µg/mL FN coated 
glass and treated with 10 µM cilengitide consistently ruffled within the activated ROI (Fig. 5.5A). 
Since we previously found that stable lamellipodia were necessary for Tiam-induced phototaxis, 
we tested if cilengitide affected phototaxis in these cells. We found that Tiam-Micro/iLID-CAAX 
expressing cells on 10 µg/mL FN treated with 10 µM cilengitide were unable to migrate 
directionally while DMSO treated control cells had a biased migration towards the more intense 
light (Fig. 5.5B). Importantly, treated cells had a similar velocity to control cells. 
The full cascade of integrin signaling is not only dependent on ligand binding but also on 
tension across the molecule produced by actin-myosin contractility (24). We therefore tested the 
role of actin-myosin contractility in stabilizing Tiam-induced protrusions by directly inhibiting 
myosin with blebbistatin and indirect inhibition with the ROCK inhibitor Y-27632. As expected, 
upon treatment with either inhibitor, cells had an enlarged footprint, formed large lamellipodia 
and had elongated “tails” at the rear of the cell. However, we found that with both inhibitors the 
cells predominantly ruffled within the activated ROIs when plated on 10-3 µg/mL FN (Fig. 5.5C). 
Since all previous conditions which inhibited Tiam-induced stable protrusion also inhibited 
phototaxis, we hypothesized that the inhibition of myosin contractility would also inhibit 
phototaxis. In these experiments, we were limited to the use of Y-27632 since blebbistatin is 
rendered inactive by blue light (25). We found that on 10 µg/mL FN with Y-27632, cells migrated 
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randomly while cells in control conditions migrated directionally (Fig. 5.5D). As previously 
observed, Y-27632 increased cell velocity. Taken together, these data suggest that specific 
integrin adhesions and myosin contractility are necessary for a Tiam induced lamellipodia 
stability and phototactic fidelity.  
ITSN induces protrusions in the absence of FN yet requires integrin binding and myosin 
contractility. While Tiam-induced phototaxis and protrusion required a FN substrate, ITSN 
phototaxis did not. To extend our observations and address our second question (why FN is not 
necessary for ITSN induced phototaxis), we tested the ability of ITSN to produce stable 
lamellipodia on a 10 ug/ml FN or a 0.01% poly-LL substrate as before. Using a 12x12 µm ROI, 
we found that ITSN induced stable lamellipodia on a FN substrate with an average protrusion 
distance of about 20 µm. However, on poly-LL, lamellipodia would form up to the edge of the 
ROI and then ruffle (Fig.5.6A and B). We hypothesized that the induced lamellipodia required 
input from either the light or feedback from surface-bound FN to form a stable lamellipodium. 
We therefore extended the ROI to 12x24 µm. Under these conditions the cells produced stable 
lamellipodia that protruded equally as far as cells plated on FN (Fig. 5.6A and B).  
As previously shown, we had found that Tiam induced protrusion and phototaxis 
required an integrin / FN interaction as well as myosin contractility. Since ITSN induced 
protrusions and phototaxis did not require an exogenous FN substrate, we hypothesized that 
inhibiting integrins and myosin would not affect these processes. We first tested this by inducing 
local protrusions in the presence of cilengitide, blebbistatin and Y-27632. Contrary to our 
expectations, ITSN-micro/iLID-CAAX expressing cells plated on poly-LL produced ruffles in the 
presence of each inhibitor (Fig. 5.6C and D). When plated on 10 µg/mL FN, in the presence of 
cilengitide, the cells produced varied results; i.e. most cells ruffled but some formed stable 
protrusions. This led to an average kymograph trace that fell between protrusion and ruffling 
(Fig.5.6C). Interestingly, like cilengitide, Y-27632 only inhibited a subset of cells on 10 µg/mL FN 
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while blebbistatin induced ruffles in the majority of cells (Fig. 5.6D). We further examined our 
hypothesis by testing the ability of ITSN-Micro/iLID-CAAX expressing cells to phototax in the 
presence of cilengitide or Y-27632. We found that both compounds inhibited directional 
migration of the cells on poly-LL (Fig. 5.6E and F). These results suggest that although ITSN 
activity can induce a stable protrusion and bias directional motility in the absence of FN coated 
glass, integrin and myosin activities were still necessary. 
ITSN induces FN deposition and stabilizes lamellipodia. Clustered integrins form 
nascent adhesions that mature into focal adhesions under the tension of myosin contractility. To 
visualize these structures, we imaged Venus-Paxillin, an adhesion component, while inducing 
ITSN-based protrusions on poly-LL. To our surprise, we found that paxillin puncta formed under 
the newly induced protrusions which resembled nascent and focal adhesions (Fig. 5.7A). Since 
these structures should only be triggered by integrin-ECM engagement and no exogenous 
surface-bound FN was present, we hypothesized that ITSN stimulation was causing cells to 
locally deposit FN, thus causing integrin engagement, leading to stabilization of the protrusions. 
We reasoned that there are two possible FN sources: FN provided to the cells from the serum in 
the media or endogenously produced cellular FN. By western blot analysis we estimated that 
our media contained approximately 10 µg/mL of FN (Fig. 5.11A). We therefore depleted the FN 
from our serum by gelatin-sepharose extraction. We verified the depletion by western blot 
analysis (Fig. 5.11B). We then repeated the protrusion assays in cells expressing ITSN-
micro/iLID-CAAX grown in media containing the FN-depleted serum. We found that in this 
absence of serum FN, cells produced similar stable protrusions on substrates coated with FN or 
poly-LL (Fig. 5.11C).  
To test the possibility that cellular FN was critical for protrusion stability, we depleted the 
endogenously produced FN with two distinct siRNAs. Cells stably expressing ITSN-Micro/iLID-
CAAX were transfected with FN siRNAs as well as a nonspecific control siRNA. By western 
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blott, FN was not detectable in cells transfected with siRNA #1, while a faint band was present 
for siRNA #2 (Fig. 5.7B). Using these cells, we examined the contribution of serum FN and 
cellular FN to a cell’s ability to adhere and spread by plating cells on poly-LL in the presence 
and absence of serum (Fig. 5.11D). In the presence of serum, compared to control cells, FN 
siRNA treated cells spread to a similar extent but contained reduced FN signal by 
immunofluorescence imaging. In the absence of serum, the majority of FN siRNA treated cells 
failed to spread effectively and contained no FN immunofluorescence signal, while control cells 
were well spread and contained a punctuated FN signal. To test the effect of endogenous FN 
depletion on ITSN-induced protrusion, we repeated the induced protrusion assay (Fig. 5.7C). 
Cells transfected with control siRNA produced protrusions on both FN and poly-LL substrates as 
expected. However, cells transfected with FN siRNA #1 efficiently protruded on FN substrate 
but formed ruffles on poly-LL. Cells transfected with FN siRNA #2 (with incomplete knockdown) 
produced stable protrusions on a FN substrate and a mix of protrusion and ruffling on poly-LL.  
The FN depletion data suggest that, in response to ITSN translocation, the cell’s 
protrusions are stabilized by the deposition of cellular FN. To directly investigate this, we 
transfected cells with a construct encoding FN fused to YPet and induced ITSN or Tiam-based 
protrusions on a FN substrate. In a number of cells (but not all cells), we visualized YPET-FN 
puncta forming under newly induced ITSN protrusions (Fig. 5.7D and E). These puncta were 
absent from all but one Tiam induced protrusion. Since we previously found that only a small 
number of FN molecules were necessary to stabilize a protrusion we suspect that the FN 
deposition in the other cells was endogenous (unlabeled) or under our detection limit.  
We further investigated cellular FN’s role in ITSN induced directed migration on poly-LL 
using the FN-depleted cells. ITSN-Micro/iLID-CAAX expressing cells transfected with control 
siRNA or FN siRNA #1 were plated on poly-LL coated dishes and subjected to the phototaxis 
assay. We found that control siRNA transfected cells migrated with a directional bias while FN 
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siRNA cells migrated randomly (Fig. 5.7F). Taken together, these data suggest that activation of 
Cdc42 with the ITSN DH/PH induces cellular FN deposition, which stabilizes protrusion and 
leads to biased directional migration in the light gradient phototaxis experiment.  
The nucleation promoting factor (NPF), N-WASP has been shown enhance exocytic 
efficiency by inducing Arp2/3 dependent actin polymerization at the site of the exocytic event 
(26). N-WASP is a direct effector of Cdc42. We therefore knocked down N-WASP expression by 
RNAi and tested the ability of ITSN-Micro localization to induce protrusions on FN and poly-LL 
(Fig.5.7G). Compared to cells expressing a non-specific shRNA control, the N-WASP shRNA 
expressing cells ruffled when plated on poly-LL (Fig.5.7H). However, on FN the N-WASP knock 
down cells maintained their ability to efficiently protrude. These data support the hypothesis that 
localized Cdc42 activity induces exocytosis of FN through N-WASP, supporting efficient 
lamellipodial protrusion and directed migration.  
5.4 Discussion  
In this work, we have utilized an optogenetic approach to investigate specific roles of 
Rac and Cdc42 signaling in fibroblast directed migration. We found that local control of Rac and 
Cdc42 activity induced protrusions sufficient to drive directed whole cell migration. The stability 
of these protrusions was highly dependent on a small number integrin-fibronectin interactions. 
Furthermore, our findings suggest that activation of Cdc42 elicits deposition of fibronectin that is 
sufficient to support stable protrusion and directed migration while Rac activation does not.  
Cellular optogenetics provided us with a unique tool in this study, empowering our 
experimental design to answer novel questions about the role of well-studied GTPases. Here, 
by optogenetically targeting multiple endogenous GTPases, we linked their specific activity to 
differences in protrusion and directed migration. Furthermore, spatial and temporal control of 
their activity allowed us to investigate the contributions of adhesion to individual protrusions, 
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thus revealing critical, but unappreciated aspects of GTPase function during migration. Our 
phototaxis experiment using the gradient of light allowed us to place these results in the context 
of whole cell migration. The ability to precisely control protein activity in space and time with 
optogenetics will undoubtedly provide many novel biological insights in future studies, without 
the confounding problems associated with genetic approaches. 
Our findings demonstrate that both Rac and Cdc42 activities, through Arp2/3-based 
protrusions, are sufficient to drive directed whole cell migration over long timescales (>12hrs). 
Consistent with previous studies, local activation of Rac produced lamellipodia protrusions that 
were dependent on the Arp2/3 complex. Somewhat more surprising was the fact that Cdc42 
activation also produced lamellipodia; likely due to cross talk between Cdc42 and Rac that was 
previously observed (12, 13). The ability of ITSN to generate filopodia in the absence of Arp2/3 
complex bolsters this argument. Regardless of the precise mechanisms by which each GTPase 
produces lamellipodia, our novel phototaxis assay shows that lamellipodia are sufficient to drive 
directional migration. We directly tested this link between GTPase driven lamellipodia and 
directed migration through the inhibition of Arp2/3 activity. In these conditions neither 
asymmetric Rac nor Cdc42 activity produced lamellipodial protrusion or directed migration, 
demonstrating the need for lamellipodia. Interestingly, ITSN induced filopodia production was 
not sufficient to drive directed migration. Future studies will be needed to dissect the possible 
role(s) of filopodia in directed migration. 
One of our most striking findings was the stark difference in Rac- and Cdc42-driven 
protrusion and directed migration in the absence of an ECM substrate. On poly-LL, localized 
Rac activity failed to produce stable lamellipodia and asymmetric Rac activation in the 
phototaxis assay did not produce directed migration. On the other hand, localized Cdc42 activity 
produced lamellipodia and led to directed migration on poly-LL. These results prompted us to 
address why differential Tiam localization (Rac activity) is insufficient to directionally bias 
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migration in the absence of a FN substrate while differential ITSN localization (Cdc42 activity) is 
sufficient independent of an ECM substrate. 
The need for FN to stabilize Rac-induced protrusions raises several interesting issues 
about the role of adhesion during protrusion. We reasoned that two possible phenomena might 
be involved in this effect: physical adhesion and integrin signaling. Due to the molecular 
interconnection between adhesion and signaling, it is difficult to experimentally decouple the two 
functions of integrins. Although more studies are needed to fully unlink signaling from adhesion, 
we postulate that induced protrusions are reinforced by integrin signaling feedback rather than 
physical stabilization. We found that Rac induced protrusions were supported by less than 10 
possible FN/integrin interactions per protrusion. We find it unlikely that this small number of 
FN/integrin interactions would be sufficient to provide physical stabilization to the newly formed 
structure. Additional support for our hypothesis comes from the inhibition of myosin contractility. 
In the presence of either blebbistatin or Y-27632, endogenous lamellipodia become 
exaggerated, possibly due to myosin no longer providing tension to retract them. We therefore 
initially hypothesized that Rac-induced protrusions would be larger in the presence of 
contractility inhibitors. To our surprise, we found the contrary; myosin inhibition caused ruffling 
upon Rac activation. These data suggest that contractility is necessary to provide tension on 
integrins to trigger the full signaling feedback and support new protrusions rather than simply 
provide a retraction force. Further experiments will be required to interrogate the nature of the 
integrin signaling required to stabilize protrusions.  
Surprisingly, we found that biased Cdc42 activity was sufficient to drive lamellipodia and 
directed migration in the absence of an exogenous FN substrate. The appearance of focal 
adhesion-like structures under ITSN-induced protrusions on poly-LL and the sensitivity of 
protrusion and directed migration to cilengitide strongly suggested that integrin signaling was 
occurring on poly-LL. Our data indicate that Cdc42 activity not only induces lamellipodia 
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protrusions, but signals to the cell to locally deposit cellular FN; which triggers this integrin 
signaling and leads to new protrusion. To our knowledge, this is the first report linking Cdc42 
activity to FN deposition. However, there is support for this notion in the literature. Cdc42 has 
well established roles in endocytosis and exocytosis in other contexts (26, 27). Furthermore, 
full-length endogenous ITSN is a known regulator of endo- and exocytosis and is thought to 
function through the Cdc42 effector, N-WASP(9, 28). N-WASP is known to enhance the 
efficiency of exocytosis through Arp2/3 nucleated actin polymerization at the exocytic cite (26). 
The DH/PH domain in our construct locally activates Cdc42 and this may activate additional 
effectors beyond those involved in protrusion that initiate FN deposition, including N-WASP. 
Indeed, Lengfeld et al. showed a link between Cdc42 and collagen (another ECM protein) 
release in vascular smooth muscle cells (29). In support of this hypothesis, we found that the 
Cdc42 effector, N-WASP, is necessary for efficient ITSN-Micro induced protrusion on poly-LL. 
However, N-WASP was not necessary for protusion on a FN substrate, reinforcing the notion of 
N-WASPs involvement in exocytosis but not lamellipodia formation. By depositing FN as the cell 
protrudes, the cell effectively lays down its own tracks to reinforce and support both protrusion 
and directed migration. This may represent a novel pathway by which cells remodel the ECM to 
produce an autonomous feedback, reinforcing directed migration. Future studies will be directed 
at delineating this pathway and how it might be used in other directed migration events. 
5.5 Materials and Methods 
Materials, reagents and cell culture - Lentiviral iLID plasmids are available from 
Addgene. pHLSec2-FN-YPet was a gift from Harold Erickson (Addgene plasmid # 65421) 
mVenus-Paxillin-22 was a gift from Michael Davidson (Addgene plasmid # 56620). Venus-
wRBD was a gift from N. Gautam. YPet-pGBD was a gift from Klaus Hahn. Fibronectin antibody 
was purchased from abcam (ab2413). Fibronectin antibody was used at 1:500 for both western 
blotting and immunofluorescence. GAPDH antibody was purchased from Ambion (Clone 6C5) 
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and used at 1:10000 dilution for western blotting. siRNAs were purchased from quiagen (FN 
siRNA #1 - SI01004066; FN siRNA #2 - SI01004080). siRNA transfection was performed using 
Lipofectamine RNAiMAX (Thermo Fischer) according to the manufacturer protocol. Lentiviral 
shRNA was used as in King et. al (4). Drugs treatments were performed with 150 µM CK666 
(millipore), 10 µM cilengitide (Selleck Chemical) and 15 µM Y-27632 (Sigma) and blebbistatin 
(Sigma). Mouse IA32 fibroblasts and conditional arpc2 MEFs were cultured in DMEM 
supplemented with 10% (v/v) FBS (HyClone), and 292 µg/mL L-glutamine. Cells were cultured 
at a constant 37 °C and 5% (v/v) CO2. Conditional arpc2 MEFs were rendered null as 
previously reported (29). Cells were transiently transfected in 6-well cell culture dishes using 1 
μg of total DNA at a 1:1:1 ratio with NanoJuice (EMD Millipore) transfection reagent, as 
recommended by the manufacturer. 
Creating stable Venus-iLID-CAAX / Tiam-RFP and ITSN-RFP cell lines - Lentivirus 
production and infection were performed as previously described (30). IA32 cells were co-
infected with the virus encoding Venus-iLID-CAAX and Tiam-RFP or ITSN-RFP. Cell 
populations were sorted based on expression by fluorescence-activated cell sorting using a Bio-
Rad S3 cell sorter.  
Western blotting - Western blotting was performed as previously described (31). 
Coating glass with substrate - Purified human plasma fibronectin (Corning 354008) was 
brought to the desired concentration in PBS. 3.5 cm Mattek Dishes were coated with 900 µl of 
fibronectin solution and incubated at 37°C for 1hr. Dishes were then washed with PBS one time 
and treated with 900 µl of 0.01% poly-L-lysine solution (Sigma) for 1 hr at 37°C.  Dishes were 
then rinsed in PBS one time and 95% ethanol one time and allowed to dry completely. All 
dishes were used within 24 hours of coating. 
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Phototaxis setup, image acquisition and analysis - To produce a gradient of blue light we 
produced a device consisting of three main pieces; a housing, a 467 nm LED light source (Thor 
Labs) and a gradient neutral density filter (Thor Labs, N.D. =0.04 to 4.0).  The housing was 
custom designed using TinkerCAD and 3D printed on a Printrbot Metal Plus printer (.stl files for 
device are available upon request). It positions the LED 3 cm above the neutral density filter. 
The neutral density filter is positioned within the housing so that the projected area starts 10 mm 
from the clear end. The LED is powered by a 9v battery in line with a 1 kohm resistor. This 
setup projects a 1x1 cm area of graded light intensity. The housing is placed over a 3.5 cm 
Mattek culture dish and fit into an OlympusVivaView FL microscope with a 20× objective and a 
motorized magnification changer set to ×1.Cells were imaged every 15 min for 20 hours. Cells 
of interest were initially imaged by fluorescence to ensure protein expression and then imaged 
every 15 min for up to 24 hours by bright field imaging. The bright field image was collected 
from the graded LED light source and was used to measure the gradient slope. The bright field 
images were then analyzed to track the cell trajectories over time using Manual Tracking 
ImageJ plugin. Trajectories are processed using the Chemotaxis tool (Ibidi) ImageJ plugin to 
quantify FMI, velocity and rose plots. Rose Plots were redrawn using the Matlab SecPlot plugin. 
Drug treatments were performed 1hr before beginning imaging.  
Immunofluorescence - Samples were fixed in a cold 4% w/v paraformaldehyde solution for 5 
minutes. If samples were permeabolized it was performed using 0.1% Triton X-100 for 5 
minutes. Samples were blocked in 10% w/v BSA in PBS for 30 minutes at room temperature. 
Primary and secondary antibodies were diluted in 1% w/v BSA in PBS and incubated with 
samples at room temp for 1 hr. Samples were mounted with Fluoromount G (Electron 
Microscopy Sciences) 
Confocal microscopy and single cell optical activation - Fixed and live cell imaging was 
performed on an Olympus FV1000 scanning confocal microscope equipped with an 
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environmental chamber. Cell images were collected using a 0.17 N.A. 40x objective or for single 
molecule fibronectin imaging a 0.17 N.A. 100x objective. Single cell activation was performed as 
described in (32). In short, the time controller software was used to create a timeline of imaging 
and activation. For all protrusion dynamics experiments, images were acquired every 10 sec 
with constant ROI illumination in between. While imaging paxillin and fibronectin, images were 
acquired every 60 seconds with activation occurring at 10 evenly spaced intervals between 
images. Drug treatments were performed 20 minutes before beginning imaging. 
Kymography analysis - Kymographs were produced from single cell activation image 
series. A kymograph was produced along a line running perpendicular to the cell edge in the 
center of the activated ROI using FIJI (ImageJ) kymography plugin. Kymographs were then 
traced in FIJI and the position of the cell edge at each time point was interpolated using 
Microsoft Excel. Protrusion data was then normalized to the initial five images before activation, 
averaged and plotted using Prism statistical software. 
FBS fibronectin depletion - 25 mL of gelatin sepharose 4B media slurry (GE) was 
pelleted and washed with PBS. 50 mL of FBS was incubated with media overnight at 4° C. 
Media was then separated from FBS by gravity flow column chromatography. The column was 
washed with 2 column volumes of PBS and the protein was eluted off the column with 8 M urea 
in PBS. Fibronectin free FBS was verified by western blot.  
Statistics - Statistics were performed using Graphpad Prism statistical software package. 
FMI and velocity values were compared by T-test or ANOVA depending on the number of 
comparisons. Kymograph statistics were performed by comparing values of the kymographs at 
100 s time intervals starting from 750s and working backward. ANOVAs were performed for 
each set of time points and a Dunnet’s post-test was performed to compare each sample to the 
control. 
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5.7 Figures 
Figure 5.1 Differential optogenetic stimulation of Rac and Cdc42 induces lamellipodia 
and directed migration on fibronectin substrate. A) Schematic diagram of optogenetic switch 
to regulate GTPases by localizing specific GEF DH/PH domains to the cell membrane. B) 
Representative fluorescent micrographs of live IA32 fibroblasts being optogenetically activated. 
Top panels show optogenetic recruitment of RFP control while the middle and bottom show 
recruitment of the TIAM and ITSN DH/PH domains over time. Right panels are kymographs 
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along the yellow line. Blue arrows denote activated areas. Image Bar = 50 µm. Kymograph bars 
= 5 µm and 250 s. C) Schematic diagram of phototaxis chamber. D) Image of light gradient 
produced by phototaxis chamber. E) Forward migration index graph for Venus-iLID-CAAX / 
Tiam-RFP fibroblasts for haptotaxis in response to light intensities at positions demonstrated in 
D. Error = 95% C.I. F) Rose plots, FMI graphs, and velocity plots representing migration vectors 
for control, TIAM, and ITSN fibroblasts. Blue triangle represents the light gradient. Error = 95%; 
C.I.; *P<0.05; B,E, and F) Cells were plated on 10 µg/mL FN. Refer to table S1 for experimental 
details. 
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Figure 5.2 Arp2/3 activity is necessary for Rac and Cdc42 induced lamellipodia and 
phototaxis. A) Representative fluorescent micrographs depicting optogenetic recruitment of 
Tiam DH/PH in ArpC2 competent and null MEFs. Blue arrows denote area of activation. 
Enlarged image depicts area of activation.  B) Rose plots, FMI graphs, and velocity plots 
representing migration vectors for TIAM fibroblasts in the presence of DMSO or 150 µM CK666. 
Blue triangle represents the light gradient C) Representative immunofluorescence images of 
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fixed fibroblasts from B. D) Fluorescent micrographs depicting optogenetic recruitment of ITSN 
DH/PH in ArpC2 competent and null MEFs. Blue arrows denote area of activation. Enlarged 
image depicts area of activation. Yellow arrowheads denote filopodia. E) Rose plots, FMI 
graphs, and velocity plots representing migration vectors for control, ITSN fibroblasts in the 
presence of DMSO or 150 µM CK666. Blue triangle represents the light gradient. F) 
Representative immunofluorescence images of fixed fibroblasts from B. All cells were plated on 
10 µg/mL FN. Scale Bars = 50 µm; Error Bars = 95% C.I.; *P<0.005; Refer to table S1 for 
experimental details. 
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Figure 5.3 Fibronectin substrate is necessary for Tiam but not ITSN induced phototaxis. 
A) Rose plots, FMI graphs, and velocity plots representing migration vectors for TIAM fibroblasts 
plated on fibronectin or poly-L-lysine. B) Rose plots, FMI graphs, and velocity plots representing 
migration vectors for TIAM fibroblasts plated on fibronectin or poly-L-lysine. Blue triangles 
represent the light gradient. Error = 95% C.I.; *P<0.005; Refer to table S1 for experimental 
details.  
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Figure 5.4 Tiam induced protrusions require single digit concentrations of FN substrate 
for stability. A) Representative fluorescent micrographs depicting optogenetic recruitment of 
Tiam DH/PH to a ROI in a fibroblast plated on 10 µg/mL FN or poly-L-lysine. Right panels are 
kymographs along the yellow line. Blue arrows denote activated areas. Image Bar = 50 µm. 
Kymograph bars = 5 µm and 250 s. B) Average kymographs for Tiam DH/PH induced 
protrusions on the denoted concentration of FN back filled with Poly-L-lysine. C) Relationship 
between fibronectin coating concentrations and fibronectin substrate concentrations. Right axis 
denotes concentrations as the number of FN puncta that the average protrusion would contact 
before retracting as a ruffle. *P<0.05; Refer to table S2 for experimental details.  
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Figure 5.5 Tiam induced lamellipodia require active integrin and myosin. A) Average 
kymographs for Tiam DH/PH induced protrusions on the denoted concentration of FN back filled 
with Poly-L-lysine. cilengitide was used to treat cells at 10 µM. B) Rose plots, FMI graphs, and 
velocity plots representing migration vectors for TIAM fibroblasts plated on fibronectin and mock 
treated or treated with 10 µM cilengitide. C) Average kymographs for Tiam DH/PH induced 
protrusions on the denoted concentration of FN back filled with Poly-L-lysine. Y-27632 and 
blebbistatin was used to treat cells at 15 µM D) Rose plots, FMI graphs, and velocity plots 
representing migration vectors for TIAM fibroblasts plated on fibronectin and mock treated or 
treated with 15 µM Y-27632. Error bars = 95% C.I.; *P<0.05; **P<0.005; Refer to table S1 and 
S2 for experimental details.  
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Figure 5.6 Integrin and myosin activity are necessary for ITSN induced lamellipodia and 
phototaxis while a FN substrate is not. A) Representative fluorescent micrographs depicting 
optogenetic recruitment of ITSN DH/PH to a ROI in a fibroblast plated on 10 µg/mL FN or poly-
L-lysine. The size of the ROI was modified as indicated so that the long axis of the ROI is 
perpendicular to the cell edge. Right panels are kymographs along the yellow line. White boxes 
denote activated ROIs. Image Bar = 50 µm. Kymograph bars = 5 µm and 250 s. B) Average 
kymographs for ITSN DH/PH induced protrusions on the denoted concentration of FN back filled 
with Poly-L-lysine. The size of the ROI was modified as indicated so that the long axis of the 
ROI is perpendicular to the cell edge. C) Average kymographs for ITSN DH/PH induced 
protrusions on the denoted concentration of FN back filled with Poly-L-lysine. cilengitide was 
used to treat cells at 10 µM. D) Average kymographs for ITSN DH/PH induced protrusions on 
the denoted concentration of FN back filled with Poly-L-lysine. Y-27632 and blebbistatin was 
used to treat cells at 15 µM. E) Rose plots, FMI graphs, and velocity plots representing 
migration vectors for ITSN fibroblasts plated on poly-L-lysine and mock treated or treated with 
10 µM cilengitide. F) Rose plots, FMI graphs, and velocity plots representing migration vectors 
for ITSN fibroblasts plated on Poly-L-lysine and mock treated or treated with 15 µM Y-27632. 
Error bars = 95% C.I.; *P<0.05; *P<0.005 Refer to table S1 and S2 for experimental details. 
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Figure 5.7 ITSN recruitment stimulates cellular FN deposition to stabilize lamellipodia. A) 
Representative fluorescent micrographs depicting optogenetic recruitment of ITSN DH/PH in a 
fibroblast co-expressing Venus-Paxillin and Halo-iLID-CAAX. Dotted white box in top panel 
represents enlarged area displayed in bottom panels. Blue arrow denotes area of activation. B) 
Representative western blot analysis of cells treated with FN siRNA. C) Average kymographs 
for ITSN DH/PH induced protrusions on FN or Poly-L-lysine in fibroblasts treated with the 
denoted siRNA. D) Representative fluorescent micrographs depicting optogenetic recruitment of 
ITSN DH/PH in a fibroblast co-expressing YPET-FN and Halo-iLID-CAAX. Dotted white box in 
top panel represents enlarged area displayed in bottom panels. Blue arrow denotes area of 
activation. Purple line represents the cell edge. Purple arrows demark deposited YPET-FN. E) 
Box and whisker plot of the number of YPet-FN puncta counted under each induce protrusion. 
F) Rose plots, FMI graphs, and velocity plots representing migration vectors for ITSN fibroblasts 
plated on poly-LL and treated with the denoted siRNA. G) Representative western blot of cells 
treated with the denoted shRNA. H) Average kymographs for ITSN DH/PH induced protrusions 
on FN or Poly-L-lysine in fibroblasts treated with the denoted shRNA. Scale Bars = 50 µm; Error 
Bars = 95% C.I.; *P<0.05; Refer to table S1 and S2 for experimental details. 
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Figure 5.8 Biosensor imaging during activation. A) Representative images of GTPase 
biomarker localization during Tiam-Micro activation. B)Graph of biomarker fluorescence 
intensities at the region of interest before, during and after Tiam-Micro excitation. C) 
Representative images of GTPase biomarker localization during ITSN-Micro activation. B)Graph 
of biomarker fluorescence intensities at the region of interest before, during and after ITSN-
Micro excitation. Bar = 50 µm.  
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Figure 5.9 Details of phototaxis A) Picture of phototaxis chamber B) Graph of light gradient 
slope produced by the phototaxis chamber. Graph was produced from image line scans C) 
Representative image produced by phototaxis chamber D) Schematic diagram showing FMI 
calculation of a cell during migration. E) FMI graph representing migration vectors for TIAM 
fibroblasts with low and hi expression of Venus-iLID-CAAX and TIAM-RFP. 
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Figure 5.10 Fibronectin coatings and cellular fibronectin. A) Representative micrographs of 
FN on a glass substrate. Glass was first pre-treated with the designated solution then incubated 
overnight with FBS containing media or PBS and stained for FN. Bar = 10 B) Representative 
micrographs of CY-5 FN coated glass. Bar = 20 C) Representative micrographs of cells plated 
on Poly-L-Lysine and stained for intracellular and extracellular FN.  
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Figure 5.11 Serum fibronectin does not affect lamellipodia protrusion A) Western blot 
analysis of media FN content. B) Western blot and coomasie analysis of FN depletion form FBS 
C) Average kymographs for ITSN DH/PH induced protrusions on FN or Poly-L-lysine in cells 
grown in FN depleted media. D) Representative micrographs of siRNA treated fibroblasts 
stained for FN grown in the presence and absence of serum. 
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5.8 Supporting Information 
Table 5.1. Phototaxis Experiments 
Figure condition # of 
experiments 
n Mean 
FMI 
V 
(µm/hr) 
1E PosA 2 61 0.02393 11.07 
  PosB 2 60 0.08433 10.9 
  PosC 2 64 0.2122 10.35 
  PosD 2 51 0.08627 12.76 
  PosE 2 58 -0.02017 12.45 
1F RFP 2 147 -0.01959 12.57 
  TIAM 2 89 0.1607 14.18 
  ITSN 2 83 0.09675 9.557 
2B Tiam+DMSO 2 154 0.108 21.18 
  Tiam+Ck666 2 153 0.01216 20.36 
2E ITSN+DMSO 2 177 0.1532 14.03 
  ITSN+CK666 2 161 0.02522 13.43 
3A Tiam+FN 2 172 0.1191 17.3 
  Tiam+PolyLL 2 213 -0.007887 20.59 
3B ITSN+FN 2 156 0.1328 13.94 
  ITSN+PolyLL 2 147 0.09197 19.65 
6E ITSN PolyLL Control 2 96 0.09719 15.64 
  ITSN PolyLL Cilengitide 2 80 0.0255 14.03 
6F ITSN PolyLL Control 2 135 0.1262 14.27 
  ITSN PolyLL Y-27632 2 95 -0.006211 18.88 
7E ITSN PolyLL siCtrl 2 104 0.1061 10.56 
  ITSN PolyLL si1 2 180 0.004389 11.25 
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Table 5.2. Protrusion Experiments 
Figure Condition # of 
experiments 
n 
4B Tiam 101 FN 3 7 
  Tiam 1 FN 2 8 
  Tiam 10-1 FN 2 8 
  Tiam 10-2 FN 2 8 
  Tiam 10-3 FN 3 11 
  Tiam 10-4 FN 3 11 
  Tiam 10-5 FN 2 6 
  Tiam 0 FN 3 15 
5A Tiam 10-3 FN + Cilengitide 2 7 
5C Tiam 10-3 FN + Blebbistatin 2 5 
  Tiam 10-3 FN + Y-27632 2 11 
6B ITSN 10 FN + 12x12 3 9 
  ITSN 0 FN + 12x12 5 24 
  ITSN 0 FN + 12x24 2 8 
6C ITSN 10 FN + Cilengitide 2 6 
  ITSN 0 FN + Cilengitide 2 8 
6D ITSN 10 FN + Blebbistatin 2 9 
  ITSN 0 FN + Blebbistatin 2 6 
  ITSN 10 FN + Y-27632 2 6 
  ITSN 0 FN + Y-27632 2 6 
7C ITSN Ctrl FN 2 7 
  ITSN Ctrl PolyLL 2 9 
  ITSN si1 FN 2 9 
  ITSN si1 PolyLL 2 8 
  ITSN si2 FN 2 8 
  ITSN si2 PolyLL 2 9 
7H ITSN shNS-PolyLL 2 8 
 ITSN-shN-WASP FN 2 10 
 ITSN-shN-WASP Poly  10 
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CHAPTER 6: CONCLUSIONS AND FINAL THOUGHTS 
Cells are good. 
Cells are great. 
In many ways, 
they determine our fate. 
Here with light, 
the roles are swapped. 
Those damned little cells, 
have now been topped. 
Under our control, 
they do our bidding. 
We tell them what to do 
and where to go, no kidding. 
I think this means destiny 
is now in the hands of men. 
Or is it what came first 
the egg or the hen? 
 
6.1 The need for many generalized optogenetic systems. 
As discussed throughout this thesis, many optogenetic tools have been developed and 
new tools and iterations are being released at an increasing rate. Initially, many of the tools 
targeted specific biochemical pathways. In recent years, generalizable systems, including light 
inducible dimers like iLID, have been developed. I believe it is these generalized systems will 
usher in broad adoption of optogenetics by cell biologists. Many of the generalized tools are one 
or two component systems that allow for modular plug and play like functionality; analogous to 
the fluorescent protein revolution. While these systems have some overlapping function, each 
provides its own benefits and limitations. In designing the suite of iLID switches, we have tried to 
address some of these limitations. For example, the three SspB variants provide users with a 
range of affinities with which to target their proteins of interest, while variations of iLID provide 
temporal tuning. We have also provided users with an in vitro and in vivo characterization to 
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help guide the user in the application of iLID. With that said, iLID still has its limitations and the 
needs of some user’s applications may be better met by a different system. This is one reason 
why we performed benchmarking studies discussed in chapter 4. Therefore, I believe that a 
broad range of well characterized, general optogenetic systems will lead to a broad adoption of 
optogenetics in general. 
6.2 Limitations of cellular optogenetics and ideas for overcoming them. 
Even with perfect optogenetic proteins, the technique has many technical limitations. 
The wavelengths of light used to excite most optogenetic switches pairs well with the light 
sources used on many widely available fluorescence microscopes. While this provides users 
with a straightforward method of activation, the wavelengths also limit the means of observation. 
Most out-of-the box microscopes are equipped with the light sources and filters necessary for 
green, red and sometimes far red or UV imaging. This means that for a single component 
optogenetic system, one channel (usually the 488 nm line or green or green channel) is used for 
activation, leaving red and far-red or UV for imaging. Unfortunately, many optogenetic proteins 
are also activated by UV light and therefore cannot be used for imaging. Furthermore, until 
recently, far-red fluorescent proteins were rare and had poor characteristics for live cell imaging. 
This means that with a standard microscopy set-up, activation of the optogenetic switch would 
be performed with the green channel, leaving only the red channel for imaging the switch. 
However, this would limit the experiments that could be performed as you would not be able to 
image the effects of your switch by imaging a second fluorescent protein. The issue further 
compounded when using more common two-component optogenetic switches where it is useful 
to image both components simultaneously. In many labs where optogenetics is commonly used 
this issue is circumvented by using microscopes equipped with specialized filters and light 
sources that provide simultaneous activation with 488 nm light sources (blue light, green 
channel), and imaging with 514, 559 and 640 nm light (yellow, red, and far-red channels 
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respectively). This setup allows for activation, imaging of a two-component switch, and imaging 
of a third fluorescent molecule. However, this technical hurtle hinders the broad adoption of 
cellular optogenetics. 
One solution is to not image your optogenetic components which frees up an imaging 
channel for use with another protein. I have found several ways to accomplish this while 
ensuring expression of the switch. One simple way is to genetically couple your switch to a drug 
selectable marker for ubiquitous and stable expression. One issue I have found is that the 
optogenetic components become epigenetically silenced while the drug selectable marker is still 
expressed. A second option is to fuse your optogenetic component to a tag like Halo or Snap. 
These tags provide a means for in-cell dye conjugation. Using this method, cells can be 
temporarily fluorescently labeled for selection by flow cytometry. For two component systems, 
both components can be genetically linked by a 2a peptide or a IRES sequence. One 
component can be fused to a fluorescent protein. Thereby, cells can be sorted by flow 
cytometry, ensuring expression of both components. 
Recently, far-red and infrared fluorescent proteins have begun to show some promise. 
These would provide a means for a third protein of interest to be imaged in addition to a yellow 
and red fluorescent protein. Many of these fluorescent proteins require cofactors that need to be 
exogenously supplied which may limit some applications.  
Another technological limitation of optogenetics is efficiency. Most cellular optogenetic 
experiments are single cell microscopy experiments. These conditions restrict the bandwidth of 
data collection as in most cases only one cell can be imaged and activated at a time. Before 
digital microscopy, this was often an issue for live cell imaging in general. However, new 
technologies such as coded stages, allowed for imaging multiple cells through time by precisely 
cycling through a series of pre-set stage and objective positions for each time point. With 
optogenetics this is difficult to accomplish since the activating light source needs to be 
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continuously applied to each activated region and is often the same as the imaging light source. 
One way around this is to decouple the activating and imaging light source. We have 
accomplished this to some extent in our phototaxis experiments discussed in the previous 
chapter. Ideally the activating light source would be completely decoupled and provide point 
illumination to multiple regions of the sample at one time. This seems like a difficult proposition 
but not impossible. In addition, the software packages that are included with many out-of-the-
box microscopes do not include an automated or easy solution for repetitive illumination. This 
could be easily solved but would require a strong petition from the field for microscope 
companies to meet these needs. 
6.3 The future of optogenetics in studying directed migration. 
Many of the optogenetic tools that are already available target pathways involved in 
directional migration. These tools are ready for application. I believe that many of them are also 
compatible with the phototaxis setup and activation methods discussed in chapter 5. Like in 
chapter 5, this system can be used to directly probe the contribution of individual signaling 
pathways in directional migration. For example, the precise spatial patterning of Rho activity 
during directional migration is still a point of contention in the field. Many tools are now available 
to control the activity of this molecule. In addition, it is quickly becoming apparent that calcium 
signaling is a main regulator of directional migration. There is a strong temporal component to 
calcium signaling which could be easily probed using available optogenetic proteins. Overall, it 
seems like the technique stands poised and ready for broad adoption by the field.  
6.4 The future of cellular optogenetics. 
To engineer an optogenetic system, one must have significant knowledge of the 
pathway which they are targeting. This produces two challenges which I think will guide the 
future of optogenetics. First, a lack of human knowledge limits the pathways that can be 
successfully targeted. Second, it is difficult to ask novel and significant questions about a 
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pathway that has already been studied to the extent that is required for the design in the first 
place. The first challenge will be addressed with time. The second is more inspiring and the 
solutions will determine how prevalent the technique becomes in cell biology. I can offer a few 
recommendations. 
One recommendation is to study the pathway in a new context. For example, many 
biochemical pathways have been studied in vitro. The spatial, temporal, and dosage control that 
optogenetics provides may help translate some in vitro finding to in vivo. A second suggestion is 
to take advantage of the temporal component of optogenetics. This is a unique and powerful 
aspect of the technique and the kinetics of many biological processes have not been studied in 
vivo. The temporal aspect of optogenetics may also be helpful in studying the many chicken/egg 
feedback loops that permeate biology. Control over individual components of a pathway will also 
aid in studying crosstalk of signaling nodes. Lastly, many pathways have been studied in the 
context of tissue culture. Using optogenetics in the physiological context of a whole organism 
would provide precise control of spatial and temporal aspects of biology such as developmental 
cell lineages and cancer development. Lastly, the equipment and expertise developed for 
neuro-optogenetics is robust and there does not seem to be much open communication 
between the fields. This may be an untapped goldmine for cellular optogenetics.
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